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Report Background
Support and Training for the Evaluation of Programs (STEPs) at the University of Nebraska at
Omaha is a leader in conducting evaluations of and needs assessments for social service
programs and policies. The Nebraska Department of Health and Human Services (DHHS) Drug
Overdose Prevention (DOP) program contracted with STEPs in the fall of 2019 to complete a
needs assessment that included an identification and analysis of quality datasets, a survey of
outpatient treatment providers, and focus groups with treatment providers.

STEPs wishes to acknowledge the contributions of many organizations and
professionals in the preparation of this report:
• The DOP staff, especially Davidson Wissing
• The Department of Behavioral Health data team
• The Nebraska Hospital Association
• The many survey and interview participants
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INTRODUCTION

Purpose Statements
STEPs collaborated with the NE DHHS Drug Overdose Prevention (DOP) program to prepare a
purpose statement for the overall project, as well as each of its contained sub-projects.
The purpose of this needs assessment is to deepen DOP’s understanding of
individuals’ drug use behaviors in Nebraska through the lens of treatment
providers.
The results of this study will aid DOP in providing training and other resources to
treatment centers, focusing prevention efforts, and informing their strategic plan
and future studies. Ultimately, this study will support DOP’s efforts to reduce
opioid-involved fatal and non-fatal overdoses in Nebraska.

Report

Purpose

Survey Report

The purposes of the survey of treatment providers are to discover
current patterns in clients’ drug use behaviors, and the unique needs of
both substance users and treatment providers in the state of Nebraska.

Dataset Report

The purpose of the dataset analysis is to provide data on who is
receiving treatment, who is referring people to treatment, and people’s
age at first use. The current report includes analysis of quality datasets
that can be useful now and in future evaluations.

Interview Report

The purpose of the qualitative component of the Drug Use Behaviors
project was to provide NE DHHS with rich and in-depth information
regarding the professional experiences and needs of drug treatment
providers in Nebraska. Through the perspectives and insights of drug
treatment providers, NE DHHS can better understand the experiences
and needs of people with substance use disorders in Nebraska.

Final Report

The purpose of the final report is to integrate the results of evaluation
activities to provide a comprehensive summary, including
recommendations for next steps in the study of individuals’ drug use
behaviors in Nebraska.
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INTRODUCTION

Orientation to This Report
This Drug Use Behaviors: Final Report provides a comprehensive summary of the results of
three individual reports: a survey report, dataset report, and interview report; it offers overall
recommendations. Each of these reports, whether they represent primary or secondary data,
quantitative or qualitative methods, can inform NE DHHS’ Drug Overdose Prevention (DOP)
program in a unique way. Brought together, this use of multiple methods lends validity to the
overall findings and recommendations.1
Primary Data
Primary data is collected directly from study participants by members of the research team to
address a specific question or hypothesis. Primary data collection is often time consuming and
expensive,2 especially with the challenge of achieving large and representative samples.

As shown in the table below, the survey and interview reports represent primary data, as
STEPs prepared the procedures and questions specifically for this project and collected data
from treatment providers in Nebraska.

Survey Report
Dataset Report
Interview Report

Primary
Data
√

Secondary
Data

Qualitative
Methods
(√)

√
√

Quantitative
Methods
√
√

√

Important note: Substance use treatment providers include social
workers, counselors, and case managers who provide therapy, crisis
counseling, and case management and make referrals to medical providers
for physical health needs. (Click this text box to navigate to a comparison between
substance use treatment providers and medical providers.)

Secondary Data
Secondary data is often publicly available and may be collected routinely through large ongoing
surveillance systems.3 Since secondary data typically has a large sample size, it is likely more
generalizable to an overall population. However, since secondary data was collected for other
reasons and under other conditions than the current study, the data collection cannot be
tailored to the current study. Also, data may be masked to protect confidentiality, which impacts
usefulness for a rural state like Nebraska.

Secondary data utilized in the dataset report came from 3,330 inpatient and 7,712 emergency
department discharges from 2016 to 2019, as collected by the Nebraska Hospital Association; and
from 53,605 discharges from substance use treatment facilities in Nebraska from 2013 to 2017, as
collected in the Treatment Episodes Database-Discharge system. STEPs located, cleaned, and
analyzed the data for the purposes of this project, but did not design the items nor collect the data.
(STEPs also worked with the NE DHHS Division of Behavioral Health Data Team to receive data
from the Nebraska Risk and Protective Factor Student Survey from 2010 to 2018.)
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INTRODUCTION

Orientation to This Report (cont.)
Qualitative Methods
Another important consideration in reading this report is the differentiation between
quantitative and qualitative research methods. Qualitative research methods provide insight
into the perceptions, values, and opinions of a target audience, with data typically collected
through interviews and focus groups. This kind of open-ended inquiry method is essential for
exploring phenomena that do not fit neatly into predefined categories and offers voice to
participants. Qualitative data can provide a rich source of insight and is often bulky and time
consuming to code and analyze.4
The interview report represents qualitative methods like the survey report’s open-ended items.
For both the survey and interview projects, STEPs worked with NE DHHS to develop openended questions and posed them to treatment providers. In this way, participants could openly
share their perceptions and experiences in providing substance use treatment.
Quantitative Research
Quantitative research, in contrast, captures numerical data that can be statistically analyzed.
Ideally, the sample size is large enough to allow results to be more reliably generalized to an
overall population. By design, quantitative data is consistent and precise, but it may be fraught
with challenges related to instrumentation, response rates, and sampling.5
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COMPREHENSIVE SUMMARY

Comprehensive Summary
This final report includes individual reports in entirety, including key findings, methodology,
results, and recommendations. (Click on the symbol to navigate to that section.)
Report
Survey report

Key Findings

Recommendations

Dataset report
Interview report

The results of the survey, dataset, and interview reports are summarized here in response to
six research questions:
1. What are the characteristics and needs of individuals receiving substance use
treatment in Nebraska?
2. What are current trends in substance use in Nebraska?
3. What are current trends and needs in substance abuse treatment in Nebraska?
4. What is needed for prevention of substance use and overdose in Nebraska?
5. What are expressed issues/needs specific to NE DHHS?
6. What are possible next steps for research and evaluation in Nebraska?

1. What are the characteristics and needs of individuals receiving substance use
treatment in Nebraska?
Across all report data sources, the majority of individuals
Individuals receiving
receiving substance use treatment in Nebraska initiate
treatment in their 30s and
substance use at age 18 or younger. In survey results, just
40s typically initiated
over half of providers indicated most of their clients first
substance use before age 18.
misused a substance at age 14 or younger with the
overwhelming majority of providers indicating first use at the age of 18 years or younger.
Similarly, in the Treatment Episodes Discharge Dataset (TEDS-D) data, one-third of clients
reported the first use of their primary substance at age 14 or younger and two-thirds of clients
reported the first use of their primary substance at age 17 or younger.
While Nebraska Risk and Protective Factor Student Survey (NRPFSS) data suggests a relatively
small percentage of youth reporting substance use, the percentage of those who reported using
a substance in their lifetime increased as the students’ grade level increased. This suggests a
need for primary prevention efforts targeting youth.
6
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Comprehensive Summary (cont.)
While clients may have first used substances at a young age, the majority of those receiving
treatment are older. According to Nebraska Hospital Association (NHA) data, the average age of
inpatient patients with a diagnosis related to a substance was 41 years (median of 39) and the
average age of emergency department patient with diagnoses related to a substance was 34
(median of 31). Similarly, TEDS-D data indicates most clients were between the ages of 21 and
49 years in 2013 to 2017.
According to NRPFSS and NHA data, males and females tended to use substances at similar
rates. However, according to the TEDS-D data, most clients receiving treatment identified as
male. The gender gap between those using and those receiving treatment may be explained in
part by interview responses indicating women disproportionately experience financial and
childcare barriers to treatment.
The American Community Survey’s 2018 5-year race estimates for Nebraska found 5% of
Nebraskans identified as Black or African American. However, according to TEDS-D, 9% of
those in treatment for substance use identified as Black or African American. Similarly, 1% of
Nebraskans identified as American Indian or Alaska Native but accounted for 8% of those in
treatment as per TEDS-D data. These trends, along with NRPFSS findings that suggest a higher
percentage of Alaska Native and American Indian youth report substance use, indicate a
disproportionate impact on these communities.
Participants in the treatment provider interviews primarily defined the typical client by shared
experiences, rather than demographic characteristics. Almost all of the participants explicitly
identified a trauma history as something that all or most of their clients have in common. Most
participants identified childhood trauma and several participants specified complex trauma,
which refers to trauma that is chronic and long-term.

1.

2. What are current trends in substance use in Nebraska?

Depressants, including alcohol, are a primary concern Use of alcohol, methamphetamines,
in Nebraska. Outpatient providers indicated in their
and drug combinations are the
survey responses that over half of their clients
biggest concerns in Nebraska.
presented for treatment related to alcohol, followed by Opioid misuse is growing.
marijuana and methamphetamines; TEDS-D data
validates this. Analysis of NHA data showed the most common substances related to emergency
department and inpatient treatment diagnoses were depressants, stimulants, and narcotics.
NHA data indicated 4% of inpatient and 11% of emergency department patients with
substance-related diagnoses were associated with cannabis and cannabis derivatives. (Data on
alcohol was not requested.) In the interviews, providers confirmed that while a growing
number of individuals seek treatment for opioids, a much higher number of individuals seek
treatment for methamphetamines, alcohol, and drug combinations.
7
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Comprehensive Summary (cont.)
Providers indicated in their survey responses that about 25% of their clients in the past year
had an opioid use disorder. Similarly, the NHA discharge data showed that 25% of inpatient
patients and 21% of emergency room patients with substance-related diagnoses had diagnoses
related to narcotics. In contrast, TEDS-D data from 2013 to 2017, showed that 4-5% of clients
each year reported opioids as their primary substance. Participants interviewed in 2020 spoke
of opioid abuse as a growing problem in Nebraska, which may account in part for this
difference in primary and secondary data sources.
According to the NRPFSS, youth in Nebraska were more likely to report using prescription
drugs at least once in their lifetime than any other substance; inhalants were the second most
reported substance used.
Based on NHA and census data, Region 6 had a higher percentage of discharged patients (both
inpatient and emergency room) with substance use disorders than expected based on
population. Regions 3 and 4 had higher rates of stimulants related to inpatient treatment
diagnosis compared to other regions where depressants are more common. Treatment
providers did not indicate unique trends or needs for particular regions, although prevention
services and treatment delivery methods need to be adapted to overcome geographic barriers.

1.

3. What are current trends and needs in substance abuse treatment in Nebraska?

Survey respondents indicated many of their clients were
Criminal justice makes a high
prompted to receive treatment through court-related
proportion of treatment
incidents more than any other catalyst. Similarly, TEDS-D
referrals for individuals.
2017 data showed that 54% of patients were referred from
courts, criminal justice entities, and DUI/DWIs. Of criminal justice referrals, the greatest
percentage (27%) of criminal justice referrals came from law enforcement.
On average, providers indicated in survey responses that this was the first treatment
experience for 33% of their clients. 2017 TEDS-D data showed that twice as many clients
(62%) had no prior treatment episodes, which had increased from 44% in 2013.
Interview participants discussed significant barriers to individuals’ ability to access substance
abuse treatment, especially higher levels of care such as inpatient and residential treatment. In
their survey responses, providers identified many systemic barriers to treatment and called for
policy and funding changes to improve individuals’ ability to access needed treatment.
Barriers to accessing treatment are not evenly distributed across populations. Clients who are
already vulnerable or marginalized often experience more barriers and experience them more
intensely. For example, some participants identified that women need residential treatment
options that allow them to be with their children. Interviewees identified finances as an
8
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Comprehensive Summary (cont.)
especially high burden for women seeking treatment. Women and vulnerable populations
They also discussed specific barriers to accessing
experience significant barriers to
treatment for clients who are undocumented,
substance abuse treatment and
experiencing homelessness, or are currently or were
have unique treatment needs.
previously incarcerated. Barriers for vulnerable or
marginalized populations are often unique and especially burdensome.
Interview participants explained that clients also need access to housing, healthcare, and
employment for substance abuse treatment to be effective. They indicated that wraparound
services would increase both access to and effectiveness of treatment.
While the survey results show that 75% of outpatient providers reported referring for some
type of medication assisted treatment (MAT) for alcohol or opioid substance use disorder,
TEDS-D data from 2013 to 2017 in Nebraska show that 2⎼5% of clients received planned MAT
treatment for opioid substance use disorder. This discrepancy is rectified in part as providers
shared in interviews a newer trend towards harm reduction and MAT approaches.
In their survey responses, treatment providers indicated their interest in training in these
areas: co-occurring disorders, trauma-informed care, evidence-based practices, and drug use
trends. In interviews, treatment providers expressed the need for training related to reducing
overprescribing for prescribers; promoting safe use, raising awareness, and reducing stigma
for communities; and naloxone access for treatment providers.

1.

4. What is needed for prevention of substance use and overdose in Nebraska?

All data sources for this report indicated primary prevention
strategies aimed at middle and high school students, rather than
other populations, are the most needed.

Prevention strategies
aimed at middle and high
school students are
especially important.

Responses to the survey and interviews clearly showed that
treatment providers do not understand what NE DHHS is doing to prevent drug overdoses.
Survey responses also showed that providers view NE DHHS’ public service announcements as
the least helpful of all prevention tools. Treatment providers also do not view the Prescription
Drug Monitoring Program (PDMP) to be as helpful as other potential strategies (perhaps, in
part, because they are not prescribers and do not have reason to access or use PDMP).
Providers indicated their belief that substance abuse treatment plays a significant role in
overdose prevention. In interviews, participants discussed getting clients into treatment
immediately after evaluations as a way of reducing overdoses.
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Comprehensive Summary (cont.)
Interview participants spoke of the need for policies to
Stigma remains a barrier to
increase access to naloxone as crucial for overdose
prevention and intervention.
prevention; survey responses indicate that treatment
providers do not uniformly value the use of naloxone as a helpful strategy for preventing fatal
overdoses.
Many survey respondents were very concerned with stigma related to substance use. They
viewed this stigma as a barrier to clients’ ability to seek and maintain sobriety. Interviewees
shared their concern that when political leaders believe addiction is a choice, these leaders are
less interested in funding and addressing substance abuse issues. They also expressed the need
to decrease individuals’ fears of criminalization as crucial in preventing overdoses. Work is
needed to reduce stigma and to humanize interventions for people with substance use
disorders by providing an accurate understanding of who is at risk and the strengths they
possess.
1.

5. What were expressed issues/needs specific to NE DHHS?

Interview participants and some providers’ responses to
the open-ended survey items indicated they view Child and
Family Services/Child Protective Services as synonymous
with NE DHHS. A few providers alluded to clients’ lack of
trust in DHHS due to the fear of NE DHHS taking away their
children.

Providers do not have a clear
understanding of what NE
DHHS does and does not do,
and how DOP is differentiated
from other DHHS programs.

Treatment providers shared the stigmatizing experiences of their clients from NE DHHS as well
as from other organizations.
Interview participants called on DOP to partner with stakeholders in drug overdose prevention.
In addition, they suggested that DOP engage treatment providers in a way that honors their
expertise, facilitates ongoing communication, and includes them as partners in this important
work.

1.

6. What are possible next steps for research and evaluation in Nebraska?

Research participants are eager for this final report to be made available to them as evidence
that their perspectives were represented and for use in advocating for changes in practice and
policy. They also look forward to continued opportunity to offer their expertise and feedback in
shaping drug overdose prevention.
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Comprehensive Summary (cont.)
According to NHA, hospitals are currently not collecting data related to race and ethnicity
consistently. The collection of this data should be encouraged as it would allow for an
examination of health disparities and barriers to access to care based on race.
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OVERALL RECOMMENDATIONS

Overall Recommendations for Practice
STEPs offers the following overall recommendations for DOP’s consideration.
1. Provide training to policymakers, treatment providers, other community professionals, and
the general public as outlined in the table below.

Training Topics
Drug use trends
Anti-oppressive and intersectional
approaches
Treating co-occurring disorders
(substance misuse and mental health)
Medication Assisted Treatment (MAT)
How to access and use naloxone
Reducing overprescribing
Reducing stigma

Policymakers
√
√

Treatment
Providers*
√
√

Other
Community
Professionals
√
√

General
Public
√

√
√
√
√

√
√

√
√
√
(prescribers)
√

√
√
√

*Substance use treatment providers include social workers, counselors, and case managers
who provide therapy, crisis counseling, and case management, and make referrals to medical
providers for physical health needs. (A comparison between substance use treatment
providers and medical providers can be found in the survey report.)
2. Focus prevention strategies toward middle and high school students.
3. Continue to expand access to naloxone.
4. Reduce barriers to treatment through:
a. Reviewing treatment programs’ geographic locations, eligibility criteria, payment options,
and levels of care, and then addressing gaps.
b. Advocating for funding for treatment.
c. Ensuring availability of residential treatment, especially for women with children.
5. Communicate the role of DOP as distinct from other NE DHHS programs.
6. Create, maintain, and make available a database of statewide resources to help treatment
providers make appropriate referrals and connect clients to the needed level of treatment.
The database should include items like levels of care, pay sources, and eligibility criteria. The
database could also serve as an environmental scan that informs stakeholder assessment
and strategic planning.
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OVERALL RECOMMENDATIONS

Overall Recommendations for Practice (cont.)
7. Regularly convene a roundtable with treatment providers (perhaps meeting quarterly) to
increase collaboration and understanding of trends in substance use and treatment, and to
inform effective prevention and treatment.
8. Improve communication and collaboration among NE DHHS divisions and programs to
maximize efficiency of existing programming and to share research data and results.
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OVERALL RECOMMENDATIONS

Overall Recommendations for Evaluation and Research
Based on all work completed for the DOP program to date, STEPs offers the following
evaluation and research recommendations to allow for continued use of evidence in planning
and decision-making.
1. Create a logic model for the DOP program that shows activities, outcomes, and impacts. This
logic model can inform DOP’s planning and work, enhance communication with
stakeholders, and inform ongoing evaluation and research.
2. Utilize primary, mixed methods research methods to assess the impact of the current
pandemic on all areas of DOP’s work.
3. Evaluate DOP’s prevention efforts to allow the use of data to inform prevention and outreach
and to showcase efforts and outcomes to treatment providers and others.
4. Conduct an environmental scan to identify and remedy gaps in drug treatment services. This
scan could lead to an interactive resource assisting in linkages to care. Elements to assess
and show include geographic locations of services, referral criteria, payment types, levels of
care, and treatment modalities.
5. Seek the perspectives of prescribers, local health departments, and other community
professionals, as well as other DHHS programs, on substance use trends, prevention,
treatment access, and stigma.
6. Discover the effectiveness of mandated treatment compared to voluntary treatment in the
professional literature and consider applicability to Nebraska.
7. Continue to consider how to ethically collect data directly from individuals who may be
using or misusing substances to learn about substance use trends, prevention, treatment
access, and stigma.
8. Evaluate the effectiveness of DOP’s consumer awareness campaigns, including the
effectiveness and acceptability of public service announcements for specific populations.
9. Synthesize findings from STEPs’ 3 years of reporting to identify commonalities and reinforce
trends and highest priorities in Nebraska.
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Purpose
The goal of this needs assessment is to deepen DOP’s understanding of individuals’ drug
use behaviors in Nebraska through the lens of treatment providers.
The results of this study will aid DOP in providing training and other resources to treatment
centers, focusing prevention efforts, and informing their strategic plan and future studies.
Ultimately, this study will support DOP’s efforts to reduce opioid-involved fatal and non-fatal
overdoses in Nebraska.
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KEY FINDINGS

Key Findings
Medication Assisted Treatment: Most providers indicated referring clients for at least one
medication used in medication assisted treatment (MAT). Rural providers indicated
providing referrals for MAT medication less often than urban providers. This may
be due to a lack of access to MAT providers or a lower percentage of substance use
disorders requiring MAT. Across regions, providers indicated clients need financial assistance
to receive MAT more often than any other resource option.
Common Substances Used: Providers indicated alcohol is the most common substance used,
followed by marijuana and methamphetamines. For polysubstance users, providers
reported these three drugs are consistently paired with each other. Across multiple
items, providers reported approximately 25% of their clients have an opioid use
disorder.
Adolescence: Most providers indicated adolescence as a key age during which many clients
initiated substance use. Many providers also identified middle school and high
school students as a population in need of prevention efforts, and indicated schoolbased prevention programs as helpful.
Systemic Barriers: Providers consistently identified insufficient health care coverage and
wait times to access services as significant barriers to treatment. Providers shared
that insufficient health care coverage prevents clients from accessing necessary
services, especially MAT, detoxification, and chemical dependency evaluations. For
those clients possessing resources and motivation to access treatment, providers indicated
treatment wait lists can be a deterrent. These wait lists point to a gap in treatment availability
and were the second most commonly indicated resource need. In addition, many providers
reported clients’ access to substance use treatment is limited by the gap in support services,
such as transportation, childcare, and housing.
Future Training Topics: Many providers indicated interest in receiving training on evidencebased practices. Evidence-based practice topics specifically mentioned by providers
included Cognitive Behavioral Therapy, Dialectical Behavior Therapy, standardized
assessment instruments, and trauma-informed care.
Focused Efforts: While national trends call for efforts targeting women of child-bearing age,
Native American populations, naloxone distribution, and prescription drug
monitoring, providers indicated these efforts were among the least needed. It is
unknown if providers do not find these current efforts helpful, or rather, if the need
in the community has already been filled by existing programming. Providers indicated access
to mental health treatment as a helpful prevention effort more often than any other effort.
Regional Differences: Most providers, regardless of geographic area, indicated similar
substance use trends and needs among their clients. Additionally, systemic barriers
18
and training interests were also fairly consistent across the state.

LADC/PLADC Quantitative Survey

SAMPLE DESCRIPTION

Survey Purpose
The purposes of the quantitative survey of treatment providers are to discover current
patterns in clients’ drug use behaviors, and the unique needs of both substance users
and treatment providers in the state of Nebraska.

Sample Description
Substance use treatment providers support individuals’ ability to understand and overcome
their substance use disorder and maintain recovery.
Providers offer
• Intake, assessment, and treatment planning,
• Counseling for individuals, groups, and significant others,
• Case management and crisis intervention, and
• Referrals to medical providers and other professionals when appropriate.
Providers support
• Individuals with substance use, mental health, or co-occurring disorders, and
• Clients in self-help recovery groups, outpatient treatment, intensive outpatient treatment,
residential or inpatient treatment, or continuing care.
Common Licenses Held by Providers
• Licensed or Provisionally Licensed Alcohol and Drug Counselor (LADC/PLADC)
• Licensed Mental Health Practitioner (LMHP)
• Licensed Independent Clinical Social Worker (LICSW)

Substance Use
Treatment Providers
• Provide therapy, crisis
counseling, and case
management
• Include social workers,
counselors, and case
managers
• Refer to medical
providers for physical
health needs

Both
• Involved in
substance use
treatment
programs and
treatment planning
• Collaborate with
other professionals
to meet client
needs

Medical Providers
• Prescribe medication;
provide medical care
• Includes doctors,
psychiatrists, physicians
assistants, nurses and nurse
practitioners
• Refer to substance use
treatment providers for
mental and emotional
health needs

19
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SAMPLE DESCRIPTION

Sample Description
Survey Administration
DHHS partnered with STEPs in the fall of 2019 to survey outpatient treatment providers,
specifically Licensed Alcohol and Drug Counselors (LADCs) and Provisional Licensed Alcohol
and Drug Counselors (PLADCs) in the state of Nebraska. On February 5, 2020, STEPs emailed a
Qualtrics survey link to the 1,131 registered LADCs and PLADCs in Nebraska.
Sample Size (n=193)
Of the 1,131 registered LADCs and PLADCs contacted, 213
treatment providers responded to the survey for a 19%
response rate. However, 20 providers answered only the
demographic questions and identified the medications they refer for,
but did not answer any additional questions. These 20 individuals
were included in the analyses for medication referral, but were
removed from all other analyses. Thus the sample size for the majority
of this report equates to 193 substance use treatment providers.

193
Survey participants

Missing Data
Missing data was handled using pairwise deletion in which participant responses were included
in analysis regardless of whether the participant responded to all 24 items. The number of
participant responses for each item is shown by the “(n= )” in the item headings.
Comparisons
STEPs analyzed the responses to each survey item by provider region and by the provision of
outpatient provision. STEPs indicated any notable differences, where applicable, in the analyses.
For the majority of items, no differences were found.
Outpatient Treatment (n=191)
The majority of providers (85%)
indicated providing outpatient
treatment. Since the survey did
not specify any treatment types,
no conclusions can be drawn
regarding the type of service
provided (if any) by the
remaining 15% of respondents.

85%
Provided outpatient treatment
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SAMPLE DESCRIPTION

Sample Description
Other Licenses or Certificates (n=193)
Most providers (72%) indicated holding other licenses or certificates in addition to their LADC
or PLADC. Nearly half of providers (47%) indicated also being a Licensed Independent Mental
Health Provider (LIMHP) and approximately one in four providers indicated being a Licensed or
Provisionally Licensed Mental Health Provider (LMHP or PLMHP). Just over one in four (28%)
providers indicated only holding a LADC or PLADC license. The percentages in the below
graph do not sum to 100% because providers could indicate holding multiple other licenses or
certificates. An acronym index can be found in Appendix C.
Other Licenses or Certificates Held by LADCs and PLADCs
46%

LIMHP

27%

15%

LMHP or PLMHP LPC or PLPC

9%

4%

3%

LICSW

LIPC

CMSW or PCMSW

Grouping Nebraska Regions
Providers responding to this survey indicated serving 66 of Nebraska’s 93 counties. In order to
compare trends by similar geographic regions, STEPs grouped Nebraska counties according to
four regions with similar characteristics, including public health region, size and location of
cities and towns, relative population, and primary economic forces (i.e. agricultural v. other
service industries). These four regions also allowed for sample sizes to be more comparable
between regions for the purpose of statistical analyses. The four regions include:
1. Lancaster County;
2. Omaha Metro, including Douglas County and Sarpy County;
3. Rural East, including all eastern counties, with the exclusion of Lancaster County and Omaha
Metro areas; and
4. West, including all counties west of Knox County.
A detailed table of all 93 counties according to these four regions is provided in Appendix D.
Location of Services
When asked to identify the county or counties in which they provide substance use
treatment, 39 providers identified more than one county. In these cases, providers
were categorized according to the following criteria.
• Providers who listed both rural and urban counties were categorized according to the urban
county listed (e.g. “Hall County, Lancaster County” = Lancaster).
• If a provider listed both an Omaha Metro county and Lancaster County, they were categorized
into the Omaha Metro region (e.g. “Douglas County, Lancaster County” = Omaha Metro).
• Providers listing counties in multiple rural regions were categorized into the region in which
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Sample Description
Providers by Region (n=189)
As indicated in the table below, the majority of providers served counties in the
Omaha Metro (42%) and Lancaster regions (24%). Only 24 providers (13%)
reported serving Western Nebraska.
Number of Providers by Region

125

Providers indicated serving
at least one urban county

64

Providers indicated serving
only rural counties

Region

Count

Percentage

Omaha Metro
80
42%
Lancaster
45
24%
Rural East
40
21%
West
24
13%
Note: Providers could identify providing
treatment in more than one county.

Providers by County (n=189)
The below map of Nebraska is divided into the four geographic regions used for analysis: West,
Rural East, Omaha Metro, and Lancaster. The number in the middle of each county represents
the number of providers who indicated serving that county. Those counties with a higher count
of providers are shaded in a darker blue. Over 80 providers indicated serving Douglas County,
which is included in the Omaha Metro region and shaded a dark blue.

Number of
participants
serving each
county
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Referral for Medications
For the remainder of this report, the survey question will be stated in full inside the box,
followed by the relevant analysis.
Referral for Medications (n=129)
Do you refer clients for any of the following medications? (select all that apply)
• Buprenorphine
• Disulfiram
• Suboxone
• Naltrexone
• Medications for psychiatric disorders
• Acamprosate
• Other
• Methadone
MAT Referral by Outpatient Providers
In preliminary analyses, STEPs discovered that providers who indicated
providing outpatient treatment had a higher rate of MAT referral than those who
did NOT indicate providing outpatient treatment. Because the survey cannot
assure that providers working in other settings are providing direct care (which would be the
setting appropriate for medication referral), STEPs excluded non-outpatient providers from all
analyses for this item, in order to give a more accurate picture of medication referral.
Most outpatient providers (75%) referred for some type of MAT.
Over half of providers (60%) indicated they referred for one or
more medications used in MAT to treat both alcohol and opioid
SUDs, whether that be naltrexone or a combination of other
medications.
MAT Referral by Outpatient Providers

Providers refer for MAT

MAT Medications by SUD Treated
Alcohol SUD

60%

13%
Both Alcohol and
Opioid SUD

75%

Opioid SUD

2%

Opioid SUD

Naltrexone

Naltrexone

Disulfiram

Methadone

Acamprosate

Buprenorphine

Alcohol SUD

Specifically, over half of providers (60%) referred clients for
naltrexone, a medication indicated for use in both alcohol and
opioid use disorders. Fewer providers referred for disulfiram
(22%) or acamprosate (16%), medications used only for treatment
of alcohol use disorder. Only 17 providers (12%) referred clients
for methadone, a medication used in treating opioid use disorder.

Suboxone

25%
Providers do not refer
for any MAT medication
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Referral for Medications
Regional Differences in MAT Referral (n=129)
Slightly more providers from the West region indicated only referring for MAT medications used
in treating alcohol use disorder (12%). Providers serving the West region were also less likely to
referred for medications used in MAT for opioid use disorder (6%). However, STEPs noted little
difference in substance use trends between regions.
No MAT Medication Referrals by Region (n=115)
A greater percentage of outpatient providers serving Rural East counties indicated
providing no referrals for MAT medications (42%). Approximately 20% of outpatient
providers from the Omaha Metro, Lancaster, and West regions indicated providing no
referrals for MAT medications.
Only 115 outpatient providers indicated answers for both the county(ies) served and
medication referral items.

No MAT Medication Referrals by Region
Rural East (n=19)
Omaha Metro (n=49)
Lancaster (n=30)
West (n=17)

42%
22%
20%
18%

Outpatient Psychiatric Medication Referral (n=129)
The majority of outpatient providers (85%)
indicated providing referrals for psychiatric
medication. However, 15% of outpatient
providers did not indicate providing referrals for
psychiatric medication.

85%
Providers refer for psychiatric medication
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Substance Use Trends
Substances Used by Clients (n=193)
Thinking about clients presenting for substance use over the past year, approximately what
percentage of these clients have presented needing treatment for the use of:

Note: Providers responded to each substance independently. Thus, since many clients present
with multiple substance use disorders, the cumulative percentage exceeded 100%.
Clients Needing Treatment by Substance
Providers indicated over half of their clients presented for treatment related to
alcohol (61%), followed by marijuana (58%), and methamphetamines (54%) in the
past year. Providers from different regions indicated similar substance use trends.
Alcohol

61%

Marijuana

58%

Methamphetamines

54%

Prescription pain relievers

26%

Benzodiazepines

20%

Cocaine/crack

14%

Heroin

11%

Antidepressants

9%

Fentanyl

8%

Hallucinogens

7%

Inhalants
Other

4%
1%

Providers’ answers to the
survey item, “Thinking
about clients you treated
for substance use over
the past year, what have
been their most common
primary drugs of choice?”
closely mirrored answers
to this item.

Clients with Opioid Use Disorder (n=180)
In the past year, what percentage of your clients have had an opioid use disorder (prescription
pain relievers, fentanyl, heroin)?
On average, providers indicated 25% of their clients in
the past year had an opioid use disorder. However,
answers to this item ranged from 0% to 100%.
Providers indicated little difference between the rates of opioid
use disorder by region.

25%
Clients with an Opioid
Use Disorder
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Substance Use Trends
Clients Who Are Polysubstance Dependent (n=184)
In the past year, what percentage of your clients were polysubstance dependent?
On average, providers indicated 59% of their clients in the past
year were polysubstance dependent. Providers’ responses to
this item ranged from 0% to 100%. Providers indicated little
difference in the rates of polysubstance dependence by region.

59%
Clients who were
polysubstance dependent

Most Common Polysubstance Drug Pairings (n=177)
We would like to know about trends you are seeing in the use of multiple substances. For each
of the primary substances listed below, please indicate the drug or drugs that you commonly
see paired with each substance.
Primary Drug Pairings
Providers indicated alcohol, methamphetamines, and marijuana are the primary drugs being
used, and are often paired with each other, particularly alcohol and marijuana. While providers
reported a variety of other drugs also being paired with these three main drugs, other pairings
were reported much less often.
Secondary Drug Pairings
Some providers indicated
clients pair pain relievers and
benzodiazepines with
alcohol or marijuana, and slightly
less often with methamphetamines.
Other providers indicated the pairing of
antidepressants with alcohol.

Primary Drug Pairings:

Alcohol  Methamphetamines  Marijuana

Tertiary Drug Pairings
A few providers indicated those who use
cocaine/crack and heroin as their primary
drug pair these with alcohol, methamphetamines,
and marijuana.

Sometimes paired with:
Pain Relievers,
Benzodiazepines,
Antidepressants
Less often paired
with:
Cocaine/Crack
Heroin

Variation in Substance Pairings
For this item, 177 providers indicated a drug pairing for
at least one primary drug, but as few as 21 providers
indicated a drug pairing for less common substances, such as
inhalants. For those substances included in this visual,
responses ranged from 168 providers indicating a drug paired with alcohol to 55 providers
indicating a drug paired with heroin. Providers from different regions indicated little difference
in substance use trends.
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Drug Use Initiation
Most Common Substance First Misused (n=191)
What is your perception of the most common substance that is first misused by your clients?
Across regions, providers indicated alcohol (59%),
followed by marijuana (33%), to be the most
common substances first misused. However, 1 in 10
providers serving the Rural East region
indicated their clients used methamphetamines
first, which is substantially more than those in any
other region.

Other, 8%
Marijuana
33%

Alcohol
59%

Age of First Use (n=189)
What age do most clients you serve indicate as their first misuse?
Just over half of providers indicated most of their
Age of First Misuse
clients first misused a substance at age 14 or
younger. 1 in 10 providers from the Rural East
and Omaha Metro regions indicated their clients
54%
first misused a substance at age 19 or older,
39%
compared to few providers from the Lancaster (2%)
or the West regions (0%). Because opioid use can be
related to a later age of first misuse, STEPs
7%
compared rates of opioid use between regions and
found a slightly higher rate of prescription pain
14 years or 15-18 years 19 years or
relievers being the first misused substance for
younger
old
older
clients in Rural East and Omaha Metro regions. The
slightly elevated rate of prescription pain relievers
as the first misused substance and
the later age of first misuse in the Rural East and Omaha Metro region are consistent with
findings from the 2018-2019 DOP DUB survey of inpatient facility administrators.7
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Drug Use Initiation
Most Common Reason for First Misuse (n=191)
In your opinion, what are the most common reasons for clients’ first substance misuse?
Response Options
• Pain relief
• Relax or relieve tension
• Experiment/see what it’s like
• Feel good/get high
• Help with sleep
• Help be alert or stay awake

•
•
•
•
•
•

Help study or concentrate
Help with feelings or emotions
Help lose weight
Parents or other family members encouraged them to
Peers encouraged them to
Other reason

Providers indicated the top two most common reasons for their clients’ first
substance misuse was peer pressure or their desire to “experiment/see what it’s
like.” The top four answers were consistent with those of inpatient administrators
from the 2018-2019 DOP DUB survey.7 However, inpatient administrators from the 2018-2019
survey rated “parents or other family members encouraged them to” as the fifth most common
reason for clients’ first misuse, compared to LADC and PLADC providers who indicated clients
first used to "relax or relieve tension“ as more common. Providers’ responses differed little
across regions.
Top Five Reasons for First Misuse
Peers encouraged them to

58%

Experiment/see what it’s like

56%

Help with feelings or emotions

41%

Feel good/get high
Relax or relieve tension

39%
26%
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Drug Use Initiation
Source of First Misuse (n=191)
Where did clients most commonly get the substance they first misused?
Response Options:
• From a doctor
• Stole from doctor’s office, clinic,
hospital, or pharmacy
• From friend or relative for free
• Bought from friend or relative
According to the majority of providers,
clients most commonly obtained their
first misused substance “from a friend
or relative for free.” The top three
answers for providers all related to the
source being a friend or relative. These
responses closely mirror those of
inpatient administrators from the 20182019 DOP DUB report.7 Providers’
answers differed little across regions.

• Took from friend or relative without asking
• Bought from drug dealer or other stranger
• Some other way

Source of First Misuse

77%

10%

5%

From a friend or Took from friend Bought from a
relative for free
or relative
friend or relative
without asking

Treatment Barriers and Facilitators
Reasons to Not Receive Treatment (n=191)
What are the most common reasons people do NOT receive treatment?
The full list of response options are provided in Appendix B.
For this item, providers could choose
multiple reasons from the list provided
as to why clients did not seek treatment.
Providers gave a collective total of 937
responses (n=191). Of those 937
responses, STEPs classified 45% as
“intrinsic reasons,” 39% were deemed
“access to treatment” issues, and 16%
were classified as “lack of support.”

Reasons to Not Receive Treatment
45%

39%
16%

Intrinsic Reasons

Access to
Treatment

Lack of Support

This breakdown resembles that of the inpatient administrators from the 2018-2019 DOP DUB
survey.7 However, in the previous survey, 64% of the responses were categorized as “intrinsic
reasons” and only 22% were categorized as “access to treatment.”
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Intrinsic Reasons
Most providers indicated
clients did not seek
treatment due to intrinsic
reasons. One in four responses related
to clients not wanting treatment or not
thinking they needed treatment (28%).

72%
Providers indicated individuals did not
seek treatment because they did not
want treatment
Access to Treatment
Nearly 40% of responses
related to systemic
barriers to accessing
treatment. The most common systemic
barrier related to individuals’ lack of
health insurance. In contrast, the most
common barriers reported by inpatient
administrators from the 2018-2019
survey7 involved the availability of
treatment beds.
Lack of Support
Few providers reported a
lack of support as a
treatment barrier for people.
The most common “lack of support”
barrier indicated by providers related
to fear of children being removed from
the home.

SURVEY FINDINGS
Intrinsic Reasons
Do not want treatment

138

Do not think they need
treatment
Do not think treatment
will help

123
58

Unsure how to access

52

Too ashamed

51

Access to Treatment
No health care

136

No transportation or too
far away

65

Wait times too long
Hours inconvenient

52
30

Lack of Support
Fear of children being
48
taken
Unsupportive family

39

Other problems

39

Do not want others to
find out

26

30

LADC/PLADC Quantitative Survey

SURVEY FINDINGS

Treatment Barriers and Facilitators
Reasons for Not Receiving Treatment by Region (n=187)
Providers from the Lancaster region (n=44) most often indicated a lack of health care
coverage as a treatment barrier (82%), followed by “do not think they need treatment” (70%).
The majority of providers serving the West region (n=24) also indicated no health care
coverage as a primary treatment barrier (75%), followed by “takes too long to access
treatment” (71%). Rural East (n=39) providers most often identified “takes too long to access
treatment” (82%) and “do not think they need treatment” (77%). Finally, providers from the
Omaha Metro region (n=80) indicated a lack of health care coverage and the wait time for
accessing treatment were barriers to treatment at the same rate (71%).
Providers indicated “no health care coverage” and “takes too long to access treatment” as
treatment barriers more often than any other option. While “no transportation/too far away”
was not the most common answer for any region, providers’ answers did vary significantly by
region. The regional breakdown for these three notable barriers is shown in the graphs below.
No Health Care Coverage
As indicated in the graph to
the right, most providers
from the Lancaster, West, and
Omaha Metro regions indicated lacking
health care coverage impeded
individuals from receiving treatment.
However, fewer providers in the Rural
East indicated health care as a barrier.
Takes Too Long to Access Treatment
While wait times were a
significant factor for clients
not receiving treatment in all
areas, more providers in the Rural East
indicated wait times as a notable
barrier.
No Transportation/Too Far Away
Approximately 40% of
providers in the West, Rural
East, and Lancaster regions
indicated transportation as a barrier to
accessing treatment, in contrast to only
24% of providers serving the Omaha
Metro region.

No Health Care Coverage
82%

75%

Lancaster
(n=44)

West (n=24)

71%

56%

Omaha
Rural East
Metro (n=80) (n=39)

Takes Too Long to Access Treatment
82%
71%
71%
66%

Rural East
Omaha
West (n=24)
(n=39) Metro (n=80)

Lancaster
(n=44)

No Transportation/Too Far Away
42%

41%

West (n=24) Rural East
(n=39)

41%

24%

Lancaster
Omaha
(n=44) Metro (n=80)
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Treatment Barriers and Facilitators
Information for DHHS (n=100)
What would you most like DHHS to know about your clients, and your work?
When given an open-ended opportunity to reflect on the most important issues impacting their
work, providers passionately described service gaps and access barriers. Four primary themes
emerged from providers’ responses:
1. Description of clients and reduction in stigma
2. Gaps in services
3. Barriers to service, and
4. Relationships between gaps and barriers.
Theme 1: Description of clients and reduction in stigma
Many providers viewed this question as an opportunity to “set the record straight”
regarding the humanity and personhood of their clients. At times, this message
seemed to be pointedly addressed toward stigma they perceived coming from DHHS.
Those provider responses categorized into Theme 1 varied little across region.
“They are not just another number or problem on [the DHHS] caseload.”
“[DHHS is] not willing to help clients.”
“[Clients] don’t trust DHHS.”
“Nobody is a monster!”
Providers articulated the many hardships and barriers their clients encounter, especially the
rigorous and sometimes conflictual requirements required by multiple systems in which
their clients are involved (i.e. child protective services, courts, public assistance, schools, etc.).
“They have an illness. Not every family looks the same. Do not set a standard for them to live up to
that is not realistic.”
In light of these difficulties, many providers described practices they have found to be more
effective than many current practices, which they described as being shame-inducing and
stigmatizing. Those practices most often identified by providers as beneficial included:
• Partnering and establishing a relationship with the client,
• Reducing or eliminating waiting lists to ensure treatment is accessible when they are ready,
• Meeting basic needs (i.e. housing, food, childcare) so clients are able to focus on treatment,
and
• Carefully reconsidering mandated treatment, because it is often NOT helpful.
“There needs to be treatment available when clients are ready, waiting list [sic] are death
sentences for some and cruel to the rest.”
“Court ordering treatment does not work [sic] The client needs to want this for themselves, or it is
32
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Treatment Barriers and Facilitators
Information for DHHS (n=100)
What would you most like DHHS to know about your clients, and your work?
Theme 2: Gaps in services
Many providers pointed to systemic gaps which often acted as barriers to clients overcoming
substance use disorders. While a few gaps appeared to be community specific, the most
prominent gaps described seem to exist across the state, regardless of the provider’s location.
The most common gaps noted across the state included:
• Adequate provider reimbursement from public insurance,
“NE total Care and Wellcare suck in regards to everything this survey is seeking data on. Wellcare
and NTC pretend like they do, but we see their patients every day with nowhere else to go and are
forced to turn them away. Despite repeatedly expressing concern [NTC and Wellcare] just don't
care. This is probably how they make a 15% profit on their contracts with the state despite being
capped at 3% by contract. NTC and Wellcare provide profit for their shareholders and limit patient
access to care. That has been our only experience and persists to this day.”
“I quit taking Medicaid.”
• Necessary services are often not covered by insurance, most notably chemical dependency
evaluations and detoxification,
• Services to assist with basic needs (i.e. transportation, childcare, housing),
• Funding for essential services that support substance use treatment (i.e. healthcare, case
management, community outreach),
“Programs are less helpful when under funded. MAT is dangerous when not appropriately
monitored.”
• Early prevention services (targeted at younger age groups),
• Training for professionals, especially related to trauma and co-occurring disorders, and
• Wait lists for substance use treatment services.
Additionally, providers articulated the region-specific gaps provided below.
Lancaster County:
• Services for adolescents
• Services for those involved in the criminal justice system
• Services for women and their children
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Treatment Barriers and Facilitators
Information for DHHS (n=100)
What would you most like DHHS to know about your clients, and your work?

Theme 2: Gaps in services
Douglas and Sarpy County:
• Recent closure of facilities resulting in significant gaps in community services and certain
levels of care
“It is important that Nebraska has multiple programs that offer all of the levels of care. There have
been several good substance abuse programs that closed in the last few years and it has left gaps
in resources.”
• Services for those involved in the criminal justice system
• Training on MAT
Rural East and West Counties:
• Availability of 12-step groups
• Availability of treatment for co-occurring disorders
• Availability of all levels of care
• Workforce capacity
“Funding is the number one concern, followed by capacity/access to treatment without extensive
intake paperwork, followed by a provider workforce that understands co-occurring disorders.”

Theme 3: Barriers to service
Often as a result of the gaps discussed, providers reported clients encounter significant barriers
in accessing substance use treatment services, as well as services that support their recovery.
Providers identified similar barriers across the state, regardless of geographic area.
The most common barriers noted across the state include:
• Inability to pay/lack of insurance coverage,
“Most of our patients are trying very hard to complete treatment, but have financial issues in
paying for treatment.”
• Extensive wait lists and lost opportunities for obtaining treatment,
“Long wait lists make it difficult to get people into treatment because substances [sic] users often
change their mind as to if they want treatment or not.”
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Treatment Barriers and Facilitators
Information for DHHS (n=100)
What would you most like DHHS to know about your clients, and your work?
Theme 3: Barriers to service
• Unmet basic needs, especially housing, transportation, and childcare, and
“Often times the biggest barriers to someone getting the help they need is basic things like
transportation, gas money, and insurance. We need more in-home providers as well.”
• Fear of losing custody of children.
“Losing their children often times pushes them into deeper substance use because they can't cope
with the devastating loss of their kids.”

“Transportation and childcare are two
significant barriers when it comes to treatment.
Many are on probation or involved with DHHS
and expected to attend meetings, counseling,
have a job, doing family counseling, UA daily,
attend parenting class, practice family activities
within the home and go to probation classes all
within a 7 day week and there is limited means
of transportation or they have kids who can not
attend probation classes or therapy with them.
Many can't drive or have no car. We often have
kids waiting in the waiting room which is not
always ideal and parents get distracted working
in sessions. There are many single parent
households so when they have an AA meeting or
probation class, they rely on friends or family to
watch the kids because daycares are closed in
the evenings.”
- Outpatient Substance Use Treatment
Provider
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Treatment Barriers and Facilitators
Information for DHHS (n=100)
What would you most like DHHS to know about your clients, and your work?
Theme 4: Relationship between gaps and barriers
While providers discussed both gaps in the community, as well as barriers encountered by
clients, a clear connection between the two phenomena became apparent.

Gaps in the Community

Lead to

Inadequate reimbursement to
providers from public insurance

Barriers for Clients
Lack of quality providers for low-income
individuals

“Medicaid reimbursement for treatment doesn't sustain programs and isn't financially
viable if you want to keep qualified clinicians doing the hardest work.”
Lack of funding for services often not
covered by insurance (i.e.
detoxification, evaluations)

Since these services are often prerequisites for entering treatment, clients
are not able to access treatment

“Omaha and Nebraska have disgracefully few treatment alternatives for the uninsured
and almost no realistic detox options.”
Inadequate services to help meet
basic needs, especially
transportation, housing, and
childcare

Inhibits clients’ ability to connect with, or
fulfill the obligations of treatment

“The more support they are provided with the better the outcomes i.e....transportation
child care housing energy assistance etc…”
Lack of funding to organizations for
support services, such as healthcare,
case management, and outreach

Inhibits clients’ ability to successfully
complete treatment, transition to selfsufficiency, or maintain sobriety

“My individuals are at most need for services in the community for when then [sic]
transition to life.”
Few treatment facility options, with
long wait lists

Missed opportunities for clients to seek
treatment within the window of
opportunity in their lives

“Our waitlist hovers around 2-6 months and often times those on the waitlist can’t wait
that long for treatment and get lost in the shuffle waiting for services.”
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Treatment Barriers and Facilitators
Catalysts for Treatment (n=191)
Which of these statements best describes how your clients were prompted to get treatment?
The full list of response options are provided in Appendix B.
For this item, providers could choose multiple reasons
from the list provided as to why their clients seek
treatment. Providers gave a collective 402 responses
(n=191). Of those 402 responses, 66% were extrinsic
reasons, categorized as “courts and other legal entities”
(45%) and “other people” (21%), and 34% were
categorized as “intrinsic reasons.” Inpatient
administrators from the 2018-2019 DOP DUB survey7
also identified “courts” as the most common catalyst
(53%), but identified “other people” as a catalyst for
treatment slightly more often (25%) than “intrinsic
reasons” (22%).7
Courts and Other Legal Entities
Providers indicated their
clients were prompted to
receive treatment due to
court-related incidents more than
any other catalyst.
Intrinsic Reasons
Approximately one-third
of provider responses
indicated clients sought
treatment due to intrinsic reasons.
One-third of all providers indicated
their clients decided to get treatment
on their own.

Other People
Nearly half of providers
indicated their clients
sought treatment because
someone else thought they should.

Catalysts for Treatment

45%

Courts

34%

21%

Intrinisic
Reasons

Other
People

Courts

Ordered to get treatment

181

Intrinsic Reasons

Decided on their own
Other health issue
Injury or near-death
experience
Overdose or witnessing
an overdose

62
25
25

24

Other People
Someone else thought
they should

85
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Treatment Barriers and Facilitators
Catalyst for Treatment by Region (n=187)
In each region, providers most often indicated “they were ordered to get treatment” as the
reason someone sought treatment, followed by “they got treatment because someone else
thought they should.” The regional breakdown for these two notable treatment catalysts is
included below.
Ordered to Get Treatment
Most providers from all
regions indicated clients
sought treatment due to
having been ordered to get treatment,
but this was especially pronounced in
the western half of the state.
Someone Else Thought They Should
Over twice as many
Lancaster providers as
West and Rural East
providers indicated the influence of
others was a significant reason their
clients sought treatment.

96%

Ordered to Get Treatment
92%
88%

West (n=24) Rural East
(n=39)

Omaha
Metro
(n=80)

86%

Lancaster
(n=44)

Someone Else Thought They Should
64%

Lancaster
(n=44)

First Treatment Experience (n=187)

45%

Omaha
Metro
(n=80)

29%

28%

West (n=24) Rural East
(n=39)

For what percentage of your clients in the past year was this their first treatment experience
EVER?
On average, providers indicated it was
the first treatment experience for 33%
of their clients in the past year.

Average Percentage of First Treatment
Experience
40%

First treatment experience
for one in three clients
Providers from the West region
indicated a slightly higher percentage
of their clients in the past year had
never had a previous treatment
experience (40%).

34%

West (n=24) Lancaster
(n=44)

34%

27%

Omaha
Metro
(n=80)

Rural East
(n=39)
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Prevention Efforts
Helpful Prevention Efforts (n=189)
In your opinion, what prevention efforts are most helpful?
The full list of response options are provided in Appendix B.

Most Often Indicated Prevention Efforts
Nearly half of providers (44%) indicated prevention programs targeting middle school students
are helpful primary prevention efforts and just over half indicated addiction screening at
primary (medical) care facilities is a helpful secondary prevention effort (52%). Nearly 80% of
providers indicated increased access to mental health treatment is an effective prevention
effort. Access to mental health treatment was the most often indicated effort in the
tertiary prevention category and overall. Little difference existed in the answers of providers
from different regions.
Most Often Indicated Prevention Efforts by Category
Primary Prevention

Secondary Prevention

Tertiary Prevention

School-based substance use
prevention programs for
middle school students

Addiction screening at
primary care facilities

Increased access to mental
health treatment

Least Often Indicated Prevention Efforts
Only 18 providers (9%) indicated public service announcements are helpful primary
prevention efforts. In the secondary and tertiary prevention categories, use of the Prescription
Drug Monitoring Program and naloxone training and access were the strategies identified least
often as being helpful. This is similar to findings from the previous 2018-2019 DOP-DUB
report7, in which inpatient administrators indicated MAT treatment and increased access/
training on naloxone as helpful the least often. Few inpatient administrators from the 20182019 report indicated public service announcements as a helpful prevention effort and only
slightly more indicated use of the Prescription Drug Monitoring Program as a helpful
prevention effort.
Least Often Indicated Prevention Efforts by Category
Primary Prevention

Secondary Prevention

Tertiary Prevention

Public service
announcements and media
campaigns for general public

Use of Prescription Drug
Monitoring Program before
prescribing controlled
substances

Increased access to and
training on naloxone

The full chart of prevention efforts ranked from most often indicated to least often indicated
39 is
provided in Appendix E.

LADC/PLADC Quantitative Survey

SURVEY FINDINGS

Prevention Efforts
Populations in Need of Prevention (n=189)
In your opinion, what populations are most in need of additional substance use prevention
efforts?
The full list of response options are provided in Appendix B.
Most Often Indicated Populations
Providers most often indicated
middle school students and
high school students (62%),
and young adults (61%) as populations
in need of prevention efforts, closely
followed by individuals with mental
illness (58%). These answers are
consistent with providers’ rating of
helpful prevention efforts in the previous
item. Little difference existed in the
answers of providers from different
regions.
Least Often Indicated Populations
Approximately 10% of providers
indicated American Indians/Alaska
Natives and women of child-bearing age
are in need of prevention efforts. Only
2% of providers indicated
Latinos/Latinas are a population in need
of prevention efforts.

Populations in Need of Prevention
Most
Often
Indicated

1. Middle school and high school
students
2. Young adults (18-25 years)
3. Individuals with mental illness
…
…
…

Least
Often
Indicated

11. American Indians/Alaska Natives
12. Women of child-bearing age
13. Latinos/Latinas
Note: The darker shade of blue
indicates more providers identified this
population as in need of prevention
efforts.

The full chart of populations ranked from
the most often indicated to least often
indicated is provided in Appendix F.
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Training and Resources for Treatment Providers
Future Training (n=188)
Which of the below topics would be useful for future training for yourself or other staff at your
facility?
Most Often Indicated Training Topics
Over half of providers
indicated interest in trainings
on co-occurring disorders
(56%) and evidence-based treatments
(54%). Nearly 40% of providers
indicated interest in trauma-informed
care and alternative pain management
strategies for future training topics. Little
difference existed in the answers of
providers from different regions.
Least Often Indicated Training Topics
Providers indicated little interest in
trainings related to naloxone use, PDMP,
or treatment for methamphetamine
addiction.

The full chart of future training topics
ranked from most often indicated to least
often indicated is provided in Appendix
G.

Future Training Topics
Most
Often
Indicated

1. Co-occurring disorders
2. Evidence-based treatments
3. Alternative pain management
strategies
4. Trauma informed care

…
…
14. Naloxone use and/or
administration
Least
Often
Indicated

15. Prescription Drug Monitoring
Program
16. Treatment for methamphetamine
addiction
Note: The darker shade of blue
indicates providers identified interest
in this training topic more often.
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Training and Resources for Treatment Providers
Additional Resources for Clients (n=178)
What additional resources do your clients need?
Most Often Indicated Resources
Approximately half of
providers indicated financial
assistance for MAT and a
reduction in wait time to access
treatment, both systematic barriers to
treatment, are additional resources
needed by clients. Nearly half of
providers also indicated community
outreach as a necessary resource for
clients. Little difference existed in the
answers of providers from different
regions.
Least Often Indicated Resources
Consistent with the rating of prevention
efforts and future training topics, few
providers indicated clients need
additional naloxone kits. Providers who
indicated “other” specified a range of
answers including transportation
assistance, assistance with children while
in treatment, and aftercare services.

Additional Resources
Most
Often
Indicated

1. Financial assistance for MAT
2. Reduction in waiting lists and wait
time
3. Community outreach
…
…
…

Least
Often
Indicated

11. Naloxone kits
12. Condom distribution
13. Other
Note: The darker shade of blue
indicates providers identified a need
for this resource more often.

The full chart of additional resource
options ranked from most often indicated
to least often indicated is provided in
Appendix H.
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Training and Resources for Treatment Providers
Helpful Training Received (n=126)
What training have you received that has been helpful to your work?

Provider responses to this item generally mirror the same types of training they
indicated they would find helpful in the future (see previous item).
1. Evidence-Based Practices (other than trauma)
Providers most often indicated that training on evidence-based practices (EBPs) was
helpful. This was especially true in the Rural East region, as over half of responses in
this category were from this region.
EBPs specifically mentioned in this category were those NOT focused on trauma, including
Cognitive Behavior Therapy, Dialectical Behavior Therapy and training on the following
standardized assessment instruments:
• Adverse Childhood Experiences Scale
• Addiction Severity Index
• Comprehensive Adolescent Severity Index
• Substance Abuse Subtle Screening inventory
2. Trauma-Informed Care (including EBPs)
Many respondents also expressed that trainings on trauma informed care have been
helpful. These included both evidence-based models (i.e. Eye Movement
Desensitization and Reprocessing, Trauma-Focused Cognitive Behavioral Therapy), as
well as general trauma trainings and treatment strategies.
3. Substance Use Trends
Many respondents reported training on substance use trends was useful. This was especially
true for those in the Omaha Metro region, and those in the West region, with approximately
20% of responses coming from each of those regions.
4. Biological Components of Addiction
Several respondents indicated that trainings related to biological aspects of
addiction have been most helpful. These include training on MAT,
psychopharmacology, and neurobiology of addiction.
5. Co-Occurring Disorders
Several respondents indicated trainings related to co-occurring disorders have been helpful.
However, significantly more providers indicated this type of training would be helpful in
the future (see previous item), than has already been helpful (current item). This may
illustrate a great need in this area.
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Training and Resources for Treatment Providers
Helpful Training Received (n=126)
What training have you received that has been helpful to your work?

6. General Training
Many respondents indicated that, in general, participating in training is helpful. More general
trainings mentioned by providers included trainings that provide continuing education credit,
trainings from the American Society of Addiction Medicine, post-secondary training, and clinical
experience.
7. Other
Other trainings that providers indicated as helpful included topics such as harm reduction
strategies, wholistic or alternative treatments, and special populations or issues such as
domestic violence, sexual addiction, criminal justice, and cultural competency.
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Recommendations
Clarify DHHS’ Role: Some providers’ responses to the open-ended survey items indicated
they may see Child Protective Services as synonymous with DHHS. A few providers alluded to
clients’ lack of trust in DHHS due to the fear of DHHS taking away their children. Clarifying the
role of DHHS in supporting the provision of substance use treatment may resolve
misconceptions currently held by providers.
Work to Reduce Stigma: Many providers were most concerned with stigma from
organizations, including DHHS, targeted at their clients. They viewed this stigma as a barrier
to their clients’ ability to seek and maintain sobriety. Additional investigation into the sources
and communication of this stigma may be warranted.
Evaluate Current DHHS Efforts: In the 2018-2019 DOP DUB report7, approximately half of
inpatient administrators indicated naloxone as a helpful prevention effort, but few LADC and
PLADC providers found naloxone helpful. Additionally, few LADC and PLADC viewed strategies
such as the Prescription Drug Monitoring Program and Public Service Announcements helpful
prevention tools. Instead, providers overwhelmingly indicated prevention strategies aimed at
middle and high school students, rather than other populations, are the most helpful.
Additional investigation into the delivery and effectiveness of current DHHS efforts may be
useful to inform outreach and prevention strategies.
Meet Training Needs: Training needs across the state include topics such as co-occurring
disorders, trauma-informed care, EBPs, and drug use trends. Any offerings DHHS may be able
to offer in these areas would be helpful for providers.
Target Efforts: Most results indicate that trends and needs for both clients and providers are
consistent across the state. While delivery methods may need to be adapted to overcome
geographic barriers, it does not appear as if DHHS needs to target most efforts to a particular
area or region.
Alleviate Treatment Barriers: Providers noted many systemic barriers to treatment, both
from the perspective of providers and clients. Any policy or funding changes that can be made
to alleviate these barriers would greatly increase the ability of clients to access treatment.
Share Findings: Share the findings of this needs assessment with DHHS staff, community
members, providers, and other stakeholders. Sharing the results of the survey with those who
provided input can make participants feel heard and valued, increasing their likelihood of
participation in future evaluation efforts. By sharing information from this report with the
Nebraska community, DHHS can be recognized for their efforts to better understand drug use
behaviors and the needs of treatment providers. Publishing this needs assessment may also
contribute to the knowledge base of substance use treatment for providers, public
administrators, and researchers, leading to an increase in evidence-informed decision making
for a variety of practitioners.
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Limitations
1. Response Rate
STEPs emailed the anonymous survey link to each registered LADC and PLADC
licensed by DHHS. Some individuals did not provide an email or the email provided
was no longer active. In addition, emails may have inadvertently been sent to a spam
folder or recipients may not have recognized the sender and ignored the email. STEPs used
multiple rounds of follow-up emails to increase the response rate. Due to these technological
barriers, some providers were not reached which negatively impacted the response rate.
2. Incomplete Survey Responses
A total of 213 providers started the survey, but only 193 respondents completed
both the demographic items, the medication referral item, and at least one other
item. These 20 individuals may have unintentionally only completed the first page of
items on the survey, without realizing there were items beyond the first page. Other providers
only completed some of the survey items (as noted by total n for each survey item).
3. Disproportionate Representation from Urban Counties
Nearly twice as many urban providers responded as rural providers. Only 24
providers serving the West responded, compared to 40 providers serving the Rural
East. As such, we know less about drug use behaviors and provider needs in the
West region. Additionally, nearly twice as many Omaha Metro providers responded
as Lancaster providers.
4. Limited Scope of Services Sampled
This report only included those individuals who hold a LADC or PLADC in Nebraska.
The perspectives of those individuals who provide services to this population, but do
not hold a LADC or PLADC may differ substantially from this sample.
5. Provider Self-Report
The measurement instrument asked providers to reflect on their perceptions of
their clients’ experiences and behaviors. This may be less valid than asking
individual clients directly about their own experiences.
6. Aggregate Data
This survey asked providers to estimate the percentage of clients they see engaging
in various drug use behaviors in aggregate form. This does not reflect an actual
count of providers referring clients for MAT or clients engaging in a specific drug use
behavior. From this survey, it is unknown at which rate clients actually engage in particular
behaviors.
7. COVID-19
STEPs obtained survey data prior to the outbreak of COVID-19 in Nebraska.
Challenges faced by both treatment providers and clients may be substantially
different post-COVID.
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Drug Use Behaviors Background
Support and Training for the Evaluation of Programs (STEPs) at the University of Nebraska at
Omaha is a leader in conducting evaluations of and needs assessments for social service
programs and policies. The Nebraska Department of Health and Human Services (DHHS) Drug
Overdose Program (DOP) contracted with STEPs in the fall of 2019 to complete a needs
assessment that included an identification and analysis of quality datasets, a survey of
outpatient treatment providers, and focus groups with treatment providers.

Purpose
The goal of this needs assessment is to deepen DOP’s understanding of individuals’ drug
use behaviors in Nebraska through the lens of treatment providers.
The results of this study will aid DOP in providing training and other resources to treatment
centers, focusing prevention efforts, and informing their strategic plan and future studies.
Ultimately, this study will support DOP’s efforts to reduce opioid-involved fatal and non-fatal
overdoses in Nebraska.
*Table of Contents updated on 8/6/2020
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INTRODUCTION

Dataset Purpose
Introduction
The purpose of the dataset analysis is to provide data on who is receiving treatment, who
is referring people to treatment, and people’s age at first use. The current report includes
analysis of quality datasets that can be useful now and in future evaluations.
Methodology
Below is an outline of the activities STEPs completed to identify, select, and analyze quality
secondary datasets.

1

STEPs conducted a review of the literature on health indicators, which found consistent
references to documents published by the Centers for Disease Control and Prevention
(CDC), the Substance Abuse and Mental Health Services Administration (SAMHSA), and
the Council of State and Territorial Epidemiologists (CSTE). STEPs weighed the
prevalence of established substance use indicators when determining the usefulness
and quality of datasets. The CSTE’s Recommended CSTE Surveillance Indicators for
Substance Abuse and Mental Health identified 10 substance use indicators
recommended for use in surveillance systems (2019). Of these 10 indicators, 5 are
included in the table below, and target non-alcohol drug use.
Five Recommended Substance Use Indicators
(CSTE, 2019, p. 14)

Drug
overdose
mortality

2

3

Hospitalization
attributable to drugs
with potential for
abuse and dependence

Prescription
opioid sales
per capita

Drug or alcohol
dependence or
abuse in the last
year

Prevalence of
use of selected
prescription and
illicit drugs

STEPs identified 12 secondary datasets relevant to substance use. Utilizing the
substance use indicator literature and the CDC’s “Guidelines for Evaluating Public
Health Surveillance Systems,” STEPs selected the following datasets to be used over
time: the Nebraska Risk and Protective Factor Student Survey (NRPFSS), Nebraska
Hospital Association Hospital Discharge Data (HDD), and Treatment Episode Data Set
(TEDS). For more information on indicators and dataset selection, please see the Drug
Overdose Prevention Dataset Methodology report in Appendix I.
Following the identification of datasets, STEPs downloaded publicly available data and
requested non-public data from appropriate sources including the Nebraska Hospital
Association and the Nebraska DHHS Division of Behavioral Health (DBH). STEPs
analyzed available data in Microsoft Excel and SPSS.*

*Section updated on 8/6/2020
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NHA INPATIENT DISCHARGES

Nebraska Hospital Association (NHA) Inpatient Discharges
The Nebraska Hospital Association (NHA) provided STEPs inpatient hospital discharge data for
cases with diagnoses related to substance use. The dataset included information on patients’
diagnosis, sex, age, home address, hospital location, and length of stay. The dataset included
3,330 discharges between January 1, 2016 and September 30, 2019.

What are the characteristics of individuals discharged from inpatient treatment with
diagnoses related to substance use?

Male,
48%

Femal
e,
52%

Patient Sex (n=3,329)
For the entire population of Nebraska in 2018 (n=1,904,760), 50% of
the population was female (n=954,850) and 50% was male
(n=949,910) (United States Census Bureau, 2018). The percentage of
female and male patients discharged from inpatient treatment related
to substance abuse was similar with 52% (n=1,733) patients
identifying as female and 48% (n=1,596) identifying as male.

41

4

Patient Age in Years (n=3,330)
Patient ages ranged from 0 to 97 years with an
average age 41 years (SD=17) and a median
age of 39 years.

Patient Length of Stay in Days (n=3,330)
Patients’ lengths of stay ranged from 1 to 45
days with an average length of 4 days (SD=4)
and a median length of 2 days.

Substance Related to Patient Diagnosis (n=3,330)
The most common substances related to the inpatient diagnoses were depressants (33%,
n=1,105) followed by stimulants (26%, n=861) and narcotics (25%, n=841). 130 patients
(4%) did not have a substance specified in their diagnosis code. Instead, their diagnoses were
related to substance use complicating pregnancy, childbirth, or puerperium.
For a sample of diagnosis codes and their related substance category, see Appendix J.
Depressants
Stimulants
Narcotics
Cannabis
Hallucinogens
Other psychoactive substances
No substance specified*

1,105
861
841
138
39
216
130
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What are the characteristics of individuals discharged from inpatient treatment with
diagnoses related to substance use? (cont.)
Behavioral Health Region by Patient Address (n=3,325)
The greatest proportion (48%) of all hospital inpatient discharges were for patients whose
home address was in Region 6 (n=1,582). Region 5 had the second greatest proportion (20%,
n=671) of residents discharged.
1,582

671
218

311

Region 2

Region 3

102
Region 1

250

191
Region 4

Region 5

Region 6

Out of State

The table below compares the percentage of discharged patients with home addresses in each
behavioral health region in Nebraska (excluding patients with missing or out-of-state home
addresses, n=3,075) to the percentage of all Nebraskans residing in each region (n=1,904,760,
United States Census Bureau, 2018). As shown, Region 6 had a higher percentage of
discharged patients than expected based on population (51% compared to 43%).
Region 4 had only 6% of inpatient discharges while comprising 11% of the population.
Behavioral
Health Region

% of all discharges
(n=3,075)

% of Nebraska
population (n=1,904,760)

Region 1

3% (n=102)

4% (n=85,550)

Region 2

7% (n=218)

5% (n=99,028)

Region 3

10% (n=311)

12% (n=230,690)

Region 4

6% (n=191)

11% (n=205,654)

Region 5

22% (n=671)

25% (n=467,891)

Region 6

51% (n=1,582)

43% (n=815,947)
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What are the trends for the characteristics of individuals discharged from inpatient
treatment with diagnoses related to substance use since 2016?
Many of the characteristics of individuals discharged from inpatient treatment with diagnoses
related to substance use have remained stable since 2016. Patient sex, age, and length of stay
have remained consistent. See Appendix K for tables.
Number of Inpatient Treatment
Discharges by Year (n=2,672)
The total number of inpatient
discharges between January 1 and
September 30 of each year is
shown to the right. The
comparison includes only
discharges during this time as
quarter 4 data for 2019 was not
yet available at the time of this
report. As shown, the number of
inpatient discharges was at its
highest point in 2017 and has
seen modest declines in the
following 2 years.
Substance Related to Patient
Diagnosis (n=3,330)
While depressants have been the
most common substances related
to inpatient treatment diagnoses
overall, the 4-year trend analysis
shows the percentage of
diagnoses related to
depressants have consistently
decreased since 2016. A similar
trend exists for narcotics. In
contrast, diagnoses related to
stimulants have been steadily
increasing since 2016. The
percentage of other substances
related to diagnoses has remained
consistent over time. See
Appendix K for information on
other substances.

701

697

2017

2018

610

2016

664

2019

The percentage of depressant-related diagnoses has
decreased since 2016.
36%

34%

32%

29%

The percentage of narcotic-related diagnoses has
decreased since 2016.
28%

26%

25%

21%

The percentage of stimulant-related diagnoses has
increased since 2016.
21%

25%

27%

32%
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What are the trends for the characteristics of individuals discharged from inpatient
treatment with diagnoses related to substance use by behavioral health region since
2016?
STEPs investigated changes in the characteristics of individuals discharged from
inpatient treatment with diagnoses related to substance use behavior by behavioral
health region and year. The behavioral health region was determined based on the
patient’s home address. Five individuals discharged were excluded from the analysis as home
address information was not provided. Notable findings are summarized below with additional
tables located in Appendix K.
Percentage of Patient Discharges by Behavioral Health Region and Year (n=3,325)
The percentage of individuals discharged from inpatient treatment residing in each behavioral
health region stayed relatively consistent over the past 4 years. Two notable exceptions include
Regions 3 and 6. Since 2017, the percentage of individuals discharged who resided in
Region 3 increased by 2 percentage points. Conversely, since 2016, the percentage of
individuals discharged who resided in Region 6 decreased each year resulting in a 7percentage-point decrease from 2016 to 2019.
Behavioral
Health Region

2016
(n=822)

2017
(n=931)

2018
(n=910)

2019
(n=662)

Region 1

3%

4%

3%

3%

Region 2

7%

6%

6%

8%

Region 3

8%

8%

10%

12%

Region 4

6%

7%

5%

5%

Region 5

18%

21%

21%

20%

Region 6

51%

48%

46%

44%

8%

7%

8%

8%

Out of State

Patient Sex (n=3,325)
The percentages of female and male patients by
behavioral health region are similar to overall
findings; a higher percentage of patients
discharged from inpatient treatment with
diagnoses related to substance use were
female compared to male. There are some
exceptions with Regions 1, 3, and 5 having a
lower percentage of female patients than other
health regions. Region 2 has a much higher
percentage of female patients than other regions.

Region 1 (n=102)

Region 2 (n=218)
Region 3 (n=311)
Region 4 (n=191)
Region 5 (n=671)

47%
59%
46%
53%
47%

53%
41%
54%
47%
53%

Region 6 (n=1,582)

54%

46%

Out of State (n=250)

54%

46%

Female

Male
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What are the trends for the characteristics of individuals discharged from inpatient
treatment with diagnoses related to substance use by behavioral health region since
2016? (cont.)
Patient Age in Years (n=3,325)
Overall, the average age for patients does not vary greatly across behavioral health regions.
The average ages ranged from 39 to 42 years old.
Patient Length of Stay in Days (n=3,325)
Overall, the average length of stay for patients does not vary greatly across behavioral
health regions. The average lengths of stay ranged from 3 to 4 days.
Substance Related to Patient Diagnosis (n=3,325)
For most regions, the most common substances related to inpatient treatment diagnoses were
depressants. Exceptions include Region 3 and Region 4, which had stimulants and narcotics,
respectively, as their most common substances. The highlighted cells indicate the most common
substance for each region.
Region 1
(n=102)

Region 2
(n=218)

Region 3
(n=311)

Region 4
(n=191)

Region 5
(n=671)

Region 6
(n=1,582)

Out of
State
(n=250)

Depressants

34%

31%

23%

26%

32%

36%

36%

Stimulants

20%

19%

42%

25%

28%

23%

27%

Narcotics

21%

25%

19%

27%

28%

26%

22%

Cannabis

4%

3%

3%

4%

3%

5%

5%

Hallucinogens

0%

0%

1%

1%

1%

1%

1%

Other
psychoactive
substances

9%

19%

5%

14%

4%

5%

4%

13%

2%

5%

4%

4%

3%

4%

No substance
specified
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NHA Emergency Department Discharges
NHA provided STEPs with emergency department discharge data for cases with diagnoses
related to substance use. The dataset included information on patients’ diagnosis, sex, age, home
address, hospital location, and length of stay. The dataset included 7,712 discharges between
January 1, 2016 and September 30, 2019.
What are the characteristics of individuals discharged from emergency departments
with diagnoses related to substance use?

Female,
47%

Male,
53%

Patient Sex (n=7,709)
There was a slightly higher percentage of male than female patients
discharged from emergency departments with diagnoses related to
substance use with 53% (n=4,070) of patients identifying as male and
47% (n=3,639) identifying as female.

34

1

Patient Age in Years (n=7,712)
Patient ages ranged from 0 to 97 years with an
average age of 34 years (SD=16) and a median
age of 31 years.

Patient Length of Stay in Days (n=7,712)
Patients’ lengths of stay ranged from 1 to 45
days with an average and median length of 1
day (SD=1).

Substance Related to Patient Diagnosis (n=7,712)
The most common substances related to the emergency department diagnoses were
stimulants (31%, n=2,389), followed by narcotics (21%, n=1,634) and depressants (20%,
n=1,559). 36 patients did not have a substance specified in their diagnosis code. Instead, their
diagnoses were related to substance use complicating pregnancy or neonatal withdrawal.
For a sample of diagnosis codes and their related substance category, see Appendix J.
Depressants
Stimulants
Narcotics
Cannabis
Hallucinogens
Other psychoactive substances
No substance specified*

1,559
2,389
1,634
855
181
1,058
36
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What are the characteristics of individuals discharged from emergency departments
with diagnoses related to substance use? (cont.)
Behavioral Health Region by Patient Address (n=7,712)
The greatest proportion of all emergency department discharges were for patients whose
address was in Region 6 (48%, n=3,719). Region 5 had the second greatest proportion (24%,
n=1,853) of residents discharged.
3,719
1,853
362

246

Region 1

Region 2

741
Region 3

406

385
Region 4

Region 5

Region 6

Out of State

The table below compares the percentage of discharged patients with home addresses in each
behavioral health region in Nebraska (excluding patients with out-of-state home addresses,
n=7,306) to the percentage of all Nebraskans residing in each region (n=1,904,760, U.S. Census
Bureau, 2018). As shown, Region 6 had a higher percentage of discharged patients than
expected based on population (51% compared to 43%).
Region 4 had only 5% of inpatient discharges while comprising 11% of the population.
Behavioral
Health Region

% of all discharges
(n=7,306)

% of Nebraska population
(n=1,904,760)

Region 1

5% (n=362)

4% (n=85,550)

Region 2

3% (n=246)

5% (n=99,028)

Region 3

10% (n=741)

12% (n=230,690)

Region 4

5% (n=385)

11% (n=205,654)

Region 5

25% (n=1,853)

25% (n=467,891)

Region 6

51% (n=3,719)

43% (n=815,947)
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What are the trends for the characteristics of individuals discharged from emergency
departments with diagnoses related to substance use since 2016?
Many of the characteristics of individuals discharged from emergency departments with
diagnoses related to substance use have remained stable since 2016. Patient sex, age, and length
of stay have remained consistent. See Appendix L for tables.
1,675
1,635
Number of Emergency Department
1,479
1,461
Discharges by Year (n=6,250)
The total number of inpatient
discharges between January 1 and
September 30 of each year is shown to
the right. The comparison includes
only discharges during these months
as quarter 4 data for 2019 was not yet
available at the time of this report. As
shown, the number of emergency
department discharges was at the
lowest point in 2017 and saw
increases in the following two
2016
2017
2018
2019
years.
Substance Related to Patient
Diagnosis (n=7,712)
Like the trends seen in inpatient
treatment, the substances related
to emergency department
diagnoses show the percentage
of diagnoses related to
depressants and narcotics have
decreased over time. In
contrast, diagnoses related to
stimulants have been steadily
increasing since 2016. The
percentage of diagnoses related to
cannabis use also increased
during this timeframe. The
percentage of other substances
related to diagnoses have
remained consistent over time.
See Appendix L for information
on other substances.

The percentage of depressant-related diagnoses has
decreased since 2017.
22%

22%

20%

17%

The percentage of narcotic-related diagnoses has
decreased since 2016.
25%

23%

20%

16%

The percentage of stimulant-related diagnoses has
increased since 2016.
25%

29%

37%

33%
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What are the trends for the characteristics of individuals discharged from emergency
departments with diagnoses related to substance use by behavioral health region
since 2016?
STEPs investigated changes in the characteristics of individuals discharged from
emergency departments with diagnoses related to substance use by behavioral
health region and year. The behavioral health region was determined based on the
patient’s home address. Notable findings are summarized below with additional tables located
in Appendix L.
Percentage of Patient Discharges by Behavioral Health Region and Year (n=7,712)
The percentage of individuals discharged from emergency departments residing in each
behavioral health region has stayed relatively consistent over the past 4 years except for Region
6. Since 2017, the percentage of individuals discharged who resided in Region 6 has
increased by 7 percentage points and 209 patients.
Behavioral
Health Region

2016
(n=1,938)

2017
(n=1,914)

2018
(n=2,185)

2019
(n=1,675)

Region 1

6%

5%

4%

4%

Region 2

3%

3%

3%

3%

Region 3

11%

9%

9%

9%

Region 4

5%

6%

5%

5%

Region 5

24%

24%

25%

22%

Region 6

45%

49%

47%

52%

6%

4%

6%

5%

Out of State

Number of Patient Discharges by
Behavioral Health Region and
Year (n=6,250)
The total number of emergency
department discharges between
January 1 and September 30 of
each year is shown to the right for
each behavioral health region. The
comparison includes only
discharges during these months as
quarter 4 data for 2019 was not yet
available at the time of this report.

Behavioral Health
Region

2016

2017

2018

2019

Region 1 (n=293)

85

67

78

63

Region 2 (n=192)

49

47

50

46

Region 3 (n=584)

152

131

150

151

Region 4 (n=314)

69

82

86

77

Region 5 (n=1,521)

369

368

411

373

Region 6 (n=3,023)

668

706

772

877

Out of State (n=323)

87

60

88

88
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What are the trends for the characteristics of individuals discharged from emergency
departments with diagnoses related to substance use by behavioral health region
since 2016? (cont.)
Patient Sex (n=7,709)
Region 1 (n=362)
The percentages of female and male
Region 2 (n=246)
patients varied across health regions with
Region 3 (n=741)
Regions 2, 3, and 4 having higher
Region 4 (n=385)
percentages of female patients and
Regions 1, 4, and 6 having higher
Region 5 (n=1,851)
percentages of male patients.
Region 6 (n=3,719)
Out of State (n=405)

48%

52%

61%
55%

45%

55%

45%

44%

56%

46%

54%

44%

Female

39%

56%

Male

Patient Age in Years (n=7,712)
Overall, the average age for patients did not vary greatly across behavioral health regions. The
average ages ranged from 33 to 36 years old.
Patient Length of Stay in Days (n=7,712)
Overall, the average length of stay for patients did not vary across behavioral health regions.
The average lengths of stay for each region was 1 day.
Substance Related to Patient Diagnosis (n=7,712)
For most regions, the most common substances related to emergency department diagnoses
was stimulants. The highlighted cell indicates the most common substance for each region.
Region 1
(n=362)

Region 2
(n=246)

Region 3
(n=741)

Region 4
(n=385)

Region 5

Region 6

(n=1,853)

(n=3,719)

Out of
State
(n=406)

Depressants

19%

33%

28%

22%

19%

19%

13%

Stimulants

27%

27%

28%

31%

31%

32%

34%

Narcotics

31%

26%

23%

24%

18%

20%

26%

Cannabis

12%

4%

11%

9%

9%

13%

12%

Hallucinogens

2%

0%

1%

2%

2%

3%

2%

Other
psychoactive
substances

11%

9%

10%

12%

21%

12%

14%

No substance
specified

0%

1%

0%

0%

0%

1%

0%
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Treatment Episodes Data Set–Discharges (TEDS-D)
The Treatment Episode Data Set (TEDS) is a compilation of admission and discharge
data from substance use treatment facilities nationwide. TEDS–Discharges (TEDS-D)
provides data from approximately 1.6 million discharges across the U.S. This data
provides an opportunity to understand substance use treatment trends including demographic,
substance use, and treatment episode characteristics.
Sample Size
TEDS-D includes 53,605 discharges from substance use
treatment facilities in Nebraska from 2013 to 2017. Sample
sizes by year ranged from 8,275 discharges in 2014, to 13,198
discharges in 2016 and 2017. TEDS-D reports information on
admissions and discharges to treatment facilities, not
individuals. Therefore, someone who is admitted to a treatment
facility twice in one year may be included in two data points.
The following analysis includes year-by-year comparisons for
relevant items.

Sample Sizes by Year
Discharge
Year
2013
2014
2015
2016
2017
Total

Sample
Size
10,103
8,275
8,831
13,198
13,198
53,605

Missing Data
Missing data was handled using pairwise deletion in which client data were included in analysis
regardless of whether that client had data for all items. The number of client data present for
each item is shown by the “(n= )” in the item headings.
What substance use treatment trends exist in Nebraska over the past 5 years?
Client Age at Admission by Year
Between 2013 and 2017, the percentage of clients between 30 and 39 years old at admission
increased slightly from 26% (n=10,103) to 32% (n=10,162). Concurrently, the percentage of
clients between 40 and 49 years old and those over 50 years old decreased slightly. The
percentage of clients between 21 and 29 years of age and those 20 years of age and younger
stayed consistent at approximately 28% and 6% respectively. For the full Age at Admission by
Year table, see Appendix M.
30-39 Years Old
The percentage of clients between 30 and 39 years old increased slightly.

26%

25%

27%

30%

32%

2013
(n=10,103)

2014
(n=8,275)

2015
(n=8,831)

2016
(n=13,198)

2017
(n=10,162)

Note: The y-axis ranges from 0% to 50% to emphasize the percentage
increase.
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What substance use treatment trends exist in Nebraska over the past 5 years?
(cont.)

Client Sex by Year
Across years, approximately 69% of clients
identified as male and 31% identified as
female.

69%

Client Ethnicity by Year
Between 2013 and 2017, approximately 8%
of clients identified as being of Hispanic or
Latino origin.

8%

Male

Hispanic or Latino Origin

Client Race by Year
Clients who identified as White consistently made up the majority of treatment
discharges, approximately 80%. Clients who identified as Black or African American
made up approximately 9% of discharges and those who identified as American
Indian comprised 8% of discharges between 2013 and 2017. For the full Race by Year table, see
Appendix M.
American Indian
8%
Black
Other
9%
3%

White
80%

Client Marital Status by Year
The percentage of clients by marital status stayed relatively consistent from 2013 to 2017. On
average, 59% of clients had never married; 28% identified as either divorced, widowed, or
separated; and 12% reported being married each year. For the full Marital Status by Year table,
see Appendix M.
Never
married
59%

Divorced/wid
owed/separat
ed
28%

Client Pregnant at Admission by Year
Approximately 3% of clients reported being pregnant at
admission between 2013 and 2017. *Due to NE DHHS’ interest in
drug use behaviors by women of childbearing age, STEPs
requested additional data regarding client pregnancy status at
admission from the DBH Data Team. Between 2013 and 2017,
fewer than 0.5% of female clients were up to 6 weeks postpartum
at time of admission. Overwhelmingly, female clients were neither
pregnant nor within 6 weeks postpartum at time of admission.
*Section updated on 8/6/2020

Married
12%

3%
Pregnant at Admission

<0.5%
*Up to 6 Weeks
Postpartum
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What substance use treatment trends exist in Nebraska over the past 5 years?
(cont.)

Client Education by Year
The educational attainment of discharged clients varied little between 2013 and
2017. The percentage of clients who indicated having 12 years of education or a GED
increased slightly from 50% in 2013 (n=9,483) to 53% in 2017 (n=7,752).
Concurrently, the percentage of clients who reported less than 12 years of education decreased
slightly from 20% in 2013 to 18% in 2014 (n=7,569) through 2017 (n=7,752). For the full
Education by Year table, see Appendix M.

Less than 12
years
18%

More than 12
years
31%

12 years
51%

Client Employment Status at Admission by Year
A higher percentage (22%, n=8,529) of discharged clients
reported full-time employment at admission in 2017
compared to clients in 2013 (16%, n=10,096). Similarly,
slightly less clients reported not being in the labor force at
admission in 2017 (36%) compared to 2013 (41%). The
percentage of clients who reported working part-time or
being unemployed at admission stayed relatively consistent
across the 4 years. For the full Employment Status at
Admission by Year table, see Appendix M.

The percentage of
clients reporting full-

time employment
increased between
2013 and 2017.

Not in labor force
41%
40%

40%

38%

36%

Full-time
16%

18%

20%

20%

22%

2013
(n=10,096)

2014
(n=8,272)

2015
(n=8,820)

2016
(n=12,449)

2017
(n=8,529)

Note: The y-axis for the above graph ranges from 0% to 50% to emphasize
the percentage change.
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What substance use treatment trends exist in Nebraska over the past 5 years?
(cont.)

Client Living Arrangements at Admission by Year
The rate of clients reporting independent living at admission increased from 59% in
2013 (n=9,761) to 77% in 2017 (n=8,072). The percentage of homeless clients and
those reporting a dependent living arrangement at admission decreased at a similar
rate from 2013 to 2017.
The percentage of independent living reported by clients increased
between 2013 and 2017.
59%

61%

58%

70%

77%

2013
(n=9,761)

2014
(n=7,979)

2015
(n=8,471)

2016
(n=11,951)

2017
(n=8,072)

Source of Client Income/Support by Year
Both the percentage of clients indicating no income and those reporting wages or salary
increased between 2013 (n=10,015) and 2017 (n=8,254). The percentage of clients receiving
support from retirement, pension, or disability funding, similar to the percentage of clients
indicating “Not in Labor Force,” decreased from 10% in 2013 to 5% in 2017. The percentage of
individuals receiving public assistance remained relatively consistent. For the full Source of
Income/Support by Year table, see Appendix M.
No income/
support
49%

53%

54%

Wages/salary
29%

31%

2013
(n=10,015)

2014
(n=8,195)

57%

56%

32%

32%

34%

2015
(n=8,735)

2016
(n=12,380)

2017
(n=8,254)

Note: The y-axis for the above graph ranges from 25% to 75% to
emphasize the percentage change.
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What substance use treatment trends exist in Nebraska over the past 5 years?
(cont.)

Planned Medication-Assisted Opioid Therapy by Year
The percentage of clients receiving opioid medications, such as methadone,
buprenorphine, or naltrexone, as a part of their treatment plan stayed relatively
constant from 2013 to 2017, increasing slightly between 2016 and 2017.
2%

2%

2013
2014
(n=10,097) (n=8,272)

2%

3%

5%

2015
2016
2017
(n=8,818) (n=12,981) (n=8,443)

Reason for Client Discharge by Year
The percentage of clients who were discharged from treatment due to treatment completion
decreased slightly between 2013 (65%, n=10,103) and 2015 (60%, n=8,831). Between 2015
and 2017, however, the rate of treatment completion rose to 71% (n=10,162).
65%

61%

2013
2014
(n=10,103) (n=8,275)

60%

66%

71%

2015
2016
2017
(n=8,831) (n=13,198) (n=10,162)

Client Length of Stay in Treatment (Days) by Year
In 2013, 35% of discharged clients stayed in
treatment for 1 day (n=10,103). This
percentage decreased slightly to 27% in 2017
(n=10,162). Between 2013 and 2017, the percentage of
discharged clients in treatment for 2-30 days, 31-90
days, and over 90 days all increased slightly. For the full
Length of Stay by Year table, see Appendix M.

The length of stay in

treatment increased
slightly between 2013 and
2017.
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What substance use treatment trends exist in Nebraska over the past 5 years?
(cont.)

Treatment Referral Source by Year
Between 2013 and 2017, the percentage of client referrals from courts increased
from 49% in 2013 (n=10,099) to 54% in 2017 (n=9,626). The other approximately
half of referrals each year was split between individuals (self-referral) and other
people or entities. “Other people or entities” included alcohol/drug use care providers, other
health care providers, school (educational), employer/EAP, and other community referrals.
Referrals from courts, criminal justice entities, and DUI/DWIs
increased slightly between 2013 and 2017.
49%

52%

51%

49%

54%

2013
(n=10,099)

2014
(n=8,270)

2015
(n=8,826)

2016
(n=12,962)

2017
(n=9,626)

27%
*In the prior 2018⎼2019 drug use behavior Law Enforcement Agency
Probation
9%
study, STEPs found that Nebraska had a very
Defense Attorney
5%
high rate of treatment referrals from the
Court
Order
5%
criminal justice system compared to national
Court
Referral
2%
referrals (59% of referrals in Nebraska; 28%
Drug Court
1%
nationally) in 2017. According to TEDS-A,
Parole
1%
55% of criminal justice referrals came from
Corrections
1%
an “other” source. In addition, many separate
Pre-trial Diversion
0%
referral sources are grouped together in the
Mental
Health
Court
0%
TEDS-A data. For example, as shown above,
Prosecutor 0%
referrals from courts, criminal justice
entities and DUI/DWIs were grouped together in one category. To understand the specific
role of the criminal justice system in referring clients to treatment in Nebraska, STEPs
requested additional referral information from the DBH Data Team. According to the DBH
data, the highest percentage of criminal justice referrals come from law enforcement
agencies (e.g. police/sheriff/highway patrol), which accounted for an average of 27% of
all referrals each year from 2013 to 2017. The second highest source of referrals from the
criminal justice system was probation, which accounted for an average of 9% of all
referrals each year. For the full Detailed Referral Source by Year table, see Appendix N.
*Section updated on 8/6/2020
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What substance use treatment trends exist in Nebraska over the past 5 years?
(cont.)

Substance Use at Admission (Primary) by Year
A lower percentage of clients identified alcohol as their primary substance used at
admission in 2017 (52%, n=10,159) compared to 2013 (65%, n=10,062). At the same
time, the percentage of clients using stimulants at admission increased from 19% in
2013 to 28% in 2017. The percentage of clients using marijuana, opioids, depressants,
hallucinogens, over-the-counter medications, and other substances stayed relatively constant
across years. For the full Substance Use at Admission by Year table, see Appendix M.
Alcohol
65%

64%

59%

55%

52%

Stimulants
19%

19%

22%

26%

28%

2013
(n=10,062)

2014
(n=8,262)

2015
(n=8,820)

2016
(n=13,176)

2017
(n=10,159)

Each year, a small percentage of clients identified no substance use at admission.

None
2%

2%

2%

5%

5%

Frequency of Use at Admission by Year
The percentage breakdown of frequency of use remained relatively consistent across all 4 years.
Nearly half of clients (44%) reported daily use, 28% reported no use in the past month and 28%
reported some use. For the full Frequency of Use at Admission by Year table, see Appendix M.

Daily use
44%

Some use
28%

No use in the
past month
28%
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What substance use treatment trends exist in Nebraska over the past 5 years?
(cont.)

Client Age at First Use by Year
The percentage of clients by age at first use remained consistent from 2013 to 2017. One third
(34%) of clients used the substance identified as their primary substance at age 14 years or
younger. Another one third (32%) first used their primary substance between the ages of 15
and 17 years. The final one third of clients first used their primary substance at age 18 years or
older. For the full Frequency of Use at Admission by Year table, see Appendix M.
14 years or
younger
34%

15-17 years
32%

18-20 yearsOver 21 years
17%
16%

*Number of Previous Substance Use Treatment Episodes by Year
The percentage of clients with no prior treatment episodes increased from 44% in 2013
(n=10,090) to 62% in 2017 (n=10,141).
The percentage of clients with no prior treatment episodes increased
nearly every year.
44%

50%

47%

53%

62%

2013
(n=10,090)

2014
(n=8,266)

2015
(n=8,819)

2016
(n=13,173)

2017
(n=10,141)

*Section moved from original page on 8/6/2020
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*Nebraska Risk and Protective Factor Student Survey
The NRPFSS captures data on students’ risk and protective factors related to substance use and
other behaviors. The data is collected every other fall and made available the following spring or
summer. The current report utilizes data provided to STEPs by the DBH Data Team. Respondents
includes youth enrolled in 8th, 10th, and 12th grades across Nebraska in 2010, 2012, 2014, 2016,
and 2018.
What trends exist for youth substance use in Nebraska?
*Percentage of Youth Indicating Lifetime Substance Use by Substance and Year
Youth were asked to indicate the frequency with which they had used each substance during
their lives. The table below summarizes the percentage of youth who indicated they had used
the substance at least once in their lifetime. As shown, the highest percentage of youth
indicated using prescription drugs at least once in their life followed by inhalants. Over the
past five administrations of NRPFSS, the percentage of youth reporting lifetime use of each
substance has remained relatively stable.
Year

LSD/Other
Psychedelics

Cocaine/Crack

Meth

Prescription
Drugs

Inhalants

2010

2%

2%

1%

6%

7%

2012

2%

1%

1%

4%

5%

2014

2%

1%

1%

4%

5%

2016

3%

1%

1%

3%

5%

2018

2%

1%

0%

4%

4%

*Percentage of Youth Indicating Lifetime Substance Use by Substance and Sex
Youth who identified as male had consistently higher rates of reported lifetime use of
LSD/other psychedelics and cocaine/crack compared to youth identifying as female. In
contrast, youth who identified as female reported higher rates of lifetime use of inhalants and
prescription drugs. The reported lifetime use of meth did not vary much across sexes. For the
full percentages of youth indicating lifetime substance use by substance, sex, and year, see
Appendix O.
5.4%5.1%
4.6%
3.9%
2.4%
1.8%
1.1%1.6%
0.8%0.7%
LSD/Other
Psychedelics

Cocaine/Crack

*Sections added on 8/6/2020

Meth
Female

Inhalants
Male

Prescription
Drugs
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What trends exist for youth substance use in Nebraska? (cont.)
*Percentage of Youth Indicating Lifetime Substance Use by Substance and Grade
On average across survey years, youth in 12th grade reported the highest percentages of lifetime
use of each substance with the exception of inhalants. Youth in 8th grade reported the highest
average lifetime use of inhalants across survey years. The highlighted cell indicates the most
common substance for each grade level.
Substance

8th Grade

10th Grade

12th Grade

LSD/Other
Psychedelics

1%

2%

4%

Cocaine/Crack

0%

1%

3%

Meth

0%

1%

1%

Inhalants

5%

4%

4%

Prescription
Drugs

2%

5%

9%

*Percentage of Youth Indicating Lifetime Substance Use by Substance and Race
On average across survey years, youth identifying as Alaska Native reported the highest
percentage of lifetime use for all substances except for inhalants. Youth identifying as American
Indian reported the higher percentage of lifetime use for inhalants. The highlighted cell indicates
the most common substance for each racial category.

Race

LSD/Other
Psychedelics

Cocaine/
Crack

Black

3%

2%

1%

5%

7%

Asian

12%**

1%

1%

4%

5%

American
Indian

4%

3%

2%

8%

8%

Pacific
Islander

3%

2%

2%

6%

9%

Alaska
Native

6%

4%

3%

6%

11%

White

2%

1%

1%

4%

5%

Other

2%

2%

1%

7%

5%

Meth

Inhalants

Prescription
Drugs

*Sections added on 8/6/2020
**The 2012 DBH data indicated 51% of youth identifying as Asian reported using LSD/Other Psychedelics.
This data should be double-checked for accuracy.
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Summary
Nebraska Hospital Association Discharge Data
1. The number of inpatient discharges with diagnoses related to substance use between January
1 and September 30 of the past 4 years was at its highest point in 2017 and has modestly
declined in the past 2 years. An opposite trend occurred in the emergency department
discharge data with the number of diagnoses related to substance use at its lowest point in
2017 and increased the following 2 years.
2. Individuals discharged from inpatient treatment with diagnoses related to substance use
tended to be older than those discharged from the emergency department. The percentage of
female patients was also slightly higher for inpatient discharges than emergency department
discharges.
3. For both inpatient and emergency department discharges, depressants, stimulants, and
narcotics were the most common substances indicated in diagnoses. However, while the
percentage of depressant- and narcotic-related diagnoses decreased since 2016, the
percentage of stimulant-related diagnoses increased.
4. Behavior Health Region 6 had the highest number of both inpatient and emergency
department discharges. For inpatient discharges, the percentage of patients who resided in
Region 6 had decreased each year since 2016. In contrast, the number of individuals residing
in Region 6 discharged from emergency departments increased each year since 2016.
5. Demographic trends for individuals who were discharged from inpatient and emergency
department treatment stayed relatively consistent in Nebraska since 2016.
TEDS-D
1. Between 2013 and 2017, the percentage of clients who indicated being employed full-time at
admission and those who indicated receiving wages or salary increased slightly.
2. The percentage of clients who reported alcohol as their primary substance decreased between
2013 and 2017, and the percentage of clients who reported stimulant use increased.
3. Across all years, the demographics of discharged clients, such as age, race, ethnicity, and
marital status varied little.
4. The increase in clients reporting independent living from 2013 to 2017 was the most
significant trend indicated by the data.
5. Compared to 2013, clients in 2017 were more likely to indicate no prior treatment episodes
and have a longer stay in treatment.
*Nebraska Risk and Protective Factor Student Survey
1. Youth in Nebraska were more likely to report using prescription drugs at least once in their
lifetime than any other substance. Inhalants were the second most reported substance used.
2. Youth who identified as male had consistently higher rates of reported lifetime use of
LSD/other psychedelics and cocaine/crack compared to youth identifying as female. In
contrast, youth who identified as female reported higher rates of lifetime use of inhalants and
prescription drugs.
3. Youth in 12th grade were more likely to report having used a substance at least once in their
lifetime compared to youth in 8th or 10th grades.
4. On average, youth identifying as Alaska Native reported the highest percentage of lifetime use
for all substances except for inhalants.
*Section added on 8/6/2020
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Directions for Future Research
Nebraska Hospital Association Discharge Data
1. Support Additional Data Collection by Hospitals: According to NHA, hospitals are currently
not collecting data related to race and ethnicity consistently. The collection of this data should
be encouraged as it would allow for an examination of health disparities and barriers to
access to care based on race.
2. Examine Differences between Inpatient and Emergency Department Patients: This
analysis provided some insight to differences between inpatient and emergency department
patients with diagnoses related to substance use. However, the reasons for these differences
have not yet been explored. Some areas for exploration may include comparisons of services
received, health insurance information, and access and availability of treatment options. This
direction for research may provide useful insight for how individuals in Nebraska are
accessing and receiving treatment, as well as any health disparities that may exist. Results
may potentially be used to inform outreach efforts, develop practitioner and research
knowledge, support substance use disorder screening at primary care facilities, encourage
collaborations across healthcare facilities and treatment providers, and design tertiary
prevention efforts.
TEDS-D
1. Continue Longitudinal Analyses: TEDS-D presents several emerging trends in substance use
treatment across Nebraska. The analysis of 2018, 2019, and future years of TEDS data will
help determine the consistency of these trends and monitor any changes that arise. By
continuing to analyze TEDS data as it is published, DHHS will gain additional longitudinal
data, increasing the reliability of results.

2. Conduct Additional Bivariate Analyses: Additional bivariate analyses of the 2013 to 2017
TEDS-D data will support DHHS’ understanding of substance use treatment trends. For
example, an analysis of client race by primary substance used or referral source may further
inform treatment and prevention efforts. This may be particularly relevant for those
populations currently targeted by DHHS efforts.
*Nebraska Risk and Protective Factor Student Survey
1. Utilize Results to Inform Analysis of Other Datasets: Based on the findings that youth of
different gender and racial identities may utilize substances at different rates, consider
examining the primary substance used by client sex and race from the TEDS-D dataset to
understand if these differences persist in adulthood. This may provide insight on how to
provide specific prevention messaging based on target populations.
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LIMITATIONS

Limitations
Nebraska Hospital Association Data
1. Due to the timing of this report, quarter 4 discharge data for 2019 had not been finalized.
This means any year-to-year comparisons for total counts excluded quarter 4 data for 20162018.
2. These datasets included information on hospital discharges from inpatient and emergency
departments, not individuals. Someone who is discharged from inpatient or emergency
department treatment may be represented more than once within the data.
3. As per the CSTE (2019), hospital discharge data “captures [information] for which drug use is
the primary reason, per the admitting physician. Thus, it does not capture admissions for
which drug use may be an ancillary or indirect reason, e.g., a motor vehicle crash injury
caused by drug-impaired driving” (p. 33). This means additional instances of substance use
resulting in inpatient or emergency department admissions are likely excluded from this
dataset.
4. The diagnoses related to substance use are contingent on “the recognition, documentation
and coding of drug use and drug-related diagnoses by hospital staff, all of which are known to
vary” (CSTE, 2019, p. 33). This suggests diagnosis coding may vary across hospitals, which
limits the ability to draw concrete conclusions across jurisdictions.
5. Because diagnosis description data included 297 unique diagnosis descriptions, diagnosis
information needed to be condensed into usable categories for analysis and interpretation.
This condensing may have resulted in a loss of detail on diagnoses, including specific
substances and level of severity.
TEDS-D Data
1. TEDS-D reports information on admissions and discharges to treatment facilities, not
individuals. Someone who is admitted to treatment twice in one year, therefore, may
represent two data points. A client transferring from one service type to another (such as
inpatient to outpatient) may be recorded as an additional admission or discharge depending
on the facility, even if the services were provided within the span of one treatment episode.
2. Most substance use treatment facilities in Nebraska are located within Douglas and Lancaster
counties. TEDS data may disproportionately represent an urban demographic due to their
proximity to treatment facilities and subsequent ease of access to treatment.
3. The sample sizes of variables throughout this report vary due to missing data and differences
in sample sizes across years. These variations in sample size are important to consider when
looking at percentages throughout the report.
4. Not all treatment admissions or discharges are captured by TEDS. While TEDS collects data
from facilities receiving state funds, private treatment facilities and those operated by
hospitals or correctional systems may not be included.
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Limitations (cont.)
*Nebraska Risk and Protective Factor Student Survey
1. Due to differences in survey text across years, the frequency of lifetime use by substances was
analyzed using only two categories: 1) youth who reported never using a substance in their
lifetime and 2) youth who reported using a substance in their lifetime at least once. The
necessary condensing of categories to allow for comparisons across time may have resulted in
the loss of detailed data (for example, any differences among those who have used a given
substance 1-2 times compared to those who have used 10 or more times).
2. While the survey is administered to students in 6th, 8th, 10th, and 12th grade students, a
different version is administered to 6th graders, and it does not include substance use
variables. Therefore, conclusions cannot be drawn about substance use by youth below 8th
grade.
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KEY FINDINGS

Key Findings
STEPs conducted semi-structured interviews with 18 substance abuse treatment providers in
Nebraska. Interviewers asked participants about the clients they serve, the field of substance
abuse treatment, their professional needs, opinions on drug overdose prevention, and what
they would want from a relationship with NE DHHS. STEPs engaged in several rounds of
qualitative data analysis that identified important categories and relationships within the data.
The following are key findings from the analysis of the data:
1. Clients are often caught in a cycle of substance abuse fueled by trauma and mental health
problems but have many strengths and are determined to make positive changes in their
lives.
2. While opioid use is increasing, participants described methamphetamine as the most
commonly used drug in Nebraska. Some participants do not feel NE DHHS is paying enough
attention to methamphetamine use.
3. Substance abuse treatment is drug overdose prevention.
4. There are significant barriers to accessing substance abuse treatment, especially in
residential treatment and especially for women with children and other vulnerable and
marginalized populations.
5. For substance abuse treatment to be effective, clients also need access to housing,
healthcare, and employment. Wraparound services would increase access to and
effectiveness of treatment.
6. When political leaders believe addiction is a choice, they are less interested in funding and
addressing substance abuse issues.
7. Policies that increase access to naloxone and decrease fears of criminalization are crucial in
preventing overdoses, but awareness and knowledge are inconsistent.
8. Education efforts are necessary to reduce overprescribing, promote safe use, raise
awareness and reduce stigma within communities.
9. Treatment providers do not have a clear understanding of who NE DHHS is or their role in
drug overdose prevention. Many defined NE DHHS by their interactions with specific
divisions and sections, like CFS.
10. Participants want an ongoing relationship with NE DHHS and suggested that NE DHHS
develop and maintain a statewide substance abuse treatment resource guide and facilitate
quarterly roundtable discussions.
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RECOMMENDATIONS

Recommendations
Based on interviews with 18 substance abuse treatment providers in Nebraska and the analysis
of the data, STEPs offers the following recommendations:
1. Prioritize Nebraska-specific data when making decisions regarding drug overdose
prevention efforts. While opioid use is a growing concern, treatment providers on the front
lines are still seeing more methamphetamine use and mixed substance use, including
alcohol use.
2. Understand the needs of various stakeholders regarding drug overdose prevention.
Treatment providers have insights into the needs of people who abuse substances, other
professionals, and community members, but these needs may be best identified by these
groups themselves. Consider directly hearing from these voices in future evaluation and
assessment efforts.
3. Provide and advocate for education that reduces overprescribing, promotes safe use,
raises awareness, and reduces stigma within communities. Education should be targeted to
the needs of specific stakeholders. Substance abuse treatment providers identified that they
have educational gaps regarding naloxone access that, if filled, could help them reduce drug
overdoses.
4. Reduce stigma associated with substance use disorders and substance abuse treatment.
While stigma is widespread, intervention activities that target policy makers and political
leadership for stigma reduction may be especially effective in facilitating an environment
that supports treatment and reduces drug overdoses. Interventions should humanize
people with substance use disorders by providing an accurate understanding of who is at
risk and the strengths they possess.
5. Establish an identity for the Drug Overdose Prevention program that is independent of
other state entities that are viewed negatively or with mistrust by treatment providers and
substance use disorder clients, such as CFS and probation. Engaging treatment providers in
a way that honors their expertise and facilitates ongoing communication will help
treatment providers view the Drug Overdose Prevention program as a partner.
6. Create and maintain a statewide resource guide that helps treatment providers make
efficient referrals and connect clients to the right level of treatment. The resource guide
could also serve as an environmental scan that helps inform stakeholder assessment and
strategic planning.
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METHODOLOGY SUMMARY

Methodology Summary
This section summarizes the methodology of the qualitative component of the Drug Use
Behaviors project. The full methodology is described in Appendix P of this report.
Purpose
The purpose of the qualitative component of the Drug Use Behaviors project was to provide NE
DHHS with rich and in-depth information regarding the professional experiences and needs of
drug treatment providers in Nebraska. Through the perspectives and insights of drug treatment
providers, NE DHHS can better understand the experiences and needs of people with substance
use disorders in Nebraska.
Through semi-structured interviews with substance abuse treatment providers and qualitative
data analysis, STEPs answered two primary questions:
1. What insights regarding drug use behaviors do drug treatment providers in Nebraska
have that may inform drug use prevention planning?
2. What are the professional needs of drug treatment providers in Nebraska?
Sampling
Through the survey component of the Drug Use Behaviors project, STEPs developed a sample
pool of 77 substance abuse treatment providers in Nebraska who were interested in
participating in a qualitative interview. From this sample pool, STEPs staff interviewed 18
participants between April 29, 2020 and June 2, 2020. See Appendix Q for interview request
template and Appendix R for the consent handout.
Data Collection
STEPs conducted semi-structured interviews over Zoom, an online videoconferencing service.
STEPs staff followed an interview protocol consisting of six primary questions and multiple,
flexible follow-up questions. See Appendix S for the full interview protocol.
Sample Demographics
STEPs staff collected demographic information from all participants. Participants’ years of
experience in the field ranged from 1 year to 33 years, with 10 years of experience on average.
Participants were all licensed in Nebraska, with the most common license types being Licensed
Alcohol and Drug Counselor (LADC) and Licensed Independent Mental Health Provider
(LIMHP). The diversity of the sample’s geographic and practice settings are summarized in the
following graphics.
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METHODOLOGY SUMMARY

Methodology Summary (cont.)
Geographic Regions Served
West – 2
Rural East – 5
Omaha Metro – 8
Lancaster – 8

Practice Settings and Roles
Field
• Substance Abuse
Treatment

Practice Settings
•
•
•
•
•

Nonprofit
Private practice
Corrections
Residential treatment
Hospital

Roles
•
•
•
•
•

Clinician
Clinical Director
Clinical Supervisor
Community Outreach
Intake Coordinator

Data Analysis
STEPs analyzed the data using the methods of constructivist grounded theory (Charmaz, 2014).
Data analysis included multiple, iterative stages initial coding, focused coding and
categorization, and theory development. The purpose was not to develop a theory in the
traditional sense, but to identify meaningful relationships between the categories and codes
that could tell a narrative about the data. STEPs staff also engaged in memoing throughout the
data analysis process.

Initial Coding

Focused Coding
and
Categorization

Theory Building

Memoing Throughout
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Results
STEPs’ analysis of the data yielded seven key narratives which address the following topics:
1. Client Profile
2. Drug Use Trends
3. Treatment Trends
4. Access to Treatment
5. Funding and Stigma
6. Drug Overdose Prevention
7. Relationship with NE DHHS
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RESULTS

Client Profile
Section highlights:
1. The typical substance use disorder client is defined by shared experiences, rather than
shared identities.
2. Clients are caught in a cycle of substance abuse fueled by trauma and mental health
problems.
3. Clients have many strengths and are very determined to make positive changes in their lives.
4. Women face additional challenges and stressors but are often highly motivated by their
children.
As part of the qualitative interview protocol, STEPs asked all participants, “Please
tell me a little bit about the clients that you serve. Would you say that there is a
typical story among your clients? Or something that all or most of them have in
common?” Based on the analysis of the participants’ responses, STEPs developed a composite
description of clients treated for substance use disorder.
While a few participants used demographic terms, most participants defined the “typical”
substance use disorder client by experiences rather than identities. Participants were
quick to point out that they see clients with a wide variety of identities and backgrounds.
Several participants used similar phrasing to exemplify the variation, “everybody from
multimillionaires to homeless people.” Participants were clear that substance use disorders
affect people of all ages, races, genders, and income level. As one participant stated, “It doesn't
discriminate, it picks on anyone.”

Instead of commonalities in identity, participants highlighted the shared experiences of their
clients. At the core of these shared experiences is trauma. All but two participants explicitly
identified a trauma history as something that all or most of their clients have in common.
“Experiencing trauma” was among the most frequently occurring initial codes within the
analysis. Most participants identified trauma that their clients experienced in childhood and
several participants specified complex trauma, which is trauma that is chronic and long-term.
Participants named poverty; neglect; and physical, verbal, and sexual abuse, as well as
witnessing abuse such as domestic violence, as common types of trauma that their clients have
experienced.
One participant summarized the presence of trauma by saying, “I guess the thing that I feel like
everyone has in common is some form of underlying trauma. The shapes that that takes varies
some, but I very rarely work with someone with a substance use disorder who does not have either
complex developmental trauma or some sort of, usually, relational-based trauma.”
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Client Profile (cont.)
Participants also described clients as typically having a family history of substance abuse,
which was often implicated in their trauma experiences. As one participant put it, “9 times
out of 10 there was a substance use disorder in a close family member or a parent.”
However, there were differences in how participants made meaning of this commonality. Some
participants pointed to a genetic or hereditary component to addiction, while others discussed
environments where drug use was normalized, including children who began using with their
parents. Other participants identified the family history of drug use as leading to children
experiencing abuse, neglect, or other traumatic experiences.
Perhaps unsurprisingly, given their clients’ experiences of trauma and family histories of
substance abuse, participants identified that many of their clients have co-occurring mental
health problems and dual diagnoses. There was variation in how participants described the
proportions of their clients who have or qualify for a dual diagnosis, with estimates from “50%
at least” to “most of them” to “practically everyone.”
Participants brought up clients with dual diagnoses at all stages of the interview, not just when
describing their typical client. In particular, participants noted the lack of substance use
treatment providers and programs prepared to address the needs of dual diagnosis clients.
Additional details on dual diagnoses are discussed in the “Access to Treatment” section of this
report.

In the face of all of these difficulties, participants observed a severe lack of adaptive coping
mechanisms and strategies among their clients, even among clients who had previous
treatment experience. One participant said, “I think again it comes down to a lot of people do not
have coping skills and, even when they've been to treatment and whatnot, they just have not
developed coping skills.”
In the absence of adaptive coping skills, substance use becomes their primary
mechanism. Another participant described this saying, “The majority of drug
and alcohol clients that I [see] have a really difficult time with self-regulation, with
dealing with emotion … it's kind of coping, they just have a difficult time coping and
drugs or alcohol tend to be an escape for them or a way to get away.”
Some participants described these typical client experiences and characteristics without
directly applying a linear, causal relationship to them. Other participants, however, identified
relationships in which these experiences were connected. As one participant put it, “There's
always a reason for addiction, right? Nobody wakes up and says, ‘I wanna be an addict today.’”
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Client Profile (cont.)
Participants identified these relationships as
patterns, processes, or cycles. While no single
participant linearly identified all of these
relationships, the data taken as a whole suggests
that many substance use disorder clients are
caught in cycles that generationally
perpetuate substance abuse.

Family
History

Substance
Use

Trauma
Experiences

Mental Health
Challenges

The participants were clear that their clients
Poor
want to break these cycles. A participant described
Coping
this struggle saying, “I think that [clients] want people to know
that they're just regular people who happen to get caught up in
that addictive process … If you don't treat the trauma, then you can't really treat the addiction. A
lot of what they deal with is multigenerational trauma. And I think that most everybody I work
with would really want you to know that they they're just regular people. They want to be parents,
they want to live their lives like other people do, and they really find themselves struggling to not
be in the middle of their addictive process.”
While attempting to break these cycles can be a significant undertaking, substance use disorder
clients also possess strengths that they can leverage in this struggle. Participants identified a
number of strengths that their clients possess.
Participants described their clients as adaptable, brave, caring, charismatic, compassionate,
connected, creative, determined, driven, empathetic, entrepreneurial, hardworking, humble,
intelligent, motivated, open, patient, persevering, problem-solving, resilient, resourceful,
strong, supportive, survivors, vulnerable, willing, and worthy. The most commonly referenced
client strength was determination.
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Client Profile (cont.)
One participant said of her clients, “I would say that the majority of them have great potential
and drive to be successful. I think that it's very interesting that the majority of them have solid
goals that they want for their life. And they want to achieve things just like everybody else, but of
course, they're dealing with many barriers.” This participant also emphasized that any
investment that NE DHHS makes in providing resources or help to people with substance use
disorders will be used, because clients “want help, they need help, and with that help, they
can be successful citizens.”

Gender-Based Differences
STEPs also asked participants in what ways, if any, the experiences of women,
especially women of a childbearing age, were different. In general, participants
expressed that women with substance use disorders often face additional
challenges and stressors.
Participants identified finances to be a stressor for most clients, but that the burden was
especially high for women. Women start at a financial disadvantage due to gender-based wage
gaps, which participants suggest may be especially large for women with substance use
disorders due to generally lower educational attainment and spotty work histories.
Additionally, several participants highlighted that many women with substance use disorders
have been financially dependent on a man, such as a boyfriend or spouse, including for their
substance use. This financial dependency can make them more vulnerable to abusive
relationships and create additional barriers to leaving abusive relationships and seeking
substance abuse treatment.
Women are also disproportionately responsible for childcare, which can create barriers to
steady employment and additional challenges to finding and affording healthcare, housing, and
supplemental childcare. These stressors can keep women from accessing and continuing
substance abuse treatment and can be triggers for women’s continued substance use.
One participant told us, “We know that women won't go to treatment because they don't want to
leave their children. So, in order to engage women and to help them get into recovery, we have to
not do it the way we think it needs to be done, but we need to listen to what they're telling us, and
they're telling us they need to have their kids with them.”
For women with substance use disorders who have had children removed from their care,
these stressors can be magnified. Participants were clear that, while removal is sometimes
necessary for the safety of the child, disrupting families fuels substance use.
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Client Profile (cont.)
One participant illustrated the dynamic as follows: “The police or whoever has contact with the
family, and there's some substance use going on there, and they automatically pull the kids out of
the home. But then sometimes there's no contact for weeks, just trying to get back into the court
system. I think sometimes that fuels the substance use more than it helps it.” And the burdens of
Children and Family Services (CFS) or law enforcement involvement disproportionately
impacts women because, as one participant told us, “women are expected to do more to get their
kids back.”

While these are significant barriers and challenges that disproportionately affect women,
participants also spoke to women’s strengths. In particular, participants told us that women
are highly motivated by their children to stop or manage their substance use.
Whereas some participants felt that men were more motivated by their employment to seek
treatment, women were often motivated by their children’s well-being and their strong desire
to be good mothers. One participant framed it like this, “We know from the research and from
my practical experience that women are more likely to recover and stay in recovery if they have
their children placed back with them because the biggest motivation, the biggest driving factor, in
women getting clean and staying clean is that they desperately want to be with their kids and to
be really, really good moms.”
Age-Based Differences
STEPs did not directly ask about age-based differences, but several participants
identified ways in which younger clients differed from older clients. Participants
stated their younger clients are more commonly using marijuana and alcohol,
while older clients are more commonly using methamphetamines and alcohol.
Participants also indicated that while involvement with law enforcement was a common
pathway for all clients, younger clients were more likely to be in treatment due to pressure
from family members. However, this dynamic is complicated by some participants reporting
that it is common for younger clients to use substances around or even with their parents.
While these differences are notable, they should also be treated tentatively, as they were not
discussed extensively or consistently by participants.
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Drug Use Trends
Section highlights:
1. Participants identified methamphetamines as the most commonly used drug in Nebraska,
but some do not feel that NE DHHS is prioritizing it appropriately.
2. Opioid use is increasing, and participants want to see interventions that address abuse and
overdoses.
3. More clients are mixing drugs or using any drug type that is available to them.
4. Marijuana use has remained constant, but the marijuana has become more potent and
available.
As part of the qualitative interview protocol, STEPs asked all participants to
identify changes or trends they had observed within the field of substance use
treatment. Almost all participants commented on the use of specific drug types,
although the consensus among participants was that they are not seeing many
changes in this area. According to our participants, the drugs of choice in Nebraska have
consistently been methamphetamines and alcohol.
While many participants identified that dominant methamphetamine and alcohol use has been
the case for some time, they felt that this has not been reflected in NE DHHS priorities. One
participant said, “I would say 90–95% of the folks I work with, meth is their drug of choice. And
meth is still a huge problem in Nebraska, and I feel like we keep forgetting about that. So, I would
just like to remind DHHS of that sometimes. And alcohol will always be one of the top two.”
Instead, some participants felt that NE DHHS is chasing national trends that do not reflect
Nebraska, specifically opioid use. One participant encouraged NE DHHS to stay focused on the
realities of drug use in Nebraska, saying “I think it can be really easy to focus on one aspect of a
problem and get a little bit of tunnel vision on it, which happens a lot in substance use treatment
overall, and not just in Nebraska. There just tends to be an area of treatment where things get
trendy, or things become buzzwords, and then the focus of funding and the focus of training and
the focus of new initiatives becomes very pigeonholed. And that's not always in the client's best
interest, you know.”
This is not to say, however, that participants were not concerned with opioid use in Nebraska.
Opioids were the most frequently discussed drug type in the interviews. While participants did
not view opioid use as being as widespread as methamphetamines, many identified opioid
abuse as a growing problem in Nebraska.
Participants frequently discussed opioids in the specific context of overdose prevention,
highlighting the need for greater access to naloxone and interventions to address
overprescribing. These suggestions are presented in greater detail in the “Drug Overdose
Prevention” section of this report.
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Drug Use Trends (cont.)
In addition to increases in opioid abuse, participants identified increases in clients mixing
drug types and an increase in clients with no drug of choice as trends that they have
observed. Participants stated that abusing alcohol in addition to illicit or prescription drugs has
been common for some time, with one participant saying, “I mean alcohol seems to be a part of
everything.”
Increasingly, though, participants are seeing clients abuse both methamphetamines and opioids
or, in some cases, using mixtures of the two. Some participants felt that they were seeing an
increasing number of clients with no drug type preferences whatsoever, indiscriminate in their
abuse of drugs.
One participant stated, “There's a lot of meth addiction, but they're combining it with other
things such as alcohol and the opiates and the benzos. There's just a lot of multiple drug use. I
don't know if maybe in the past if people just used one, they had a drug of choice. But now it's like
just, ‘Whatever's in front of me.’”
Participants also identified marijuana use as common and consistent, but they
believed that the potency, availability, and potential negative consequences
of using marijuana had increased over time. Speaking to the potency issue,
one participant stated, “I'd also add that just the difference in marijuana from now
and even 2011, when I started in the field. It's just a lot stronger now. It's just not
the same marijuana that it was.”
Other participants spoke to the changes that have come with the legalization of marijuana in
other states, which has changed people’s perceptions of the drug. Participants also noted that
legalization has made marijuana more available and available in more forms than it previously
has been.
One participant pointed to the potential consequences of these changes, even without an
increase in overall marijuana use, saying, “Marijuana used to be kind of a different situation
where it was just viewed as a gateway drug or that type of thing, or it's not as serious. But some of
this high THC-level type things we're seeing from different dispensaries with higher THC levels,
you are seeing a little bit more influx or increase in psychotic symptoms with that use and more
people being hospitalized around that… You can get a lot less or not as much use with more
serious consequences sometimes.”

Finally, while not speaking to any specific drug type, some participants believed that depth of
individual’s substance abuse has become more severe. One participant told us, “It seems to have
gotten a lot worse. People are having a lot more problems in my opinion. So, for a long time I was
with the drug court and I thought I was seeing what could possibly be the worst, but it's gotten
worse since then.”
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Treatment Trends
Section highlights:
1. Regardless of their length of time in the field, participants have seen improvements in
substance abuse treatment.
2. Diagnostic changes have led to more individualized treatment and potentially less stigma
for clients.
3. The field has moved away from abstinence- and shame-based models and has largely
embraced harm reduction and medication assisted treatment approaches.
4. Participants want to see even more individualization in substance abuse treatment.
As part of the qualitative interview protocol, STEPs asked all participants to
identify changes or trends they had observed within the field of substance use
treatment. In addition to trends in clients’ drug use, participants also
substantively discussed trends in substance abuse treatment.
In general, the consensus among participants was that substance abuse treatment has
improved during their time in the field. This was true for both participants with significant
tenure in the field and those who are newer practitioners, suggesting that there are ongoing
positive treatment developments occurring within the field.
One positive treatment development noted by participants is the evolution in diagnostic
conceptualization, criteria, and terminology regarding substance use disorders.
Participants noted the changes that have occurred specifically between the 4th and 5th editions
of the Diagnostic and Statistical Manual of Mental Disorders (DSM).
While many of the details of these changes are technical and primarily of interest to clinical
audiences, participants noted that some of these changes have real impacts on clients. For
example, several participants identified that previous editions of the DSM had differentiated
between clients’ experiences of substance abuse and substance dependence. In the DSM-5,
however, there is one diagnosis of substance use disorder and a continuum of qualifiers, from
mild to moderate to severe.
One participant described how this change has helped her treat her clients saying, “So when we
diagnose someone with a substance use disorder it's on a continuum rather than just, ‘Oh you're
abusing meth,’ or ‘You're addicted to meth,’ which is just black and white. So that's changed a lot
and helps us to kind of meet clients where they're at and match them up to the right level of care.”
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Treatment Trends (cont.)
Another participant noted the change also removes the language of “dependent” or “addict”
when describing the client, which can help reduce stigmatization. Another participant noted
that the change in the remission criteria from 30 days sober to 90 days sober can also help
clients access needed treatment options. In summary, a participant stated that these changes
are not solely semantic but have “changed the way we think” about substance use disorders and
their treatment.
Participants also noted trends of moving away from specific treatment models, especially
ones that required clients to maintain complete abstinence from all substance use and
models that either explicitly or implicitly relied on shaming the client. Participants were
clear that these approaches to treatment still exist and, in some cases, individual treatment
providers or clients may even prefer them, but they are less dominant than they once were.
As the dominance of these approaches wanes, there is increasing room within the field for
other approaches. A participant framed this shift saying, “I would say even 6 years ago, the 12step model was pretty much really what was encouraged, and I feel like [now] facilities are more
open to other types of models for clients in terms of their path of recovery.” Similarly, another
participant stated, “I'd also say that substance use treatment, even before I was in the field, used
to be really, I don't know if ‘punitive’ is the right word, but very, you know, you'd put someone in
the hot seat, and you'd tell them everything that was wrong with them. And put them on the spot
in group therapy and just kind of scare them into sobriety, for lack of a better word. And now
we're a lot more client centered.”
A specific way that participants observed this change was in how the field has
come to treat client relapses back into substance use. Many participants
identified that, within these abstinence- and shame-based models, relapse was
treated as a failure on the part of the client and their treatment. Participants
noted that this approach was both shaming and inconducive to keeping people
in treatment.
One participant described the previous way of viewing relapse as follows: “In an abstinencebased model, with your outcomes, any type of a relapse is considered a failure sometimes. And so
it's kind of looked at that way in programs or in treatment, then sometimes our clients or
participants view it that way, too.” Another participant contrasted this view of relapse with what
they believed was a more contemporary understanding, “I mean, people relapsing is not a
failure. It's a learning process.”
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In the place of these models, participants noted trends of moving towards harm reduction
and medication assisted treatment (MAT) approaches. Participants highlighted many
different treatment approaches and models that have gained greater acceptance in the decline
of abstinence- and shame-based models, including motivational interviewing, eye movement
desensitization and reprocessing (EMDR), and mindfulness-based therapies. However, the
most commonly and frequently referenced treatment approaches were harm reduction and
MAT approaches.

Participants also frequently framed this shift as one of the biggest changes that they have
observed in the field. For example, one participant stated, “Treatment has changed quite a bit
as far as just focusing on relapse prevention or abstinence-type treatment, moving more into
kind of harm reduction or other medication assisted treatment. That's been probably the biggest
change I've seen over the past 18 years.”
Across the board, participants acknowledged the ascent of these approaches and generally
considered this a positive shift. One participant explained, “I think sometimes it's unrealistic to
think the first time that you try to stop using substances, you're going to be completely abstinent
the rest of your life and that's the expectation. Sometimes, harm reduction is the goal.” Similarly,
another participant stated, “Harm reduction is a big thing now. If I'm seeing someone and
you're smoking weed, drinking on the weekends, and using IV meth daily, if I can get you to stop
using IV meth daily, that's a win, you know.”
While participants were generally supportive of these shifts, they did note
several barriers and problems associated with the move towards harm
reduction and MAT. For example, several participants noted that their ability
to fully embrace harm reduction and MAT in client treatment was stifled by
systems to which their clients were accountable, most notably CFS and probation.
One participant summarized the situation, stating, “Sometimes [harm reduction] is not
accepted by HHS or by probation or parole type entities. 'Cause you know you have that strict
guideline of no use whatsoever. So even some appropriate use or healthy use is viewed as a
violation at that point in time. And so sometimes, a treatment model of harm reduction would be
more appropriate for the person you're working with, but because of their legal circumstances,
you can't use it.”
Additionally, some participants noted that they did not use harm reduction approaches in
their work because their treatment setting, residential and corrections, did not allow for it.
One participant stated that, in a residential setting, any drug use on the part of a client could
be triggering to other clients. They also pointed out that not all clients are interested in a
harm reduction approach, stating that harm reduction “doesn't seem to be effective and a lot of
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While not a specific shift in treatment model, several participants identified greater use of
trauma-informed practices as a positive trend. One participant was discussing changes in the
field and stated “What really comes to mind is the focus on trauma. In the past, trauma was kind
of reserved for the strictly mental health domain. And now there's much more focus on [trauma].
While you can go to substance use treatment and learn your recovery and relapse prevention
skills, you really have to heal from those deeper wounds and that deeper pain in order to truly
prevent returning to use in the future.”

While this participant saw greater trauma-informed care in the field, they also qualified the
trend as “leveling-off” and identified a need for greater growth in this area.
Overall, participants were happy with the shifts in treatment approaches, but
they were not completely satisfied with the current state of treatment.
Participants identified several treatment changes that they wanted to see in the
field. The most commonly and frequently identified change was a need for
greater levels of individualization within substance abuse treatment.

Participants repeatedly referenced the need for treatment and treatment providers to “meet
clients where they are.” While participants used this sentiment to advance several changes to the
current state of treatment, they most frequently expressed a need for clients to be able to
access the right level of service at the right time and the need for higher levels of client
self-determination.
One participant made the case for this approach by saying, “We know that when an addict's
ready to get help, they're willing in that moment. And we have to capture that willingness when
it's available because we know the nature of addiction means they're going to go on a bender
again, and it could have the potential for an overdose.”
While participants identified several barriers to greater levels of individualization within
substance abuse treatment, participants frequently named NE DHHS and other state
agencies as significant barriers. In some cases, this was in reference to necessary treatments
not being covered by Medicaid or the regional behavioral health system. In other cases,
participants were referencing actions by CFS or probation that were not client-centered or
interfered with treatment in some way.
One participant spoke to this dynamic, saying, “We have a lot of providers within the agency that
don't want to take HHS cases because they're dictating the care and the level of treatment. And it
just fuels that earlier concept of that, you know, the clients feel like it's a ‘me versus them’
mentality.”
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Section highlights:
1. Substance abuse treatment is drug overdose prevention.
2. There are significant barriers to accessing treatment, especially residential treatment and
especially for women with children and other vulnerable and marginalized populations.
3. For substance abuse treatment to be effective, clients need access to housing, healthcare,
and employment.
4. Participants viewed NE DHHS as a barrier to meeting these basic needs.
5. Some level of wraparound services would increase access to and effectiveness of treatment.
As part of the qualitative interview protocol, STEPs asked all participants about
the resources they needed, changes they believed would reduce drug overdoses,
and what they would want from a partnership with NE DHHS. In response to
these questions, participants mentioned the pressing need for increased access
to substance abuse treatment. Participants were clear that they believe substance abuse
treatment is drug overdose prevention.
When asked specifically about drug overdose prevention, one participant recognized the theme
across many of her responses: “I'm gonna sound like a broken record, but I would say
accessibility to care. If people can get the help when they need it, then the chance of overdose
decreases significantly.”
However, participants identified significant barriers to accessing substance abuse
treatment. Many of these barriers were financial. For many people, especially those without
health insurance or who are seeking services voluntarily, substance abuse treatment can
simply be out of reach financially.
One participant said, “I think it goes back to providing care for individuals who don't have any
resources. The individuals who need the funding to be able to enter into treatment. That's pretty
much all I can come up with as being the barrier. Just being able to provide that service to people
in need, who don't have the resources to do it.”
However, even when financial resources are available, there can still be significant delays in
accessing the needed treatment. Waitlists for services were a particularly frustrating barrier
identified by the participants. One of them said, “The waitlists are long–sometimes weeks. So if I
think that somebody is really needing inpatient treatment and I call somewhere to try to get them
on the waitlist and they'll give me a date like 6 weeks or 8 weeks or something like that. And I just
sit there and I'm like, wow.”
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While participants identified financial barriers as an issue at all levels of treatment, delays in
accessing treatment were most often specific to higher levels of care. Participants identified a
significant lack of inpatient, residential treatment options.
One participant spoke of the volatility of the situation as follows: “Where I run into problems is
maybe getting somebody into an inpatient setting. A lot of times there's waiting lists and we've
got, you know, kind of unstable patients that really shouldn't be sent home that end up being told
there's no inpatient bed.” Another participant spoke of referring Nebraska clients to residential
treatment centers in Kansas saying, “It's easier to get someone in there than it is to get them in
for treatment anywhere in Nebraska.”
For some clients, the waitlist is only one part of the delay. For example, one
participant qualified her waitlist complaint saying, “One of the hardest things is
when someone needs to get into treatment, there's nothing. It's at least a 2-week
wait, and that's if they're accepted on day one.”
And clients often face additional barriers to being accepted for service. One participant spoke
about trying to get letters of agreement so NE DHHS would pay for services, “but that process is
very long and cumbersome so you see services get delayed by a month or two to start. You see
them have delays of weeks in between while they're trying to get the payment funding going. And
again, I just think it's bureaucratic, you know, it's like the caseworker does one thing, hands it off
to another team, and so forth.”
While the general shortage of residential options and subsequent delays are likely to impact all
clients, barriers to access rarely affect all clients equally. As a general rule, barriers to
accessing treatment are not evenly distributed. Clients who are already vulnerable or
marginalized often experience more barriers and experience them more intensely.
For example, some participants identified that women need residential treatment options
that allow them to be with their children. While participants were able to identify programs
that serve mothers and their children, the need is high and the resources severely lacking.
One participant laid out the realities of the situation saying, “One of the biggest barriers that we
run into is finding sober and safe and affordable housing. Because women who don't have children
or men have wide access to halfway houses, three-quarter way houses, right? Like in Lincoln,
where I'm located, I think there are twice or three times as many Oxford houses for men as there
are for women. And, of the three Oxford houses that are available for women, not a single one of
them will allow a woman to bring a child with her at this point in time. So, I only know of one
three-quarter way house in Lincoln that takes women who need to have housing with their
children, and it only has five beds available. So, there is an utter lack of safe, sober support for
women who have children and want to have their children with them.”
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Similarly, clients in rural areas of the state also face unique challenges and barriers to
accessing treatment. For substance abuse treatment providers serving rural regions, the
frustrations abounded. One participant said, “We kind of forget about all these rural areas.
People don't have transportation. There are no treatment centers within a 60-mile radius. It's just
not the same access of care.”
It’s not only difficult accessing care, but the same participant went on to discuss
how some rural clients are punished for their difficulties in accessing treatment.
“Something specific when we look at like HHS clientele, their transportation
provider exists, but a lot of times they won't come to this area... If transportation
cancels on them 2 hours in advance, or a day in advance, they're being
consequenced [sic] for not following through with an appointment.”
And it’s not only treatment centers that are hard to access in rural areas. Participants
specifically noted the lack of rural access to detox services, AA meetings, naloxone, and even
outpatient treatment.
Participants also discussed specific barriers to accessing treatment for clients who are
undocumented, experiencing homelessness, or are currently or were previously
incarcerated. These barriers are often unique and especially burdensome.
For example, one participant who worked within correctional services discussed how many
entities, including insurance companies, use the date of incarceration as the start date of
sobriety. Then, depending on their length on incarceration, some clients are ineligible for
services upon release. The combination of forced sobriety and lack of adequate treatment can
be deadly for clients after they are released. According to the same participant, “A lot of times
they've been sober for 60 days or 90 days, and they use the exact same amount they were using
before coming to jail. They may be on a wait list for treatment, but it doesn't matter because if
they can't get into treatment when they need it, then they're at risk of going and using, and when
they use they're more likely to overdose because they don't know the amount that they can have.”
Other participants discussed the difficulties in accessing MAT while experiencing homelessness
or programs that denied funding to undocumented immigrants. These examples highlighted
the unequal distribution of treatment services with groups who are already vulnerable or
marginalized having greater difficulties accessing substance abuse treatment.
Participants were also clear that, especially for vulnerable or marginalized clients, barriers to
accessing treatment are only part of the equation. Clients with substance use disorders often
need more than just treatment. Participants identified how a general lack of resources in a
client’s life can hinder their ability to consistently attend and be successful in treatment.
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For example, one participant started listing the needs and challenges that many mothers face:
“Daycare, not having enough food to eat, finding a job, adequate transportation, adequate
housing. Usually, if they're in the middle of their own addictive process, they have therapy, they're
expected to go to 12-step meetings. They're expected to do parenting classes. Their kids are
usually in therapy, so there's just significant demands.”
A common client need that participants identified was safe and affordable
housing. While participants mentioned housing needs in a variety of contexts,
they often emphasized it in the context of women with children.
One participant told this story regarding housing: “A lot of the moms that I work with need that
long-term support where they have a place where they have safe housing and safe community
with other moms, but it's not available, right? So we're sending them out into the world, often into
whatever apartment they can find that accepts housing vouchers or Section 8 vouchers from the
Housing Authority. Very often, those are apartments in areas of town that have very concentrated
drug use. So we're sending them back out very quickly, with very little recovery time under their
belts, into the very situation that we just took them out of, and expecting them to function
differently in it, which doesn't just happen magically with just a little bit of treatment.”
Another need that participants consistently identified was for general
healthcare access. Participants described accessing healthcare as a major
source of stress for their clients.
One participant said, “When you're worried about all of these things that you can't access because
you don't have health insurance, it makes it really hard to focus on recovery. So I'd like to think
that if folks had the resources to take care of those, what we might consider like little things - like
going to your doctor's appointments, having access to your medication, having access to a dentist
when you need it - then they could use all of that energy that they'd be saving on actually focusing
on recovery and engaging in treatment and not having to worry about all this stuff in addition to
that.”
Participants also identified employment needs as being important to treatment
success for many clients. Not only does employment generally mean greater
access to financial resources, but it can also mean greater independence for some
clients.
One participant referred to this as the “domino effect,” in which successful employment triggers
“a very positive effect because when you've got someone who starts over and they feel success in
that and they see a future in recovery, there's going to be a huge decrease in drug overdoses
because there's going to be a decrease in use.”
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In some cases, participants viewed NE DHHS as a barrier to clients getting
these basic needs met. Participants described bureaucratic catch-22s in which
clients lose important benefits when they get a job, sometimes leaving them with
fewer financial resources than they had before. Participants also described
caseworkers with unrealistic, and often misguided, expectations for clients that left them with
no good options for bettering their situations. One participant discussed the “unspoken rules”
of caseworkers, which can leave clients frustrated and can unnecessarily prolong separation
from their children.
One participant told a specific and vivid story of a system-involved woman’s struggle. “I
remember a case that this lady had significant drug issues, and she struggled finding a job. She
didn't have very good history with jobs. Had difficulty getting a good reference, and the only job
she could find was a nights and weekends waitressing job. And she did well, it paid well enough to
where she was able to get her car fixed and had transportation for everything, but it didn't work
out. I mean her job interfered with visits that had to be in the afternoon because of other people's
schedule that were in the case. So she ended up basically giving up the job.
The participant felt like the situation did not need to have this outcome, stating, “She wasn't
forced to quit it, but at the same time, she wasn't given any other option for it. So it's situations
like that, that I feel we need to have an open, honest discussion about what we are asking these
parents to do. And how much can we expect them to do given any other constraints. You're asking
them to deal with a substance use disorder while they're dealing with high stress of not having
their kids, in addition to trying to find a job, and their car isn't running, but if they miss a visit,
because they can't get there because their car's broken down, then it's the end of the world.”
While participants identified many significant problems and barriers to treatment, they also
discussed solutions. Participants spoke of expanding access to telehealth services to meet rural
needs. One participant discussed starting a program that increased the availability of treatment
for women with children. Some discussed Medicaid expansion.
Many participants discussed some version or level of wraparound
services as a solution that would significantly increase access to treatment
and success within treatment. Participants felt that a treatment team approach
with coordination of care and access to a wide variety of services would
significantly improve outcomes for many of their clients.
One participant discussed a stalled attempt to implement a program in Omaha to provide these
services: “We had this vision of [a program] where all the services that are needed are under one
roof. So it's kind of a one-stop shop, and it actually got something like this going… and it had to do
with the community taking care of its own and making services available. So easily available that
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The same participant listed the agencies and services that would be needed to
meet people’s needs, saying, “And the bottom line was they put all the services,
including a court room and a judge, probation, treatment, education, whatever a
person needs, it was all not only located in the neighborhood where people needed it, but it was all
under one roof. And this was actually discussed in Omaha a long time ago, but it never went
anywhere.” While this participant’s vision was particularly comprehensive, several participants
expressed a need for a similar program or services.
The most commonly and frequently referenced solution to treatment access issues was
increased funding. Participants believed that many treatment access issues would be solved if
there was adequate funding available, whether that be provided directly to substance abuse
treatment agencies, expanded treatment subsidization, or higher reimbursement rates for
treatment providers.
While directly connected to access to treatment, funding issues were both prevalent and
nuanced enough to warrant their own analysis. See the “Funding and Stigma” section of this
report for a full discussion of funding.

99

Treatment Provider Qualitative Interviews

RESULTS

Funding and Stigma
Section highlights:
1. Funding available for substance abuse treatment is insufficient to meet the need.
2. Lack of funding is directly tied to the stigmatization of substance use and those with
substance use disorders.
3. When political leaders believe addiction is a choice, they are less interested in funding and
addressing substance abuse issues.
4. Community education about substance use and substance use disorders is needed to
increase compassion and reduce stigma.
5. Efforts to reduce stigma and increase access to treatment would benefit entire
communities.
STEPs did not ask participants about funding in the interview protocol, but
participants brought up funding issues and nearly all directly discussed them.
Participants mentioned funding in the context of both the financial needs of
people with substance use disorders and the funding provided to agencies who
support people with substance use disorders.
In both contexts, the consensus was clear: participants felt that the funding available for
substance abuse treatment was insufficient to meet the need and that the lack of funding
is directly tied to the stigmatization of substance use and those with substance use
disorders. Without changes to the funding context, people with substance use disorders will go
without substance abuse treatment and be at risk for overdose.
Participants framed funding as a tool that helps clients access treatment and helps
providers better support clients. The participants largely see this tool as insufficient for the
amount of work that needs to be done in substance abuse treatment.
Participants identified seven funding sources that support substance abuse treatment:
1. Funding through NE DHHS,
2. Funding through state and foundation grants,
3. Funding through the regional behavioral health system,
4. Insurance reimbursement,
5. Payment for service by clients,
6. Private donations, and
7. Funding through probation vouchers.
While almost all participants discussed the need for increased funding, some generally and
some identifying specific funding sources that need increased, many participants also believed
that funding sources are often doing the best they can with what they have.
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While many participants discussed a general need for increased substance abuse treatment
funding, some participants identified specific changes to the current funding landscape.
For example, one participant discussed the need for coordination of care, but that most funding
sources do not currently reimburse for that service.
The participant wanted “reimbursable rates for coordination of care so you can have more
wraparound services for the client. You've got your behavioral health, your medical, your
medication management provider, the whole treatment team being able to collaborate, but right
now that's all unbillable time.”
Another participant identified the ongoing reimbursement rate disparity between medical and
mental health providers as a problem. Several participants also discussed Medicaid expansion
as an improvement that would increase access to substance abuse treatment.
Participants also identified specific gaps in funding that have left some clients without the
means to access substance abuse treatment. While participants recognized that substance
abuse disorders do not discriminate based on socioeconomic status, access to treatment is not
equal. Clients with limited financial resources and who are not system-involved may have
a particularly hard time accessing substance abuse treatment on a voluntary basis.
One participant stated, “If you're not involved with CPS and you're an adult, there really isn't a
system out there unless you go and commit a crime and then the probation system or the judicial
system kicks in. And even that's a minimal amount of support. So somebody who wants to go out
there and do it alone has no financial, has no emotional, has no other support to be able to do it.”
Participants shared that agencies’ use of sliding fee scales sometimes allows
this population to access services but isn’t a sustainable solution. Participants
discussed that when agencies use sliding fee scales and are not reimbursed for
the service, it impacts the available funding for other necessary services.
As one participant explained, “So we charge them on a sliding fee scale ... but we're not getting
any reimbursement for it. And so, program-wise, it is a hit to our budget. And we're deeply rooted
in social work values, so I don't ever see a time when we would turn people away, but it affects our
budget.”
Participants connected the insufficient funding for substance abuse treatment to the
stigma attached to substance at large. Like funding, STEPs did not ask participants directly
about stigma, but most brought it into their interview regardless.
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Participants expressed that the belief of “addiction is a choice” is still prominent and is a major
source of stigmatization for clients and accessing substance abuse treatment. One participant
said, “I think most of society is still in a place of wanting to punish addicts for their choices rather
than trying to understand that no one chooses to be an addict. Yes, they may have chosen to use
substances in the first place, but no one is choosing the utter hell that active, full-blown addiction
is.”
While some participants discussed seeing an overall increase in compassion for substance use
disorder clients over the years, participants were clear that stigmatization remains a major
problem.
While participants discussed stigmatization as widespread, several participants
specifically identified the stigmatizing beliefs of those in positions of political
leadership as having a negative impact on funding availability. According to these
participants, when political leaders believe addiction is a choice, they are
less interested in funding and addressing substance abuse issues.
Instead, substance use is framed as an issue of criminality. For example, several participants
discussed what they believed to be high criminal penalties for drug offenses compared to other
crimes. One participant stated, “I think we could do a better job of educating and rehabilitating
rather than throwing people in jail or prison.”
Some participants discussed decriminalizing substance use to support substance use disorder
clients and reduce stigma. Other participants discussed needle exchange programs as another
way to support clients, but they believe these programs are not available due to the stigma
attached to them. One participant explained, “I don't think it does us any good to act like there's a
moral superiority and addicts who are dying from their addiction deserve it because they made a
choice. And unfortunately, I do still see that attitude explicitly or implicitly in a lot of policy and a
lot of policy makers.”
Participants discussed the need for education in schools and communities
addressing drug use and addiction. Participants believed that education would
decrease stigma and make it easier for people with substance use disorders to
access treatment and support.
While participants believed that education would decrease stigma, they also believed it was not
currently implemented, and in some cases unlikely to be implemented due to stigma. Several
participants identified the misconception that talking about substance use will encourage
substance use as a barrier to meaningful educational interventions.
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However, some participants felt that a general mental health education intervention could be
effective and accessible in ways that substance use education might not be. One participant
described what mental health education should entail saying, “You need to talk about what
mental health is, what it looks like, what are symptoms, it's okay to talk to someone about those
things. Reduce the stigma and then educate on where to find help.”
Some participants also discussed research as a means of reducing stigma. One
participant discussed seeing a recent study showing a correlation between
menstrual cycles and craving cocaine. The participant went on to say, “It could be
the same with the men, too. Like as they age and their testosterone goes down, we
just know that older men tend to like phase out of using. Well, the belief has been for a long time,
they just get, quote, ‘tired of the life.’ But is it connected to their testosterone levels dropping?”
This participant believed that having access to up-to-date biological studies would enhance
treatment methods and the understanding of addiction. However, the participant said studies
like this are not prevalent due to stigma, the prevailing belief being, “why would you invest in
figuring out bad people?”
Participants not only believed that efforts to reduce stigma would increase funding for
substance abuse treatment and benefit people with substance use disorders, but that the
benefits would be felt by entire communities. One participant stated, “Bottom line, it's got to
be important to everyone. The communities have to see value in treating a whole person. That
there's a big investment up front for addictions recovery, but everyone has to see the long-term
effects. You know, we might pay $40,000 to treat this individual, but then they're going to go get a
job, they're going to pay taxes. You know, this is going to pay off down the road, it's just going to
take a while.”
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Section highlights:
1. Naloxone is crucial in preventing overdoses, but knowledge about how to access them is
inconsistent.
2. Pain medication prescribers need more education, training, and resources to reduce opioid
overprescribing.
3. Substance use disorder clients need harm reduction and safe use education in case of
relapse.
4. Decriminalizing drug use behaviors in circumstances where overdoses are occurring may
reduce barriers to accessing emergency services.
As part of the qualitative interview protocol, STEPs asked all participants a series of
questions directly addressing drug overdose prevention. As discussed in the “Access to
Treatment” section of this report, participants felt strongly that substance abuse
treatment is overdose prevention.

However, participants also discussed several other strategies they believed would significantly
reduce the number of drug overdoses in Nebraska. Across the board, participants believed that
increased access to naloxone was preventing overdoses, and they want access to
continue to increase.
Participants had many ideas regarding where naloxone should be distributed in order to
increase access and reduce overdoses. While many participants were aware that naloxone is
available at some pharmacies, they also felt it should be available at or distributed to drug
treatment centers and providers, homeless shelters, law enforcement officers, emergency
rooms and ambulances, hotels, stores and other public places.
Many participants emphasized the need for access not just for those who use drugs, but also
family and community members. Many participants stated that they as treatment providers
should have access or know where to access naloxone for their clients but did not feel properly
educated. One participant stated, “I bet if I walked around and asked three or four counselors
right now, do you know where you could get some NARCAN® for no money? I don't think they
would know what to say or where to go.”
Other opioid overdose prevention strategies suggested by participants focused on increasing
education, training, and resources for pain medication prescribers. Many participants
believed that increases in opioid abuse or overdoses were the result of overprescribing opioids
for pain management.
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Some participants believed that prescribers were not adequately considering patients’
substance abuse histories or exploring alternative forms of pain management before
prescribing opioids. Some participants suggested increased education and training for
prescribers on both the potential dangers of opioid abuse and the availability of alternative
pain management approaches.
While participants believed that clients, medical providers, and insurance companies all have
responsibility for decreasing the use of opioid pain medication, one participant specified that
any educational interventions directed at physicians need to come from within the physician
community in order to be effective. “Well, I think you'd have to have people within the physicians’
community do that… I think it needs to come from within their community to say, ‘Okay, we need
to change this.’”
Some participants discussed utilizing alternative pain management methods as a
way of reducing overdoses. While participants felt that this approach could be
effective, they anticipated barriers to widespread implementation, even beyond
provider education. One participant said, “The biggest barrier I see is insurances.
It's cheaper to treat somebody with one medication than it is to send them to lots of different
services as a total care of that person.”
Another participant suggested that prescribers need increased resources to ensure that opioids
are not overprescribed, such as access to a prescription tracking database.
In addition to providing education to prescribers, participants also suggested education on
harm reduction and safe use strategies targeting people at risk for a drug overdose.
While participants acknowledged that such an approach would be controversial and may not
be politically feasible in all communities, it could be a crucial strategy in preventing overdoses.
One participant said, “I think the education to the clients is one thing. I mean it seems odd to say,
‘If you go back out, don't start at your old amount.’” Several participants identified that
overdoses occur when a client resumes use at the same amount after being sober for an
extended time. Many participants felt that this strategy was not being used due to
misinformation regarding harm reduction.
One participant drew a comparison between drug overdose prevention and suicide prevention
strategies, stating that fear and misinformation keep people from doing what we know works.
“It's no different than like suicide. If you ask a client, are you thinking about suicide, there's this
belief that that's going to plant the seed. And I can see that same kind of mindset with the drug
and alcohol conversation.” The participant stated while it might feel odd to talk about, it is
crucial in preventing overdoses.
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Participants also suggested several community-based education programs.
Some participants brought up in-school and afterschool programming for young
people, but participants had different visions for these programs. Some
suggested drug use prevention education and safe drug use education, and others
envisioned general mental health awareness education. Other participants believed that the
whole community not just young people needed education. One participant felt that many
people were not aware of the level of drug use occurring within their communities and, if they
became aware, they would be more involved in substance use prevention.
Participants also noted the need for emergency services to be contacted in the
case of an overdose but believed that clients were reluctant to call out of fear of
arrest. Participants felt that decriminalizing drug use behavior in situations
where an overdose has occurred may increase the likelihood of emergency
services being contacted.
One participant stated, “The biggest piece of that, I think, is making sure that we're
decriminalizing any activity that's happening if someone were to call for help for an overdose, if
that makes sense. You know, like if there's four people in a place that has a lot of paraphernalia,
and one person is overdosing, and nobody wants to call 911 because they're afraid that they'll all
get charged with possession charges.”
Some participants also suggested other forms of drug decriminalization, such as reducing
sentencing associated with drug possession, but it was less clear that participants believed
those suggestions would reduce drug overdoses.
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Section highlights:
1. Treatment providers do not have a clear understanding of who NE DHHS is or their role in
drug overdose prevention.
2. Many participants defined all of NE DHHS by their interactions with specific divisions and
sections, like CFS.
3. Participants are interested in developing partnerships with NE DHHS if they feel that their
subject matter expertise will be valued.
4. Participants had specific suggestions for actions steps they would like NE DHHS to take,
including developing and maintaining a statewide substance abuse treatment resource
guide and facilitating quarterly roundtable discussions.
As part of the qualitative interview protocol, STEPs asked all participants, “What
would it look like if NE DHHS were to be a full partner to you in your work?” and
a series of follow-up questions regarding their experiences with and expectations
of NE DHHS.
While participants gave a notably diverse set of responses to these questions, several
participants responded by trying to understand from the interviewer what NE DHHS’ role in
overdose prevention is. One participant said, “I don't know much about how DHHS contributes to
preventing overdose and getting people substance abuse treatment. Could you give me some
information on how DHHS is doing that now?” This questioning of the interviewer exemplifies
the general confusion that participants had regarding NE DHHS and its role in preventing
drug overdoses.
Another common response from participants was to define the entirety of NE DHHS by the
division, section, or subsection with which they had the most interaction. Participants
frequently associated NE DHHS with CFS or Medicaid or even with systems outside of NE
DHHS, such as probation.
These associations made sense to the participants because of the important and emotionally
charged role that these state entities play in the lives of their clients and in their own
professional experiences. These associations were elevated in the analysis not only due to the
number of participants who made them or the frequency with which they brought it up, but
because of the intensity of the statements that they made.
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Relationship with NE DHHS (cont.)
One participant for example, shared these feelings when asked about NE DHHS: “Okay, yeah, I
have strong reactions to the CPS system. I think it is a huge failure to our families that we work
with … I know that their primary goal is child well-being and child safety and that absolutely
should be. I don't think it has to be mutually exclusive with parental involvement. I think parents
are vilified; I think they're not given chances. I think there's an automatic belief about the parents
that use substances and there's an automatic alignment with the foster parents.”
The participant explained how this belief impacts clients and their treatment success. The
participant shared, “The clients want the system to know that they are not bad people. We try so
hard to help them work on shame. And it's really hard to do that when there are systems that
continually perpetuate their belief that they should be ashamed.”
The participant went on to discuss how this relationship with NE DHHS not only impacts
clients, but also the treatment providers who work with them. “So the therapists in my
programs spend more time than what they need to be spending–because we don't get paid for this
work, right?–advocating for our clients. We're happy to do it, that's what helps with the
relationship, but [the therapists] shouldn't have to spend this much time advocating to a system.”
Not all participants had such intense and negative reactions to NE DHHS. Several
participants described generally good and functional relationships with NE
DHHS. One participant said, “I've got a pretty good working relationship with our,
well, what I consider DHHS, I'm talking about Child Protective Services and Adult
Protective Services and then Developmental Disabilities Services that I work with.”
Many other participants simply described a neutral relationship with NE DHHS. For example,
one participant discussed a primarily transactional relationship, saying, “I see the Department
of Health and Human Services as a referral source and a resource for a number of different things
that I may need or that my clients may need.” The participant went on to say, though, “As far as
seeing them as a partner in things? I feel like, especially with drug overdose stuff–and maybe I just
need to look a little bit harder–but I haven't seen a whole lot of trainings or different
opportunities to learn about what exactly they are doing when it comes to stuff like this.”
Participants were generally interested in what NE DHHS was doing to prevent drug overdoses
and how they might be a partner. Specifically, participants expressed interest in a relationship
in which NE DHHS valued treatment providers for their subject matter expertise and
were actively helping treatment providers provide better services.
Some participants expressed these interests in very general ways or described it as a feeling
that they would get when it was true, but other participants had very specific ideas for how NE
DHHS could help foster this sort of relationship. Participants brought up–and fleshed out with
some level of detail–three specific suggestions.
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Relationship with NE DHHS (cont.)
The first suggestion was for NE DHHS to create and maintain a statewide substance abuse
treatment resource guide, which would include programs and providers, the services they
offer, and accepted payment methods. One participant added, “And even knowing what levels of
care are available at what agencies and their payment sources so that we can move this along
much quicker and not have gaps in service.”
Many participants discussed not knowing what levels of care are available at each agency
because services change depending on available funding. One participant stated, “It's somewhat
hard to find. And when we do find–we've created a list, we're actually updating our list and
looking through all the different internet sources and calling all the different places, but then
levels of care change all the time or people stop providing a certain level of care or they change
their referral process. And we just don't have the resources to keep updating that list every
month.” Participants hoped that a resource guide like this would help them connect substance
use disorder clients to appropriate resources quicker and would enhance treatment for
individuals.
The next suggestion was for NE DHHS to better support their CFS caseworkers and
implement changes to improve relationships between treatment providers and
caseworkers. Some participants believed that if caseworkers were better supported through
access to advanced trainings, they’d be better equipped for the difficult situations they
encounter.
One participant suggested the following: “Maybe some education and training to the HHS
workers, like the people who are working with their clients around drug and alcohol needs and
levels of addiction and/or levels of treatment and stuff, so that way the people who maybe are
getting a call first can recognize more clearly and quickly the severity of what they're dealing
with. I don't know what they receive now. And not that their training now is poor, but I would just
say that the more people know, the better.”
Participants also discussed feeling their relationship with caseworkers was
“purely transactional,” with some noting that communication between them only
occurs “right before court.” Some participants felt this lack of communication and
teamwork hindered progress for their substance use disorder clients.
Participants believed that having conversations between all team members on
these cases would improve outcomes. One participant stated, “I think it would just help get
everybody on the same page about what perspective they're bringing that from.”
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Relationship with NE DHHS (cont.)
Other participants discussed feeling that NE DHHS caseworkers did not respect their
recommendations for clients. One participant said, “So often we might make a recommendation,
but we will get called by the caseworker wanting that recommendation changed based on they
think it‘s too much treatment, or they need less treatment, right? And I just feel like a lot of times
those caseworkers are making clinical decisions that they should not be.” Participants stated
decisions made by both practitioners and caseworkers regarding treatment “are incredibly
impactful to these families, like lifelong impacts. And sometimes these decisions appear to be
taken fairly lightly, from [the caseworker’s] end. So, them trusting more the treatment providers.”
Finally, participants discussed the segmented way the system currently works,
which leaves them feeling left out of the loop on issues that impact their practice.
Participants felt like they did not understand what decisions were being made or
how they were being made regarding issues like funding availability or the
selection of priorities or the incorporation of various standards or best practices.
Participants suggested quarterly roundtable discussions between substance abuse
treatment providers and NE DHHS administrators to help bridge this gap. Multiple
participants stated participating in the interview was a good first step in improving
communication.
As one participant put it, “I think this is the first time anyone from a policy standpoint, and I know
that's coming down through the lens of program evaluation in this specific situation, has ever
asked me what we even need, kind of like on the ground level.” Participants would like to continue
to be asked about their needs and experiences as well as informed about NE DHHS’ roles and
services.
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Limitations
All research has limitations. The findings and recommendations within this report should be
understood in the context of the following limitations:
1. STEPs made changes to the sampling procedure during the recruitment phase. In these
changes, STEPs prioritized a larger sample size, which often provides more data, over the
use of theoretical sampling, which often provides richer data.
2. While the sample size was well within the acceptable range for qualitative research, it may
not have been fully saturated, and additional findings may have developed from additional
data.
3. Participants in the qualitative study are a subsect of participants from the quantitative
survey. While the results of the two studies can inform one another, overlapping results
should not be interpreted as verification. It is not known if this sampling strategy restricted
the range of the data.

4. STEPs used purposeful, criterion sampling. While STEPs attempted to recruit a
geographically diverse sample of substance use treatment providers, the sample should not
be viewed as representative of all substance use treatment providers in Nebraska.
5. STEPs conducted all interviews via Zoom, an online videoconferencing platform. While
researcher and participant satisfaction with qualitative data collection via Zoom has been
documented, it is unknown if the use of this platform affected the type or quality of data
compared to in-person interviews.
6. STEPs conducted all interviews during the COVID-19 pandemic. It is not known if this
affected the type or quality of data collected.
7. Bias exists within all research. STEPs used two coders who engaged in initial coding
independently and subsequent data analysis collaboratively in an effort to reduce the
impact of bias.
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Initial Email to Treatment Providers
Hello,
We are seeking input from outpatient substance use treatment providers throughout
Nebraska. If you are not currently an outpatient treatment provider, we ask that you please
forward this survey to any outpatient treatment providers at your practice or agency.
The Nebraska Department of Health and Human Services (DHHS) has contracted with the
University of Nebraska at Omaha's STEPs (Support and Training for the Evaluation of
Programs) to conduct a survey with treatment providers across Nebraska. Results of the
survey will be used to inform DHHS on future treatment and prevention programs.
• Survey responses will be anonymous and will be sent directly to STEPs.
• We expect this survey to take 10 to 12 minutes to complete.
• The survey will remain open until a desired number of responses are gathered, so please
make sure your voice is heard!
Please complete the survey by clicking below:

Click Here
Thank you for your help with this project. Your feedback is invaluable and will be used to
improve Nebraska’s prevention and response efforts. If you have any questions, please contact
STEPs at steps@unomaha.edu.
Follow-Up Email to Treatment Providers
Hello,
You were recently invited to participate in a 10- to 12-minute treatment provider survey
regarding clients’ misuse of substances. Please make sure your voice is heard.
• Results will be used to inform DHHS on future treatment and prevention programs.
• Responses are confidential.
• If you have already completed the survey, please disregard this email.
Please complete the survey by clicking below:

Click Here
Thank you for your help with this project. If you have any questions, please contact STEPs at
steps@unomaha.edu.
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Appendix B
Survey7

Treatment Providers
Thank you for taking part in this important survey to gauge drug use behaviors, treatment
needs, and prevention efforts through the lens of treatment providers across Nebraska.

This survey is part of a statewide needs assessment by the Nebraska Department of Health and
Human Services' (DHHS) Division of Public Health to focus prevention efforts, provide training
and other resources to treatment centers, prepare for a more in-depth study in the near future,
and inform their strategic plan.
This survey is administered by STEPs (Support and Training for the Evaluation of Programs)
through the University of Nebraska at Omaha. Aggregate responses to this survey will be used
by DHHS to allocate grant funds, resources, and develop a strategic plan.

We expect this survey to take 10-15 minutes to complete. Responses will be received and
analyzed by STEPs; you will remain anonymous. The STEPs team will provide a final report with
recommendations to DHHS using your invaluable feedback. The final report will be made
available to you through DHHS.

Provider Information
We would like to know about you and the services you offer.
1.

Which professional licenses or certifications do you have? (select all that apply)
• Licensed or Provisionally Licensed Alcohol and Drug Counselor (LADC or PLADC)
• Licensed Independent Mental Health Provider (LIMHP)
• Licensed or Provisionally Licensed Mental Health Provider (LMHP or PLMHP)
• Licensed Independent Professional Counselor (LIPC)
• Licensed or Provisionally Licensed Professional Counselor (LPC or PLPC)
• Licensed Independent Clinical Social Worker (LICSW)
• Certified or Provisionally Certified Master Social Worker (CMSW or PCMSW)
• Other (please specify): __________

2.

In which county or counties do you provide substance use treatment? (select multiple
counties by holding down Ctrl (on a PC) or Cmd (on a Mac) when clicking)
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Appendix B (cont.)
Treatment Providers
3.

Survey7

Provider Information
In which counties do your clients typically reside? (select multiple counties by holding
down Ctrl (on a PC) or Cmd (on a Mac) when clicking)

4.

Do you provide substance use treatment in an outpatient setting?
• Yes
• No

5.

Do you refer clients for any of the following medications? (select all that apply)
• Disulfiram
• Naltrexone
• Acamprosate
• Methadone
• Buprenorphine
• Suboxone
• Medications for psychiatric disorders
• Other (please specify): __________

Substance of Choice
For this section, we are interested in hearing your perceptions of the most common and most
recent trends in substance use among the clients you serve. For the following questions, please
give your best estimate based on the clients you have seen.
6.

Thinking about clients presenting for substance use over the past year,
approximately what percentage of these clients have presented needing treatment
for the use of: (choose % on a slider)
The substance indicated below need not be their primary drug of choice. (Total must sum to
100%)
• Alcohol
• Prescription pain relievers (i.e. hydrocodone, oxycodone, etc.)
• Heroin
• Fentanyl (including prescription or illicit)
• Methamphetamines
• Benzodiazepines
• Antidepressants
• Marijuana
• Hallucinogens (i.e. LSD, PCP)
• Inhalants
• Cocaine/crack
• Other (please specify): __________
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Survey7

Treatment Providers
7. Thinking about clients you treated for substance use over the past year, what have
been their most common primary drugs of choice? (select all that apply)
• Prescription pain relievers (i.e. hydrocodone, oxycodone, etc.)
• Heroin
• Fentanyl
• Methamphetamines
• Benzodiazepines
• Antidepressants
• Marijuana
• Alcohol
• Hallucinogens (i.e. LSD, PCP)
• Inhalants
• Cocaine/crack
• Other (please specify): __________
8.

In the past year, what percentage of your clients have had an opioid use disorder
(prescription pain relievers, fentanyl, heroin)? (choose % on a slider)

9.

In the past year, what percentage of your clients were polysubstance dependent?
(choose % on a slider)
Polysubstance dependence refers to a type of substance dependence disorder in which an
individual uses at least three different classes of substances indiscriminately and does not have
a favorite drug that qualifies for dependence on its own (Encyclopedia of Mental Disorders,
2019).

10. We would like to know about trends you are seeing in the use of multiple substances.
For each of the primary substances listed below, please indicate the drug or drugs
that you commonly see paired with each substance. (open ended box after each option)
For example, if a common substance combination is methamphetamines with alcohol and
prescription pain relievers, please type "alcohol and prescription pain relievers" in the box
next to "methamphetamines."
• Alcohol
• Prescription pain relievers (i.e. hydrocodone, oxycodone, etc.)
• Heroin
• Fentanyl
• Methamphetamines
• Benzodiazepines
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Survey7

Treatment Providers
10. (continued)
• Antidepressants
• Marijuana
• Hallucinogens (i.e. LSD, PCP)
• Inhalants
• Cocaine/crack
• Other (please specify): __________
Drug Use Initiation
For this section, we would like to hear your perceptions about your clients’ experiences of
initiation to drug use. For the purposes of this survey, “drug use initiation” is defined as the first
misuse of a substance. For example, the first time binge drinking rather than the first time
tasting alcohol.
11. What is your perception of the most common substance that is first misused by your
clients? For example, choosing alcohol would convey that most clients first began
their misuse of substances by using alcohol, regardless of the current substances they
misuse.
• Prescription pain relievers
• Heroin
• Fentanyl
• Methamphetamines
• Benzodiazepines
• Antidepressants
• Alcohol
• Marijuana
• Cocaine/crack
• Other (please specify): __________
12. What age do most clients you serve indicate as their first misuse?
• 14 years or younger
• 15-18 years old
• 19 years or older
13. In your opinion, what are the most common reasons for clients’ first substance
misuse? (select all that apply)
• Pain relief
• Relax or relieve tension
• Experiment/see what it’s like
• Feel good/get high
• Help with sleep
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Treatment Providers
13. (continued)
• Help be alert or stay awake
• Help study or concentrate
• Help with feelings or emotions
• Help lose weight
• Parents or other family members encouraged them to
• Peers encouraged them to
• Other reason (please provide the reason): __________
14. Where did clients most commonly get the substance they first misused?
• From a doctor
• Stole from doctor’s office, clinic, hospital, or pharmacy
• From friend or relative for free
• Bought from friend or relative
• Took from friend or relative without asking
• Bought from drug dealer or other stranger
• Some other way (please provide source): __________
Treatment Barriers and Facilitators
For this section, we would like to hear your perceptions about your clients’ treatment
experiences. We are interested to hear about what motivates clients to enter treatment
(facilitators) and what prevents them from seeking treatment (barriers).
15. What are the most common reasons people do NOT receive treatment? (select all
that apply)
• No healthcare coverage and cannot afford cost
• No transportation/too far away
• Hours inconvenient
• Do not want treatment; lack motivation to stop using
• Takes too long to access treatment; window of motivation closes before treatment is
available
• They do not think they need treatment
• They do not think treatment will help
• They do not want others to find out they need treatment
• Too embarrassed, ashamed, afraid, or prideful
• Other problems to deal with (emotional, family, etc.)
• Family members/others are unsupportive
• Do not know how to access treatment; do not know where to start
• Fear of having children removed from the home
• Other (please specify): __________
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Treatment Providers
16. Which of these statements best describes how your clients were prompted to get
treatment? (select all that apply)
• They decided on their own to get treatment
• They got treatment because someone else thought they should
• They were ordered to get treatment
• Injury or near-death experience
• Overdose or witnessing an overdose
• Other health issue
• Other (please specify): __________
17. For what percentage of your clients in the past year was this their first treatment
experience EVER?
A “treatment experience” refers to any professional help they have received for substance
use, inclusive of outpatient, intensive outpatient, and residential programs. (choose % on a
slider)
Prevention Efforts
For this section, we would like to hear your experiences and ideas related to current and future
prevention efforts. We would also like to know what needs you have, and what needs your
clients have, that DHHS may be able to fill in the future.
18. In your opinion, what prevention efforts are most helpful? (select up to three in each
category)
Primary Prevention (targeted at non-users and general public)
• Prescriber education
• Public service announcements (PSAs) and media campaigns for general public
• Public education about medication assisted treatment (MAT)
• School-based substance use prevention programs for elementary students
• School-based substance use prevention programs for middle school students
• School-based substance use prevention programs for high school students
Secondary Prevention (targeted at early use, before serious complications)
• Addiction screening at primary care facilities (similar to ways in which they might screen
for mental health)
• Addiction screening for those presenting for early refills (to refer for treatment and
services)
• Use of Prescription Drug Monitoring Program before prescribing controlled substances
Tertiary Prevention (rehabilitation strategies after addiction is established, targeted at
heavy users)
• Medication assisted treatment (methadone, buprenorphine, naltrexone, suboxone)
• Mandatory counseling and services with buprenorphine or naltrexone administration
(similar to methadone requirements)
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18. (continued)
Tertiary Prevention (rehabilitation strategies after addiction is established, targeted at
heavy users)
• Increased access to 12-step programs
• Increased access to mental health treatment
• Increased access to and training on naloxone
• Education about harm reduction practices (i.e. how to clean needles, reducing the
amount of the substance used)
19. In your opinion, what populations are most in need of additional substance use
prevention efforts? (select up to five)
• Current substance users
• Adults (26-64 years)
• Young adults (18-25 years)
• Middle school and high school students
• Elementary school students
• Persons in rural areas
• Families living in poverty
• Persons who lack a stable residence
• Incarcerated individuals
• Individuals with mental illness
• Women of child-bearing age
• American Indians/Alaska Natives
• Latinos/Latinas
• Other (please specify): __________
Training and Resources for Treatment Providers
For this section, we would like to know about any needs you have for training or resources, both
for yourself as a provider and for your clients.
20. What training have you received that has been helpful to your work?
21. Which of the below topics would be useful for future training for yourself or other
staff at your facility? (select up to five)
• Medication assisted treatment (methadone, buprenorphine, naltrexone, suboxone)
• Harm reduction (i.e. safe injection practices, reducing the amount of the substance used)
• Client assessments (i.e. trauma screening tools, addiction screening tools, etc.)
• Evidenced-based treatments (i.e. EMDR, DBT, TF-CBT, etc.)
• Trauma-informed care
• Alternative pain management strategies
120

APPENDICES: LADC/PLADC Quantitative Survey

Appendix B (cont.)
Survey7

Treatment Providers
21. (continued)
• Co-occurring disorders
• Compassion fatigue, stress, and burnout
• Ethics and boundaries
• Prescription Drug Monitoring Program (PDMP)
• Physical and mental effects of substance use
• Naloxone use and/or administration
• Treatment for opioid addiction
• Treatment for methamphetamine addiction
• Non-substance use addictions (i.e. gambling, internet, etc.)
• Domestic violence
• Other (please specify): __________
22. What additional resources do your clients need? (select up to five)
• Naloxone kits
• Condom distribution
• Financial assistance for medication assisted treatment (MAT)
• Childcare
• MAT prescriber
• Funding for rural area
• Education about MAT
• Reduction in waiting lists and wait time
• Facilities that accommodate women with dependent children
• Community outreach
• Other (please specify): __________
23. What would you most like DHHS to know about your clients and your work?
24. DHHS is committed to hearing directly from providers about needs and trends as they
develop future programming. Would you be willing to participate in a follow-up
interview or focus group on drug use behaviors?
• Yes (if yes, please provide email address or send a brief email to steps@unomaha.edu
indicating your interest): __________
• No
Thank you for taking the time to complete this survey.
Your responses will be used to inform the work of the Nebraska DHHS’ Division of Public Health.
STEPs will analyze responses collectively, and respondents will remain anonymous.
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Acronym Index
Acronym

Definition

CMSW or PCMSW

Certified or Provisionally Certified Master Social Worker

DHHS

Nebraska Department of Health and Human Services

DOP

Drug Overdose Prevention

DUB

Drug Use Behaviors

EBP

Evidence-based practice

LADC or PLADC

Licensed or Provisionally Licensed Alcohol and Drug Counselor

LICSW

Licensed Independent Clinical Social Worker

LIMHP

Licensed Independent Mental Health Provider

LIPC

Licensed Independent Professional Counselor

LMHP or PLMHP

Licensed or Provisionally Licensed Mental Health Provider

LPC or PLPC

Licensed or Provisionally Licensed Professional Counselor

MAT

Medication Assisted Treatment

STEPs

Support and Training for the Evaluation of Programs
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Nebraska Region Index by County
Lancaster
Lancaster

Omaha
Metro
Douglas
Sarpy

Rural East
Adams
Wayne
Antelope
Webster
Boone
York
Burt
Cass
Butler
Cedar
Clay
Colfax
Cuming
Dakota
Dixon
Dodge
Fillmore
Gage
Hall
Hamilton
Jefferson
Johnson
Knox
Madison
Merrick
Nance
Nemaha
Nuckolls
Otoe
Pawnee
Pierce
Platte
Polk
Richardson
Saline
Saunders
Seward
Stanton
Thayer
Thurston
Washington

Arthur
Banner
Blaine
Box Butte
Boyd
Brown
Buffalo
Chase
Cherry
Cheyenne
Custer
Dawes
Dawson
Deuel
Dundy
Franklin
Frontier
Furnas
Garden
Garfield
Gosper
Grant
Greeley
Harlan
Hayes
Hitchcock
Holt
Hooker
Howard
Kearney
Keith
Keya Paha
Kimball
Lincoln
Logan
Loup
McPherson

West
Morrill
Perkins
Phelps
Red Willow
Rock
Scotts Bluff
Sheridan
Sherman
Sioux
Thomas
Valley
Wheeler
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Appendix E
Helpful Prevention Efforts (n=189)
In your opinion, what prevention efforts are most helpful?
The full list of response options are provided in Appendix B.
Primary Prevention:
Percentage of Providers Who Indicated the Prevention Effort as Helpful
School-based substance use prevention
programs for middle school students

44%

School-based substance use prevention
programs for elementary students

34%

School-based substance use prevention
programs for high school students

32%

Prescriber education

32%

Public education about medication assisted
treatment
Public service announcements and media
campaigns for general public

13%

10%

Secondary Prevention:
Percentage of Providers Who Indicated the Prevention Effort as Helpful
Addiction screening at primary care facilities
Addiction screening for those presenting for
early refills
Use of Prescription Drug Monitoring Program
before prescribing controlled substances

52%
30%
26%

124

APPENDICES: LADC/PLADC Quantitative Survey

Appendix E (cont.)
Helpful Prevention Efforts (n=189)
In your opinion, what prevention efforts are most helpful?
The full list of response options are provided in Appendix B.
Tertiary Prevention:
Percentage of Providers Who Indicated the Prevention Effort as Helpful
Increased access to mental health treatment

80%

Medication assisted treatment

27%

Education about harm reduction practices

24%

Increased access to 12-step programs

21%

Mandatory counseling and services with
buprenorphine or naltrexone administration
Increased access to and training on naloxone

16%
6%
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Appendix F
Populations in Need of Prevention (n=189)
In your opinion, what populations are most in need of additional substance use prevention
efforts?
The full list of response options are provided in Appendix B.
Percentage of Providers Who Indicated the Population as Most in Need
of Prevention
Middle school and high school students

62%

Young adults (18-25 years)

61%

Individuals with mental illness

59%

Families living in poverty

40%

Current substance users

35%

Adults (26-64 years)

34%

Persons who lack a stable residence

29%

Incarcerated individuals

28%

Persons in rural areas

25%

Elementary school students

23%

American Indians/Alaska Natives

10%

Women of child-bearing age

10%

Latinos/Latinas

2%

Other

3%
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Future Training Topics (n=188)
Which of the below topics would be useful for future training for yourself or other staff at your
facility?
Percentage of Providers Who Indicated Interest in the Topic for Future
Training
Co-occurring disorders

56%

Evidenced-based treatments

54%

Alternative pain management strategies

37%

Trauma-informed care

37%

Compassion fatigue, stress, and burnout

36%

Client assessments

35%

Physical and mental effects of substance use

34%

Medication assisted treatment

34%

Non-substance use addictions

29%

Harm reduction

25%

Ethics and boundaries

23%

Domestic violence

23%

Treatment for opioid addiction

22%

Naloxone use and/or administration

15%

Prescription Drug Monitoring Program
Treatment for methamphetamine addiction
Other

11%

0%
4%
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Appendix H
Additional Resources for Clients (n=178)
What additional resources do your clients need?
Percentage of Providers Who Indicated Interest in the Future Training
Topic
Financial assistance for medication assisted
treatment (MAT)

52%

Reduction in waiting lists and wait time

51%

Community outreach

47%

Facilities that accommodate women with
dependent children

46%

Funding for rural area

45%

Childcare

45%

Education about MAT
MAT prescriber
Naloxone kits
Condom distribution
Other

22%
18%
15%
13%
10%
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Click on the section headings below to navigate to
that page. Click on the compass symbol in the top
right-hand corner of each page to return to the
overall Table of Contents.
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Drug Use Behaviors Background
Support and Training for the Evaluation of Programs (STEPs) at the University of Nebraska at
Omaha is a leader in conducting evaluations of and needs assessments for social service
programs and policies. The Nebraska Department of Health and Human Services (DHHS) Drug
Overdose Program (DOP) contracted with STEPs in the fall of 2019 to complete a needs
assessment that included an identification and analysis of quality datasets, a survey of
outpatient treatment providers, and focus groups with treatment providers.

Purpose
The goal of this needs assessment is to deepen DOP’s understanding of individuals’ drug
use behaviors in Nebraska through the lens of treatment providers.
The results of this study will aid DOP in providing training and other resources to treatment
centers, focusing prevention efforts, and informing their strategic plan and future studies.
Ultimately, this study will support DOP’s efforts to reduce opioid-involved fatal and non-fatal
overdoses in Nebraska.
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Introduction
Dataset Purpose
The purpose of the dataset analysis is to provide data on who is receiving treatment, who
is referring people to treatment, and people’s age at first use. The current report
emphasizes identifying quality datasets that can be useful now and in future evaluations.
Literature Review of Substance Use Indicators
Prior to considering the quality of secondary datasets, STEPs identified substance use indicators
commonly used by reputable public health agencies. Literature on health indicators consistently
referred to documents published by the Centers for Disease Control and Prevention (CDC), the
Substance Abuse and Mental Health Services Administration (SAMHSA), and the Council of State
and Territorial Epidemiologists (CSTE). STEPs weighed the prevalence of established substance
use indicators when determining the usefulness and quality of datasets.
The CSTE’s Recommended CSTE Surveillance Indicators for Substance Abuse and Mental Health
identified 10 substance use indicators recommended for use in surveillance systems (2019).
Five of these 10 indicators, included in the table below, target non-alcohol drug use.
Recommended Substance Use Indicators
(CSTE, 2019, p. 14)
Drug
overdose
mortality

Hospitalization
attributable to drugs
with potential for
abuse and dependence

Prescription
opioid sales
per capita

Drug or alcohol
dependence or
abuse in the last
year

Prevalence of
use of selected
prescription and
illicit drugs

The CSTE document references publications by the National Institutes of Health, U.S. DHHS, and
the CDC and has been endorsed by the National Public Health Surveillance System, U.S. DHHS,
and SAMHSA. The sources used in the development of the document and the endorsements
from other reputable organizations support the reliability of these surveillance indicators.
The United Nations Office on Drugs and Crime (2018), the Office of Disease Prevention and
Health Promotion (2020), and SAMHSA (2018) utilize similar indicators, except for the
hospitalization data and prescription opioid sales data. STEPs also assessed publications by the
CDC for relevant surveillance indicators. However, the CDC often targeted data related to alcohol
consumption and chronic diseases.
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Applying CDC’s Guidelines for Evaluating Public Health
Surveillance Systems
To determine quality datasets that can be used over time to understand drug use behavior in
Nebraska, STEPs utilized the CDC’s “Guidelines for Evaluating Public Health Surveillance
Systems.” The CDC guidelines outline nine assessment characteristics for public health
surveillance systems: simplicity, flexibility, data quality, acceptability, sensitivity, predictive
value positive, representativeness, timeliness, and stability. Of these characteristics, STEPs
prioritized those able to be assessed using publicly available information and those most
relevant to the DOP project. The selected characteristics, CDC definition, and STEPs’ application
of the characteristic can be found in the table below:
Applying CDC’s Guidelines for Evaluating Public Health Surveillance Systems
Characteristic
CDC Definition
STEPs’ Application
Simplicity
“Refers to both its structure and ease
STEPs prioritized datasets with
of operation. Surveillance systems
low barriers to access such as
should be as simple as possible while
publicness of the data, cost of data
still meeting their objectives” (CDC,
access, and accessible data
2001, Section D.2.a.)
formats.
Data quality
“The completeness and validity of the
STEPs prioritized datasets
data recorded in the public health
affiliated with leaders in
surveillance system” (CDC, 2001,
substance use expertise, such as
Section D.2.c.)
the CDC and SAMHSA, as found in
the literature review.
Representativeness “Accurately describes the occurrence of STEPs prioritized datasets providing
a health-related event over time and its place-specific data (such as those
distribution in the population by place able to be desegregated by county
and person” (CDC, 2001, Section D.2.g.) and local health department) and
demographic data.
Timeliness
“The speed between steps in a public
STEPs prioritized datasets that
health surveillance system” (CDC, 2001, publish data at least every two
Section D.2.h.)
years.
Stability
“Refers to the reliability (i.e., the ability STEPs prioritized datasets
to collect, manage, and provide data
published by reputable
properly without failure) and
organizations such as the Nebraska
availability (the ability to be operational Department of Health and Human
when it is needed) of the public health Services, as well as the CDC and
surveillance system” (CDC, 2001,
SAMHSA.
Section D.2.i.)
In addition to these characteristics, STEPs also prioritized datasets containing data not captured
in existing Nebraska DHHS reports, as well as datasets containing data closely aligned with the
CSTE Recommended Surveillance Indicators for Substance Abuse and Mental Health.
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Dataset Screening
STEPs identified 12 secondary datasets relevant to current and future evaluations. Utilizing the
previously outlined criteria, STEPs selected three quality datasets that can be used over time.
These selected datasets include the Nebraska Risk and Protective Factor Student Survey
(NRPFSS), Nebraska Hospital Association Hospital Discharge Data (HDD), and Treatment
Episode Data Set (TEDS). The tables on the following pages outline the datasets examined, their
purpose, and reason for inclusion or exclusion.
Dataset
State Emergency
Department
Databases (SEDD)
(Healthcare Cost
and Utilization
Project, 2019a)
State Inpatient
Databases (SID)
(Healthcare Cost
and Utilization
Project, 2019b)
Behavioral Risk
Factor Surveillance
System (BRFSS)
(National Center for
Chronic Disease
Prevention and
Health Promotion,
2019)
CDC WONDER
(Centers for Disease
Control and
Prevention, 2018)

Dataset Screening: Excluded from Analysis
Purpose
Exclusion Reason
SEDD, sponsored by the Agency
An alternative provider (Nebraska
for Healthcare Research and
Hospital Association) of
Quality, includes information on
emergency department discharge
those emergency department
data was recommended by DOP;
visits that do not result in
data was not publicly available.
admission to determine
longitudinal trends related to
emergency department visits.
SID, sponsored by the Agency for
An alternative provider (Nebraska
Healthcare Research and Quality,
Hospital Association) of inpatient
includes inpatient data for
discharge data was recommended
hospitals to determine
by DOP; data was not publicly
longitudinal trends related to
available.
inpatient care.
BRFSS, published by the CDC, is a
The information provided by BRFSS
collection of adult health surveys
included little direct alignment with
informing prevention and health
CSTE Recommended Surveillance
promotion efforts.
Indicators for Substance Abuse and
Mental Health.

CDC WONDER, published by the
CDC, is a collection of public health
data available to the general public.
CDC WONDER is intended to
promote data-driven decisions and
increase public access to public
health data.

Mortality-related data is already
sufficiently included in the NE
DHHS’ Division of Behavioral
Health’s Substance Use, Mental
Illness and Associated Consequences
in Nebraska: An Epidemiological
Profile report.
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Dataset Screening: Excluded from Analysis (cont.)
Dataset
Purpose
Exclusion Reason
National Survey of
N-SSATS, published by SAMHSA, is The information provided by NSubstance Abuse
a census of substance use
SSATS included little direct
Treatment Services
treatment providers. N-SSATS
alignment with CSTE Recommended
(N-SSATS)
aims to inform SAMHSA and state Surveillance Indicators for Substance
administrators on the trends and
Abuse and Mental Health.
(Substance Abuse
resource needs of treatment
and Mental Health
services.
Services
Administration,
2019)
National Survey on
NSDUH, published by SAMHSA,
Much of the publicly available data is
Drug Use and
determines the prevalence of
state-level only; this state-level data
Health (NSDUH)
substance use and mental health
is already sufficiently included in the
disorders and the receipt of care.
NE DHHS’ Division of Behavioral
(National Survey on
Health’s Substance Use, Mental
Drug Use and
Illness and Associated Consequences
Health, 2020)
in Nebraska: An Epidemiological
Profile report.
Pregnancy Risk
PRAMS, published by CDC, collects The information provided by NAssessment
data related to pre- and postnatal SSATS included little direct
Monitoring System
risk factors. PRAMS aims to
alignment with CSTE Recommended
(PRAMS)
identify at-risk populations and
Surveillance Indicators for Substance
capture state changes in the health Abuse and Mental Health.
(National Center for of mothers and infants.
Chronic Disease
Prevention and
Health Promotion,
2020)
Youth Risk Behavior YRBS, published by the CDC,
YRBS data is already sufficiently
Surveillance System collects information on the health included in the NE DHHS’ Division of
(YRBS)
behaviors of youth related to
Behavioral Health’s Substance Use,
causes of death and disability. The Mental Illness and Associated
(National Center for purpose of YRBS is to understand Consequences in Nebraska: An
HIV/AIDS, Viral
the prevalence and trends of youth Epidemiological Profile report.
Hepatitis, STD, and
health behaviors.
TB Prevention,
2018)
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Dataset
Nebraska Risk
and Protective
Factor Student
Survey
(NRPFSS)

Treatment
Episode Data
Set
Admissions
(TEDS-A)

Treatment
Episode Data
Set Discharges
(TEDS-D)

Nebraska
Hospital
Association
Statewide
Hospital
Emergency
Department
and Inpatient
Discharge
Data (HDD)

Dataset Screening: Included in Analysis
Purpose
Inclusion Reason
NRPFSS, published by BOSR- NRPFSS data is available through request at no
UNL, aims to assess
cost to researchers. Data is collected every other
students’ risk and protective fall with reports made available the following
factors related to substance
spring/summer. Data can be disaggregated by
use and other problem
health department district, grade, race, age, and
behaviors.
gender. Data is related to evaluation questions
regarding age of first substance use and trends
in youth substance use.
TEDS-A, published by
TEDS data is publicly available at no cost to
SAMHSA, captures
researchers. Data is from trusted sources such
admissions data to
as state-level administrative data and reported
substance use and mental
by SAMHSA, a leader in the field of substance
health treatment to better
use. Data can be disaggregated by location and
understand those receiving
demographic variable. Data is related to
behavioral health care.
evaluation questions and recommended
TEDS-D, published by
substance use indicators including access to and
SAMHSA, captures discharge referrals to substance use treatment. TEDS data
data from substance use and collection has remained relatively stable over
mental health treatment to
time allowing for year-by-year analyses.
better understand those
Additional state-level data was requested to
receiving behavioral health
provide more specific information about
care.
referral sources (see Data Analysis Plan
section).
HDD, published by the
HDD is available on request to researchers for a
Nebraska Hospital
small fee. This data source was referred to
Association is used to track
STEPs by DOP. Data can be disaggregated by
public health conditions and health department district, age, length of stay,
inform the development of
and gender. Data is related to evaluation
interventions.
questions and substance use indicators
including hospitalizations related to substance
use.
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Dataset Availability and Release
After identifying the quality datasets, STEPs assessed the recency of data available and the next
expected release of data. The following table outlines the data availability in the past 10 years,
the most recent data available, and the next release of new data.
Dataset Availability and Release
Years of Data
Most Recent Data
Dataset
Availability
Available
Nebraska Hospital
2016, 2017,
Fall 2019 data received
Association (NHA) Inpatient 2018, partial
in March 2020
Discharges
2019
Nebraska Hospital
2016, 2017,
Fall 2019 data received
Association (NHA)
2018, partial
in March 2020
Emergency Department
2019
Discharges
Nebraska Risk and
2010, 2012,
Fall 2018 data published
Protective Factor Student
2014, 2016,
in 2019
Survey (NRPFSS)
2018
Treatment Episode Data
Set Admissions (TEDS-A)
Treatment Episode Data
Set Discharges (TEDS-D)

2013, 2014,
2015, 2016,
2017
2013, 2014,
2015, 2016,
2017

Next Expected Data
Release
On request

On request

2017 admissions data
published in June 2019

Fall 2020 data will be
sent from BOSR-UNL
to DHHS in midspring 2021
Unknown; not
enough information

2017 discharge data
published in June 2019

Unknown; not
enough information
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The diagnosis description data provided by NHA included 297 unique diagnosis
descriptions. To analyze and interpret the diagnosis data, these unique descriptions needed
to be condensed into a smaller number of categories. Based on the information provided in
the diagnosis description, STEPs determined the most appropriate form of categorization
for the current project would be by substance classification. STEPs utilized the Drug
Enforcement Administration’s (2020) Drugs of Abuse: A DEA Resource Guide to determine
drug classes for each diagnosis substance. The substances named in the diagnoses
description and their associated categories are outlined in the table below.

Category

Diagnosis Description Substances

Cannabis

Cannabis, cannabis (derivatives)

Depressants

Antiepileptic and sedative-hypnotic drugs; barbiturates;
benzodiazepines; sedative, hypnotic or anxiolytic

Hallucinogens

Ecstasy, hallucinogen, lysergide, other psychodysleptics,
unspecified psychodysleptics

Narcotics

Heroin, methadone, opioid, opium, other narcotics, other
opioids, other synthetic narcotics, unspecified narcotics

No substance
specified*

Drug use complicating childbirth, drug use complicating
pregnancy, drug use complicating the puerperium,
neonatal withdrawal symptoms from maternal use of drugs
of addiction

Other psychoactive
substances

Other psychoactive substance

Stimulants

Amphetamines, caffeine, cocaine, methylphenidate, other
psychostimulant, other stimulant, unspecified
psychostimulants
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Below are additional data tables for the Nebraska Hospital Association (NHA) Inpatient
Discharges data.
Patient Sex by Year (n=3,329)
The trend for the percentage of female and male patients has remained relatively stable over
the past 4 years. 2019 was the only year where the percentage of males (51%) was greater than
that of females (49%).
% of Female
Patients

% of Male
Patients

2016 (n=824)

53%

47%

2017 (n=931)

53%

47%

2018 (n=911)

52%

48%

2019 (n=664)

49%

51%

Year

Patient Age in Years by Year (n=3,330)
The trend for patient age has remained stable over the past 4 years.
Year

Average Age
in Years

SD

2016 (n=824)

42

18

2017 (n=931)

41

17

2018 (n=911)

41

17

2019 (n=664)

41

17

Patient Length of Stay in Days by Year (n=3,330)
The trend for patients’ lengths of stay has remained stable over the past 4 years.

Year

Average
Length of Stay
in Days

SD

2016 (n=824)

4

4

2017 (n=931)

3

4

2018 (n=911)

4

4

2019 (n=664)

3

3
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Substance Related to Patient Diagnosis by Year (n=3,330)
Except for diagnoses related to depressants, narcotics, and stimulants (discussed within the
body of the report), the percentage of diagnoses related to other substances has remained
consistent over the past 4 years.
2016 (n=824) 2017 (n=931) 2018 (n=911) 2019 (n=664)

Depressants

36%

34%

32%

29%

Stimulants

21%

25%

27%

32%

Narcotics

28%

26%

25%

21%

Cannabis

3%

4%

4%

6%

Hallucinogens

1%

1%

2%

1%

Other psychoactive
substances

7%

6%

6%

8%

No substance specified*

3%

4%

5%

4%

Number of Inpatient Treatment Discharges by Behavioral Health Region and Year
(n=2,667)
The number of inpatient discharges between January 1 and September 30 of each year is
shown below for each behavioral health region. The comparison includes only discharges
during this time as quarter 4 data for 2019 was not yet available at the time of this report.
Behavioral Health
Region

2016

2017

2018

2019

Region 1 (n=83)

17

23

24

19

Region 2 (n=176)

37

47

38

54

Region 3 (n=250)

50

64

59

77

Region 4 (n=146)

35

49

28

34

Region 5 (n=536)

104

140

156

136

Region 6 (n=1,277)

319

330

336

292

Out of State (n=199)

46

48

55

50
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Percent of Female Patients by Behavioral Health Region and Year (n=3,324)
Overall, no trend related to the percentage of female patients by behavioral health region and
year can be discerned in this data.
Behavioral Health
Region

2016

2017

2018

2019

Region 1 (n=102)

30%

67%

30%

58%

Region 2 (n=218)

69%

60%

63%

44%

Region 3 (n=311)

52%

43%

43%

48%

Region 4 (n=191)

47%

64%

52%

44%

Region 5 (n=670)

43%

49%

47%

46%

Region 6 (n=1,582)

56%

55%

55%

51%

Out of State (n=250)

60%

46%

57%

54%

Patient Age by Behavioral Health Region and Year (n=3,325)
Overall, no trend related to the average age of patients by region and year can be discerned in
this data. One trend that may be emerging in Region 3 would be the decrease in average age,
which began in 2017.
Behavioral Health
Region

2016

2017

2018

2019

Region 1 (n=102)

37

40

34

46

Region 2 (n=218)

45

45

40

40

Region 3 (n=311)

39

42

40

37

Region 4 (n=191)

47

39

42

40

Region 5 (n=671)

40

39

41

39

Region 6 (n=1,582)

43

41

43

43

Out of State (n=250)

39

37

39

42

141

APPENDICES: Updated Dataset Results

Appendix K (cont.)
Patient Length of Stay in Days by Behavioral Health Region and Year (n=3,325)
Overall, no trend related to the average length of stay by region and year can be discerned in
this data.
Behavioral Health
Region

2016

2017

2018

2019

Region 1 (n=102)

3

3

3

5

Region 2 (n=218)

3

3

3

4

Region 3 (n=311)

5

4

4

3

Region 4 (n=191)

4

4

4

4

Region 5 (n=671)

3

3

4

3

Region 6 (n=1,582)

3

3

4

3

Out of State (n=250)

5

5

3

4

Substance Related to Diagnosis by Behavioral Health Region and Year
The tables below and on the following two pages show the percentage of inpatient discharges
related to each substance by year for each health region.
Region 1
2016
(n=23)

2017
(n=33)

2018
(n=27)

2019
(n=19)

All Discharges
(n=102)

Depressants

26%

36%

22%

58%

34%

Stimulants

30%

9%

19%

26%

20%

Narcotics

22%

21%

30%

5%

21%

Cannabis

4%

3%

7%

0%

4%

Other
psychoactive
substances

17%

3%

15%

0%

9%

No substance
specified

0%

27%

7%

11%

13%
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Region 2
2016
(n=54)

2017
(n=53)

2018
(n=57)

2019
(n=54)

All Discharges
(n=218)

Depressants

31%

34%

30%

28%

31%

Stimulants

11%

8%

25%

33%

19%

Narcotics

24%

32%

28%

17%

25%

Cannabis

4%

6%

2%

2%

3%

Other
psychoactive
substances

28%

21%

12%

17%

19%

No substance
specified

2%

0%

4%

4%

2%

Region 3
2016
(n=65)

2017
(n=77)

2018
(n=92)

2019
(n=77)

All Discharges
(n=311)

Depressants

37%

26%

21%

13%

23%

Stimulants

28%

44%

37%

58%

42%

Narcotics

25%

16%

22%

16%

19%

Cannabis

2%

4%

2%

4%

3%

Hallucinogens

2%

0%

2%

1%

1%

Other
psychoactive
substances

5%

6%

8%

3%

5%

No substance
specified

3%

4%

9%

5%

5%
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Region 4
2016
(n=49)

2017
(n=64)

2018
(n=44)

2019
(n=34)

All Discharges
(n=191)

Depressants

18%

27%

34%

24%

26%

Stimulants

20%

33%

23%

18%

25%

Narcotics

41%

19%

27%

21%

27%

Cannabis

2%

2%

2%

12%

4%

Hallucinogens

0%

2%

2%

0%

1%

Other
psychoactive
substances

16%

13%

9%

21%

14%

No substance
specified

2%

6%

2%

6%

4%

2016
(n=150)

2017
(n=192)

2018
(n=193)

2019
(n=136)

All Discharges
(n=671)

Depressants

36%

30%

34%

28%

32%

Stimulants

27%

27%

24%

38%

28%

Narcotics

26%

34%

28%

23%

28%

Cannabis

3%

2%

5%

3%

3%

Hallucinogens

1%

2%

1%

0%

1%

Other
psychoactive
substances

3%

3%

4%

7%

4%

No substance
specified

4%

4%

4%

2%

4%

Region 5
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Region 6
2016
(n=418)

2017
(n=449)

2018
(n=423)

2019
(n=292)

All Discharges
(n=1,582)

Depressants

38%

38%

34%

34%

36%

Stimulants

18%

22%

28%

24%

23%

Narcotics

32%

26%

24%

21%

26%

Cannabis

2%

6%

3%

9%

5%

Hallucinogens

1%

1%

2%

1%

1%

Other
psychoactive
substances

5%

5%

5%

7%

5%

No substance
specified

4%

2%

3%

4%

3%
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Below are additional data tables for the Nebraska Hospital Association (NHA) Emergency
Department Discharges data.
Patient Sex by Year (n=7,709)
The percentage of male patients increased slightly in 2017 and 2018. The percentage of male
and female patients in 2019 remained unchanged from 2018.
Year

% of Female
Patients

% of Male
Patients

2016 (n=1,938)

49%

51%

2017 (n=1,914)

48%

52%

2018 (n=2,185)

46%

54%

2019 (n=1,672)

46%

54%

Patient Age in Years by Year (n=7,712)
The trend for patient age has remained stable over the past 4 years.
Year

Average Age in
Years

SD

2016 (n=1,938)

34

17

2017 (n=1,914)

33

16

2018 (n=2,185)

34

16

2019 (n=1,675)

34

16

Patient Length of Stay in Days by Year (n=7,712)
The trend for patients’ lengths of stay has remained stable over the past 4 years.

Year

Average
Length of Stay
in Days

SD

2016 (n=1,938)

1

1

2017 (n=1,914)

1

0

2018 (n=2,185)

1

1

2019 (n=1,675)

1

0
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Substance Related to Diagnosis by Year (n=7,712)
Diagnoses related to depressants, narcotics, and stimulants, as discussed within the body of the
report, have changed over time. The percentage of diagnoses related to cannabis have
increased over time. The percentage of diagnoses related to other substances has remained
consistent over the past 4 years.

2016
(n=1,938)

2017
(n=1,914)

2018
(n=2,185)

2019
(n=1,675)

Depressants

22%

22%

20%

17%

Stimulants

25%

29%

33%

37%

Narcotics

25%

23%

20%

16%

Cannabis

9%

11%

12%

13%

Hallucinogens

2%

2%

2%

3%

17%

13%

13%

13%

0%

0%

1%

1%

Other psychoactive
substances
No substance specified*

Percent of Female Patients by Behavioral Health Region and Year (n=7,709)
Overall, no trend related to the percentage of female patients by behavioral health region and
year can be discerned in this data. However, it is worth noting Regions 2, 3, and 4 have
consistently had higher percentages of female than male patients, which differs from the overall
trend.
Behavioral Health
Region

2016

2017

2018

2019

Region 1 (n=362)

46%

54%

47%

48%

Region 2 (n=246)

67%

69%

55%

52%

Region 3 (n=741)

53%

56%

59%

51%

Region 4 (n=385)

61%

54%

55%

49%

Region 5 (n=1,851)

48%

43%

39%

44%

Region 6 (n=3,719)

46%

47%

46%

45%

Out of State (n=405)

50%

42%

40%

41%
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Appendix L (cont.)
Patient Age by Behavioral Health Region and Year (n=7,712)
Overall, no trend related to the average age of patients by region and year can be discerned in
this data.

Behavioral Health Region

2016

2017

2018

2019

Region 1 (n=362)

37

35

37

35

Region 2 (n=246)

35

37

38

36

Region 3 (n=741)

35

35

35

33

Region 4 (n=385)

36

34

37

34

Region 5 (n=1,853)

33

32

34

34

Region 6 (n=3,719)

33

33

33

34

Out of State (n=406)

35

34

33

34

Patient Length of Stay in Days by Behavioral Health Region and Year (n=7,712)
The average length of stay has not varied across behavioral health regions or years for the past
4 years.

Behavioral Health Region

2016

2017

2018

2019

Region 1 (n=362)

1

1

1

1

Region 2 (n=246)

1

1

1

1

Region 3 (n=741)

1

1

1

1

Region 4 (n=385)

1

1

1

1

Region 5 (n=1,853)

1

1

1

1

Region 6 (n=3,719)

1

1

1

1

Out of State (n=406)

1

1

1

1
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Appendix L (cont.)
Substance Related to Patient Diagnosis by Behavioral Health Region and Year
The tables on the following three pages show the percentage of emergency department
discharges related to each substance by year for each health region.
Region 1
2016
(n=112)

2017
(n=91)

2018
(n=96)

2019
(n=63)

All Discharges
(n=362)

Depressants

17%

20%

14%

27%

19%

Stimulants

29%

31%

18%

32%

27%

Narcotics

31%

32%

34%

22%

31%

Cannabis

15%

9%

15%

5%

12%

Hallucinogens

2%

0%

1%

5%

2%

Other
psychoactive
substances

6%

9%

19%

10%

11%

2017
(n=62)

2018
(n=75)

2019
(n=46)

All Discharges
(n=246)

Region 2
2016
(n=63)
Depressants

41%

34%

25%

33%

33%

Stimulants

19%

32%

27%

30%

27%

Narcotics

30%

24%

28%

22%

26%

Cannabis

3%

3%

5%

7%

4%

Other
psychoactive
substances

6%

6%

12%

9%

9%

No substance
specified

0%

0%

3%

0%

1%
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Region 3
2016
(n=207)

2017
(n=179)

2018
(n=204)

2019
(n=151)

All Discharges
(n=741)

Depressants

25%

31%

30%

24%

28%

Stimulants

25%

28%

26%

32%

28%

Narcotics

31%

19%

21%

18%

23%

Cannabis

7%

11%

11%

15%

11%

Hallucinogens

2%

1%

0%

1%

1%

Other
psychoactive
substances

11%

10%

11%

9%

10%

2016
(n=89)

2017
(n=109)

2018
(n=110)

2019
(n=77)

All Discharges
(n=385)

Region 4

Depressants

20%

18%

28%

22%

22%

Stimulants

24%

32%

30%

40%

31%

Narcotics

29%

27%

25%

12%

24%

Cannabis

8%

11%

5%

12%

9%

Hallucinogens

1%

0%

3%

4%

2%

Other
psychoactive
substances

17%

12%

9%

10%

12%

No substance
specified

1%

0%

0%

0%

0%
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Region 5
2016
(n=472)

2017
(n=460)

Depressants

22%

17%

Stimulants

26%

Narcotics

2018
(n=548)

2019
(n=373)

All Discharges
(n=1,853)

22%

15%

19%

28%

35%

35%

31%

19%

22%

17%

15%

18%

Cannabis

8%

10%

9%

8%

9%

Hallucinogens

2%

2%

1%

1%

2%

Other
psychoactive
substances

22%

22%

16%

25%

21%

No substance
specified

0%

0%

0%

1%

0%

2016
(n=880)

2017
(n=932)

2018
(n=1,030)

2019
(n=877)

All Discharges
(n=3,719)

Depressants

21%

23%

18%

15%

19%

Stimulants

25%

28%

35%

39%

32%

Narcotics

24%

24%

18%

14%

20%

Cannabis

10%

12%

13%

17%

13%

Hallucinogens

3%

3%

3%

4%

3%

Other
psychoactive
substances

17%

9%

11%

9%

12%

No substance
specified

0%

1%

1%

1%

1%

Region 6
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Appendix M
Below are additional data tables for the Treatment Episode Data Set–Discharges (TEDS-D).
Client Age at Admission by Year
Overall, no trend related to the age of clients by year can be discerned in this data. One trend
that may be emerging would be an increase in clients between the ages of 21 and 39 years.

Year

20 Years
and
Younger

21-29
Years

30-39
Years

40-49
Years

50 Years
and Older

2013 (n=10,103)

5%

26%

26%

24%

18%

2014 (n=8,275)

6%

27%

25%

21%

20%

2015 (n=8,831)

6%

28%

27%

21%

18%

2016 (n=13,198)

5%

28%

30%

20%

17%

2017 (n=10,162)

5%

28%

32%

19%

16%

Client Race by Year
Overall, no trend related to the race of clients by year can be discerned in this data. “Other”
race includes clients who identified as Alaska Native, Asian or Pacific Islander, Asian, other
single race, two or more races, and Native Hawaiian or Other Pacific Islander.

Year

White

Black or
African
American

American
Indian

Other

2013 (n=10,060)

78%

10%

9%

3%

2014 (n=8,251)

82%

8%

8%

2%

2015 (n=8,831)

81%

9%

7%

2%

2016 (n=12,873)

80%

10%

7%

4%

2017 (n=9,553)

77%

10%

7%

6%
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Appendix M (cont.)
Client Education by Year
Overall, no trend related to the number of school years completed by clients by year can be
discerned in this data. One trend that may be emerging would be an increase in clients who
have at least 12 years of education or a GED.

Year

12 Years
(or GED)

Less Than
12 Years

More Than
12 Years

2013 (n=9,483)

50%

20%

30%

2014 (n=7,569)

50%

18%

32%

2015 (n=7,998)

51%

18%

31%

2016 (n=11,449)

51%

18%

31%

2017 (n=7,752)

53%

18%

29%

Client Employment Status at Admission by Year
An increase in the percentage of clients who report employment at admission may be an
emerging trend.

Year

Full-time

Part-time

Unemployed

Not in Labor
Force

2013 (n=10,096)

16%

9%

34%

41%

2014 (n=8,272)

18%

9%

32%

40%

2015 (n=8,820)

20%

9%

31%

40%

2016 (n=12,449)

20%

9%

33%

38%

2017 (n=8,529)

22%

10%

32%

36%
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Appendix M (cont.)
Client Source of Income/Support by Year
Similar to the increase in employed clients, an increase in the percentage of clients who
reported receiving an income of wages or salary may be an emerging trend.

Year

Wages/
Salary

Public
Assistance

Retirement/
Pension,
Disability

Other

None

2013 (n=10,015)

29%

2%

10%

9%

49%

2014 (n=8,195)

31%

2%

8%

6%

53%

2015 (n=8,735)

32%

1%

7%

6%

54%

2016 (n=12,380)

32%

1%

5%

5%

57%

2017 (n=8,254)

34%

1%

5%

4%

56%

Client Length of Stay in Treatment (Days) by Year
The length of stay in treatment remained relatively constant between 2013 and 2017. A slight
decrease in clients staying in treatment for 1 day may be an emerging trend.
Year

1 Day

2-30 Days

31-90 Days

91 Days and Over

2013 (n=10,103)

35%

28%

18%

19%

2014 (n=8,275)

32%

28%

17%

23%

2015 (n=8,831)

29%

32%

18%

21%

2016 (n=13,198)

25%

29%

19%

26%

2017 (n=10,162)

27%

31%

23%

20%
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Appendix M (cont.)
Substance Use at Admission (Primary) by Year
Between 2013 and 2017, the rate of clients reporting alcohol as their primary substance
gradually decreased while reports of stimulant use gradually increased. The use of marijuana,
opioids, depressants, and other substances stayed relatively constant. “Other” includes
hallucinogens and over-the-counter medications.
Year

Alcohol

Depressants

Stimulants

Opioid

Marijuana

Other

None

2013
(n=10,062)

65%

0%

19%

4%

10%

0%

2%

2014
(n=8,262)

64%

0%

19%

4%

10%

1%

2%

2015
(n=8,820)

59%

0%

22%

5%

11%

1%

2%

2016
(n=13,176)

55%

0%

26%

4%

10%

1%

5%

2017
(n=10,159)

52%

0%

28%

4%

11%

0%

5%
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*Appendix N
Below is the additional data table for the detailed referral sources, as provided by NE DHHS
Division of Behavioral Health Data Centralized Data System.
Detailed Referral Source by Year
Overall, no trend related to the referral source by year can be discerned in this data. As
discussed in the body of the report, the greatest percentage of referrals came from the justice
system.
2013

2014

2015

2016

2017

(n=13,414)

(n=12,586)

(n=12,948)

(n=12,971)

(n=12,709)

Community:
Community/Social Services
Agency

2.9%

2.7%

2.5%

3.0%

3.7%

Community: Employer or
Employee Assistance
Program (EAP)

0.3%

0.3%

0.2%

0.2%

0.1%

Community: Family or Friend

3.6%

3.9%

4.0%

3.3%

2.6%

Community: Homeless
Shelter

0.5%

0.9%

0.9%

0.8%

0.7%

Community: Nebraska Family
Helpline

0.0%

0.0%

0.0%

0.0%

0.0%

Community: Nebraska
Vocational Rehabilitation

0.0%

0.0%

0.0%

0.0%

0.0%

Community: School

0.6%

0.5%

0.4%

0.3%

0.2%

Community: Self-Help Group

0.2%

0.2%

0.1%

0.2%

0.2%

Community: Tribal Elder or
Official

0.0%

0.0%

0.0%

0.0%

0.0%

Emergency/Crisis MH
Services

0.2%

0.1%

0.1%

0.3%

0.7%

Emergency/Crisis SUD
Services

2.6%

2.6%

2.4%

1.9%

1.4%

Justice System: Pre-trial
Diversion

0.4%

0.5%

0.5%

0.3%

0.3%

Justice System: Corrections

1.0%

1.2%

1.5%

1.0%

1.0%

Referral Source
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*Appendix N (cont.)
2013

2014

2015

2016

2017

(n=13,414)

(n=12,586)

(n=12,948)

(n=12,971)

(n=12,709)

Justice System: Court Order

5.0%

4.5%

4.5%

5.1%

4.6%

Justice System: Court Referral

2.1%

1.8%

1.3%

1.8%

1.1%

Justice System: Defense
Attorney

5.4%

5.6%

5.4%

4.7%

5.0%

Justice System: Drug Court

1.3%

1.8%

1.6%

1.6%

1.1%

Justice System: Law
Enforcement Agency (e.g.
Police/Sheriff/Highway
Patrol)

26.8%

28.9%

27.3%

26.8%

26.2%

Justice System: Mental Health
Court

0.1%

0.1%

0.1%

0.1%

0.0%

Justice System: Parole

1.0%

1.1%

1.5%

1.9%

1.5%

Justice System: Probation

7.6%

8.2%

8.2%

8.9%

9.8%

Justice System: Prosecutor

0.0%

0.0%

0.1%

0.1%

0.0%

MH Commitment Board

1.1%

0.9%

0.9%

0.7%

0.5%

Not Available

0.4%

0.5%

0.6%

3.7%

7.4%

Other

0.0%

0.0%

0.0%

1.9%

2.0%

Provider: Medical/Health
Care Provider

4.0%

3.7%

3.4%

2.6%

2.5%

Provider: MH Services
Provider

1.0%

0.6%

0.8%

1.1%

1.1%

Provider: SUD Services
Provider

10.3%

10.6%

10.3%

9.2%

8.6%

Regional Behavioral Health
Authority

0.0%

0.0%

0.0%

0.0%

0.0%

Regional Center/State
Psychiatric Hospital

0.2%

0.1%

0.1%

0.3%

0.1%

21.4%

18.9%

21.1%

18.2%

17.2%

Referral Source

Self (e.g. Self/Internet/Yellow
Pages)
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*Appendix O
Below are the additional data tables for the Nebraska Risk and Protective Factor Student
Survey.
Percentage of Youth Identifying as Female Lifetime Substance Use by Substance and Year
Overall, no trend related to the reported lifetime use by substance and year could be discerned
in this data. The greatest percentage of youth identifying as female reported using prescription
drugs and inhalants.

Year

LSD/Other
Psychedelics

Cocaine/Crack

Meth

Inhalants

Prescription
Drugs

2010

2%

1%

1%

6%

7%

2012

1%

1%

1%

5%

5%

2014

2%

1%

1%

4%

5%

2016

2%

1%

0%

3%

6%

2018

2%

1%

1%

4%

5%

Percentage of Youth Identifying as Male Lifetime Substance Use by Substance and Year
Overall, no trend related to the reported lifetime use by substance and year could be discerned
in this data. The greatest percentage of youth identifying as male reported using prescription
drugs and inhalants.

Year

LSD/Other
Psychedelics

Cocaine/Crack

Meth

Inhalants

Prescription
Drugs

2010

2%

2%

1%

6%

7%

2012

2%

1%

1%

4%

5%

2014

2%

2%

1%

3%

4%

2016

3%

2%

1%

3%

5%

2018

3%

1%

0%

4%

4%
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Appendix P: Full Methodology
Purpose
The purpose of the qualitative component of the Drug Use Behaviors project was to provide NE
DHHS with rich and in-depth information regarding the professional experiences and needs of
drug treatment providers in Nebraska. From the perspectives and insights of drug treatment
providers, NE DHHS can better understand the experiences and needs of people with substance
use disorders in Nebraska.
Through semi-structured interviews, STEPs collected qualitative data from drug treatment
providers in Nebraska. STEPs analyzed the data to identify information and themes relevant to
the NE DHHS Drug Overdose Prevention program. The analysis answered two primary
questions:
1. What insights regarding drug use behaviors do drug treatment providers in Nebraska
have that may inform drug use prevention planning?
2. What are the professional needs of drug treatment providers in Nebraska?

Sampling
Through the survey component of the Drug Use Behaviors project, 77 drug treatment providers
in Nebraska identified that they were willing to participate in a follow-up study and provided
an email address for follow-up. These providers formed the sample pool for the qualitative
component.
STEPs’ initial sampling procedure called for all potential participants to be grouped by the
primary behavioral health region that they serve and for potential participants to be randomly
selected from each regional group for an interview request. The purpose of these sampling
procedures was to maximize geographic representation within the qualitative component
while providing a systematic process for contacting and scheduling interviews with potential
participants. These procedures were designed to allow for theoretical sampling (Charmaz,
2014), an iterative process of simultaneous data collection and initial coding. In theoretical
sampling, rounds of data collection and initial coding continue until the emergent codes and
categories are saturated, at which point data collection is complete. While there can be
significant variability, saturation generally occurs between 15 and 30 participants.

Using this procedure, STEPs sent out an initial interview request to 17 potential participants on
April 2, 2020. After 10 days, we had received one decline and no response from the rest of the
potential participants. This was a very low response rate, especially from a pool of potential
participants who had recently completed another evaluation and had indicated interest in
participating in future studies. Many factors may have affected potential participants' ability or
willingness to respond and complete an interview. However, STEPs staff speculated that the
growing threat and realities of the COVID-19 pandemic, which was emerging at the same time
as participant recruitment was taking place, may have been a particularly salient factor. 159
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Appendix P: Full Methodology (cont.)
At this point, STEPs staff judged that potential risks of the initial sampling procedure–
inadequate sample size and delayed data collection–outweighed the potential benefits–
maximizing geographic diversity and avoiding over-saturation. In place of the original sampling
procedures, STEPs staff implemented a new procedure that called for all potential participants
to be contacted with an interview request and to schedule all interviews at the participants’
earliest convenience. Between April 13, 2020 and April 18, 2020, all potential participants were
sent an interview request, including a follow-up request to the initial potential participant
group. On May 13, 2020 all potential participants were sent a follow-up request.
After implementing the new sampling protocol, STEPs received more responses from potential
participants. It may have been that the new sampling procedure was better suited to quickly
identify interested participants, which the previous procedure would have slowly identified
over multiple rounds of targeted recruitment. It is also possible that potential participants had
better adjusted to the new realities of the pandemic at this point and had greater capacity to
participate. In total, STEPs conducted 17 interviews with 18 participants between the dates of
April 29, 2020 and June 2, 2020. See Appendix B for interview request template and Appendix
C for the consent handout.
Data Collection
STEPs conducted semi-structured interviews to collect data for the qualitative component.
STEPs conducted interviews over Zoom, an online videoconferencing service, at a time that was
convenient for participants. Both qualitative researchers and research participants have found
Zoom to be a highly satisfactory method of conducting interviews, highlighting its convenience
and user-friendliness (Archibald, Ambagtsheer, Casey, & Lawless, 2019). STEPs scheduled all
interviews for 30 minutes. Actual interview times ranged from 24 minutes to 46 minutes, with
an average interview time of 34 minutes. STEPs audio recorded the interviews and all
interviews were professionally transcribed to ensure accuracy for analysis.
The STEPs interviewer was guided by the interview protocol (see Appendix D). STEPs staff
collaboratively developed the interview protocol, drawing on multiple conversations with the
NE DHHS Drug Overdose Prevention Program staff to identify their information goals and
needs. The interview protocol was designed to facilitate a conversation with participants
around their professional experiences and needs, the experiences and needs of their clients
with substance use disorders, the participants’ thoughts and ideas on how to reduce drug
overdoses in Nebraska, as well as their needs regarding and perceptions of NE DHHS. The
interview protocol consisted of six primary questions and multiple, tentative follow-up
questions. The STEPs interviewer engaged participants consistently with the six primary
questions, but was flexible in follow-up questions in order to elicit data that was both relevant
and rich.
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Appendix P: Full Methodology (cont.)
Sample Description
The sample pool for the qualitative component came from a subsect of participants from the
quantitative survey component of the Drug Use Behaviors project. The two samples share
common parameters, such as being comprised entirely of substance use treatment providers in
Nebraska. Substance use treatment providers support individuals’ ability to understand and
overcome their substance use disorder and maintain recovery.
Providers Offer
• Intake, assessment, and treatment planning,
• Counseling for individuals, groups, and significant others,
• Case management and crisis intervention, and
• Referrals to medical providers and other professionals when appropriate.
Providers Support
• Individuals with substance use, mental health, or co-occurring disorders, and
• Clients in self-help recovery groups, outpatient treatment, intensive outpatient
treatment, residential or inpatient treatment, or continuing care.
Common Licenses Held by Providers
• Licensed or Provisionally Licensed Alcohol and Drug Counselor (LADC/PLADC),
• Licensed Mental Health Practitioner (LMHP), and
• Licensed Independent Clinical Social Worker (LICSW).

Substance Use
Treatment Providers
• Provide therapy, crisis
counseling, and case
management
• Include social workers,
counselors, and case
managers
• Refer to medical
providers for physical
health needs

Both
• Involved in
substance use
treatment
programs and
treatment planning
• Collaborate with
other professionals
to meet client
needs

Medical Providers
• Prescribe medication;
provide medical care
• Includes doctors,
psychiatrists, physicians
assistants, nurses and nurse
practitioners
• Refer to substance use
treatment providers for
mental and emotional
health needs
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Years of Experience
Participants varied in length of experience from 1 year to 33 years. On average, participants
indicated working in the field of substance abuse treatment for 10 years. In some cases, years
working in the field included roles other than direct treatment provision, such as
administration or case management.

Least Years of
Experience:

Average Years of
Experience:

Most Years of
Experience:

1

10

33

Range of experience
Licenses Held
Participants held a variety of licenses. The most frequently held were Licensed Alcohol and
Drug Counselor (LADC) and Licensed Independent Mental Health Practitioner (LIMHP). The
table below illustrates the variety of licenses held by participants. Similar to the quantitative
survey respondent demographics, LIMHP, LMHP, and LPC were the most frequently held license
besides LADC and PLADC.

License Type

Total

Licensed Alcohol and Drug Counselor

11

Licensed Independent Mental Health Practitioner

10

Licensed Mental Health Practitioner

7

Provisional Licensed Alcohol and Drug Counselor

6

Licensed Professional Counselor

4

Licensed Master Social Worker

3

Provisional Licensed Mental Health Practitioner

2

Osteopathic Physician and Surgeon

1

Provisional Dispensing Practitioner Pharmacy License

1
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Appendix P: Full Methodology (cont.)
Geographic Regions Served
STEPS identified four geographic regions for the purpose of the report: West, Rural East,
Omaha Metro, and Lancaster. The number in each region represents the number of participants
who provided services in each region. Some participants provided services in multiple regions.
The most frequently served region within the sample was Lancaster County and the Omaha
Metro.

West – 2
Rural East – 5
Omaha Metro – 8
Lancaster – 8

Practice Settings and Roles
Participants represented a variety of practice settings and roles. These settings included
nonprofits, private practice, corrections, residential treatment, and hospitals. Participants’
roles in their agencies included clinical director, clinical supervisor, community outreach,
outpatient therapist providing evaluations and treatment, and intake coordinator, and medical
provider. Many participants played multiple roles within their agency such as clinical
supervisor and outpatient therapist.
Field
• Substance Abuse
Treatment

Practice Settings
•
•
•
•
•

Nonprofit
Private practice
Corrections
Residential treatment
Hospital

Roles
•
•
•
•
•

Clinician
Clinical Director
Clinical Supervisor
Community Outreach
Intake Coordinator
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Appendix P: Full Methodology (cont.)
Data Analysis
STEPs analyzed the data using the methods of constructivist grounded theory (Charmaz, 2014).
While the purpose of the project is not to develop theory, the stages of initial coding, focused
coding and categorization, and theory development provided structure and rigor to the data
analysis process.

In the initial coding stage, two STEPs staff independently coded the interview transcripts. The
goal at the initial coding stage was to identify significant statements with tentative codes. STEPs
prioritized the use of gerund coding, using verbs that end in “–ing” in order to capture action
within the data. Descriptive coding, which labeled data based on the topic or theme, and in-vivo
coding, which labeled data using the participants’ own words, were also used when
appropriate. STEPs’ use of multiple coding strategies allowed a flexible approach to the data
and, in combination with multiple coders, allowed the construction of a wide variety of initial
codes for subsequent rounds of analysis.
From the initial coding stage, STEPs staff progressed to focused coding and categorization. In
this stage, STEPs staff identified and clustered initial codes that were conceptually similar or
overlapping. Within these emergent categories, redundant initial codes were merged and new,
overarching codes were developed for overlapping, but conceptually distinct, initial codes.
STEPs staff then reviewed all the categories and codes and, through a consensus process,
identified the categories and codes that were most crucial to telling the authentic narrative of
the data. Guiding questions included, “Is this code necessary to tell the story of the data?” and
“Would our report be incomplete without this code?” and “Would our participants be surprised
or disappointed if they read our report and didn’t see this?” These questions pushed STEPs
staff to elevate categories and codes with the greatest relevance, insight, and analytic power.
After the focused coding and categorization stage, STEPs staff engaged in a theory development
stage. The purpose of this stage was not to develop a theory in the traditional sense, but to
identify meaningful relationships between the categories and codes that could tell a narrative
about the data. Guiding questions within this stage included “What codes have led to this
code?” and “What codes are caused by this code?” and “What codes could address this code?”
As STEPs staff identified and developed relationships between categories and codes,
disconfirming evidence and dissenting voices were identified within the data. STEPs also
sought to identify how diverse identities, experiences, and contexts might affect the
relationships. STEPs specifically looked for codes and data that addressed the role of race,
socioeconomic status, gender and parenting status, and geography.
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Appendix P: Full Methodology (cont.)
STEPs then reviewed the focused codes, categories, and relationships and elevated some,
guided by similar questions as in the previous round of elevating.
Additionally, in this round, STEPs looked specifically for focused codes, categories, and
relationships that may be actionable in some way by the Drug Overdose Prevention program or
other stakeholders. STEPs staff developed recommendations based on these focused codes,
categories, and relationships.
Throughout this process, STEPs staff used MAXQDA software to facilitate data analysis. STEPs
used a two-coder system with all data initially coded independently. The two coders
collaborated and sought consensus in all subsequent stages. While the data analysis involved
progressive stages of analysis, the process was not strictly linear. At all stages of data analysis,
STEPs staff engaged in memoing, in which they captured initial impressions and
understandings of the data, including tentative ideas and hunches regarding later stages of data
analysis. These memos were consulted throughout the data analysis process.

Initial Coding

Focused Coding
and
Categorization

Theory Building

Memoing Throughout
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Appendix Q: Interview Request Template
Initial Email to Treatment Providers
Hello ______________.
Thank you for your recent participation in the Drug Use Behaviors Treatment Provider Survey!
At the conclusion of that survey, you indicated your willingness to participate in a follow-up
interview. We are excited to include you in this portion of our project, and we are thankful for
your interest in sharing your time and experience with us.
The Nebraska Department of Health and Human Services (DHHS) Division of Public Health has
contracted with the University of Nebraska at Omaha’s STEPs (Support and Training for the
Evaluation of Programs) to conduct follow-up interviews with select treatment providers
across Nebraska. The purpose of these interviews is to hear directly the voices and
experiences of outpatient treatment providers on issues relevant to drug overdose prevention
in Nebraska. Participating in this interview is an opportunity for your agency to confidentially
share your perspectives and needs with Nebraska DHHS and other relevant stakeholders.
Interviews will be scheduled at a time that is convenient for you, and they will take place over
Zoom, an online videoconferencing service. Zoom is user-friendly and participants can
connect via internet or phone, so there is no travel, no software, and no camera required. We
anticipate the interview will take approximately 30 minutes. More information can be found in
the consent document attached to this email.
If you are still willing and able to participate in the follow-up interview portion of our project,
please confirm by responding to this email by XX.XX.2020. Please include in your response 2-3
dates/times that would work best for you within the date range of XX.XX.2020 to XX.XX.2020.
We look forward to hearing from you.
If you have any questions, please contact steps@unomaha.edu.
Thank you,
[STEPs staff]
402.554.3663
steps@unomaha.edu
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Appendix R: Consent Handout
Consenting Information
Drug Use Behaviors
Treatment Provider Interviews
Thank you for your interest in participating in a treatment provider interview. Interviews are
being conducted through the Support and Training of the Evaluation of Programs (STEPs) at
the University of Nebraska at Omaha. Nebraska Department of Health and Human Services
(NE DHHS) Division of Public Health has contracted with STEPs to complete a needs
assessment for the Drug Overdose Prevention (DOP) Program. The purpose of the DOP Drug
Use Behaviors project is to equip NE DHHS with the information necessary to develop effective
drug use prevention plans, as well as provide relevant trainings and resources for treatment
providers. Hearing directly from treatment providers is crucial to the development of those
plans.
What will happen during the interview?
The interview will last approximately 30 minutes. The interview will be scheduled at a time
that is convenient for you and will take place over Zoom, an online videoconferencing service.
Zoom is user friendly and participants can connect over the internet or by phone, no software
or camera required. A link and phone number to connect with Zoom will be emailed to you
prior to your interview. The interview will consist of several open-ended questions regarding
your professional experiences and perspectives on drug use behaviors in Nebraska. You can
opt out of any question or opt out of the interview at any time. STEPs will record the interview
in order to best capture your perspectives and have a transcript of our conversation.
What will happen after the interview?
STEPs will analyze the transcript, along with the transcripts from other interviews, in order to
develop a report. Your participation in the interview will be kept confidential and no
personally identifying information will be included in the report. The report will be given to
NE DHHS, who may distribute it to relevant stakeholders. At your request, a copy of the report
can also be made available to you.
Why should I participate?
There are no direct, material benefits or incentives for you participating in the interview.
However, by sharing your professional experiences and perspectives, you can ensure that your
voice is heard by NE DHHS and other stakeholders as they develop plans relevant to your
work. By including the voices of treatment providers, we hope to improve drug overdose
prevention and treatment efforts in Nebraska.
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Appendix R: Consent Handout (cont.)
Consenting Information (cont.)
If I have questions about the interview, who can I ask?
If you have any questions prior to or after the interview, you can contact STEPs:
Liam Heerten-Rodriguez, PhD
STEPs Faculty Affiliate
6001 Dodge Street, CPACS 206
Omaha, NE 68182
Phone: 402.554.2891
Email: lheerten2@unomaha.edu
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Appendix S: Full Interview Protocol
Interview Protocol
1. Please tell me a little about your professional role involving drug treatment.
• How long have you been doing this work?
• How have things changed since you started in the field?
2. Please tell me a little about the clients that you serve.
• Would you say that there’s any “typical” story among your clients? Or something that
all or most of them have in common?
• When you think about your clients’ strengths, what comes to mind?
• What do you think your clients would want NE DHHS to know about them or their
experiences?
• NE DHHS is especially interested the experiences and needs of women of
childbearing age. In what ways, if any, are their experiences or needs different than
those of other clients?
3. Please tell me about a time when you could have done your job better if you had the
resources that you needed,
• Resources might include things like information or research, training, services, or
policies.
• What would have been different if you had had that resource?
• Why do you think you don’t have access to that resource?
4. What’s one change to the current system that you believe would reduce drug overdoses?
• Why do you think that change would be effective?
• Who do you believe is responsible for making that change?
• How likely do you think the change is?
• What barriers do you think stand in the way of the change?
• Are there any current opportunities that might make the change more likely?
5. What would it look like if NE DHHS were to be a full partner to you in your work?
• How would that be different from how you perceive their current role?
• What impact do you think that would have on your clients or on drug overdoses?
6. What else would you like NE DHHS to know?
• Why do you want them to know that?
• What do you want them to do differently because of that information?
• How will you know that DHHS has gotten your message?
* The bulleted prompts listed after each question are meant to be flexible guides to help keep
the conversation going and to dig deeper into what the interviewee is sharing. Not all prompts
need to be asked. We may also need to ask prompts that are not listed here. The goal is always
to dig deeper, eliciting stories, examples, and meaning from the interviewee. At any point in
the interview in which the experiences or needs of women of a childbearing age might be
relevant, we will ask specific follow-up questions.
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